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Abstract  
This thesis focused on the provision of economic support to improve the outcomes of patients on TB 
treatment. Although the association between poverty and tuberculosis is generally acknowledged, there 
is little evidence to guide the use of economic interventions to improve tuberculosis control. In South 
Africa, a high burden country with extensive poverty, such evidence is particularly important.  
The first part of this thesis is a Cochrane systematic review of evidence from randomized controlled 
trials regarding the effectiveness of economic support among patients with tuberculosis. Eleven trials 
were included: ten conducted among marginalised groups in the United States on economic support for 
people on prophylactic treatment for latent TB; and one from Timor-Leste on economic support for 
patients with active TB. The review found that the use of economic interventions in patients with latent 
TB may increase the return rate for reading tuberculin skin test results, probably improves clinic re-
attendance for initiation or continuation of prophylaxis and may improve completion of prophylaxis, 
compared to normal care. However, it is uncertain if economic support improves treatment completion 
in patients with active TB (low quality evidence). 
The second part of the thesis reports the findings of a pragmatic, cluster randomized controlled trial to 
evaluate the feasibility and effectiveness of delivering economic support to patients on treatment for 
active TB in South Africa. Patients with drug sensitive pulmonary TB were offered a monthly voucher 
valued at ZAR120 until completion of treatment or a maximum of eight months. Patients in control 
clinics received usual TB care. A parallel process evaluation provided contextual information to explain 
the trial findings. The qualitative component of this evaluation consisted of in-depth interviews with a 
sample of trial participants, including patients, nurses and health managers, to assess responses to the 
voucher and its administration. The quantitative component included a survey of patients’ household 
expenditure to assess patients’ levels of poverty and the effects of the voucher on these, and an analysis 
of the goods on which patients spent their vouchers. 
4091 patients were included in the trial: 1984 in the control arm (10 clinics) and 2107 in the intervention 
arm (10 clinics). Intention to treat analysis showed a small but non-significant improvement in 
treatment success rates in intervention clinics (intervention 76.2%; control 70.7%; risk difference 5.6%  
(-1.2; 12.3%), p = 0.107). Fidelity to the intervention was low, partly because nurses preferred to issue 
vouchers based on perceived financial need, rather than on eligibility. Logistical difficulties in delivering 
vouchers to clinics also undermined fidelity. The vouchers did not significantly increase patients’ 
household expenditure, but were experienced by patients as helpful, especially in providing more food 
with which to take their tablets. 
Factors related to the administration of economic support may undermine its effectiveness in improving 
TB treatment outcomes. Further research is needed to explore how best to deliver such economic 
support to those eligible to receive it, particularly in low and middle income countries where the burden 
of tuberculosis is highest.  
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Opsomming 
 
Hierdie tesis was toegespits op die verlening van ekonomiese steun om die uitkomste van pasiënte op 
tuberkulose- (TB-) behandeling te verbeter. Hoewel die verband tussen armoede en TB in die algemeen 
erken word, is daar nie veel bewyse om die gebruik van ekonomiese intervensies ter verbetering van TB-
beheer te staaf nie. In Suid-Afrika – ’n land met ’n hoë TB-las en wydverspreide armoede – is sulke 
bewyse veral belangrik.  
Die eerste deel van hierdie tesis behels ’n sistematiese Cochrane-oorweging van bewysmateriaal 
afkomstig van verewekansigde, gekontroleerde proewe oor die doeltreffendheid van ekonomiese steun 
aan pasiënte met tuberkulose.  
Altesame 11 proewe is ingesluit: Tien is gedoen onder gemarginaliseerde groepe in die Verenigde State 
met die fokus op ekonomiese ondersteuning aan mense wat profilaktiese behandeling vir latente TB 
ontvang het. Een, van Timor-Leste, was gefokus op ekonomiese ondersteuning aan pasiënte met 
aktiewe tuberkulose. Die ondersoek het aan die lig gebring dat, vergeleke met normale sorg, die gebruik 
van ekonomiese intervensies by pasiënte met latente tuberkulose tog die omdraaikoers vir die lees van 
tuberkulien-veltoetsresultate kan verhoog, waarskynlik hertoelating tot klinieke vir die inisiëring of 
voortsetting van profilakse verbeter, en die voltooiing van profilakse kan verbeter.   
Die tweede gedeelte van die tesis behels ’n verslag oor die bevindings van ’n pragmatiese,  
trosverewekansigde gekontroleerde proef, om te bepaal hoe doenlik en doeltreffend dit sou wees om 
ekonomiese steun te verleen aan pasiënte wat in Suid-Afrika vir aktiewe tuberkulose behandel word. 
Pasiënte met middelsensitiewe pulmonêre tuberkulose het tot en met die voltooiing van hul 
behandeling, of tot ’n maksimum van agt maande, ’n maandelikse koopbewys ter waarde van ZAR120 
ontvang. Pasiënte in kontroleklinieke het die gewone TB-sorg ontvang. ’n Parallelle prosesevaluering het 
kontekstuele inligting voorsien ter verklaring van die bevindinge van die proef. Die kwalitatiewe 
komponent van hierdie evaluering het bestaan uit diepte-onderhoude met ’n steekproef van alle 
deelnemers aan die proefneming, insluitend pasiënte, verpleegpersoneel en gesondheidsbestuurders, 
om hul reaksies te bepaal op die koopbewys self sowel as op die administrasie daarvan. Die 
kwantitatiewe komponent het ’n opname oor pasiënte se huishoudelike besteding ingesluit, ter 
vasstelling van hul armoedevlak en die moontlike uitwerking van die koopbewys daarop, asook ’n 
ontleding van die goedere waarop pasiënte hul koopbewyse bestee het. 
Altesame 4 091 pasiënte is by die proef ingesluit – 1 984 in die kontrole-afdeling (10 klinieke) en 2 107 in 
die intervensie-afdeling (10 klinieke). ’n Voorneme-om-te-behandel- (ITT-) ontleding toon ’n klein dog 
nie-betekenisvolle verbetering in behandelingsuksessyfers in intervensieklinieke (intervensie 76,2%; 
kontrole 70,7%; risikoverskil 5,6% (-1,2; 12,3%), p = 0.107). Getrouheid aan die intervensie was laag – 
deels omdat verpleegkundiges verkies het om die koopbewyse op grond van veronderstelde finansiële 
behoeftigheid eerder as volgens die studiekriteria uit te deel. Die koopbewyse het nie pasiënte se 
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huishoudelike besteding beduidend verhoog nie, maar pasiënte het dit wél as nuttig ervaar, veral omdat 
hulle daarmee meer kos kon koop om saam met hul pille in te neem. 
Faktore wat verband hou met die administrasie van ekonomiese ondersteuning kan die 
doeltreffendheid van sodanige steun in die verbetering van TB-behandelingsuitkomste ondermyn. 
Verdere navorsing word vereis om te verken wat die beste manier sou wees om sodanige ekonomiese 
steun te bied aan diegene wat daarvoor in aanmerking kom, veral in lae- en middel-inkomstelande, waar 
die TB-las die hoogste is. 
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Definition of terms 
 
Absolute poverty: The lack of the minimum level of material goods (food, shelter etc) that are 
necessary to sustain life in the purely biological sense (Alcock 2006: 64) 
Active tuberculosis: “a disease that is caused by Mycobacterium tuberculosis or other members 
of the Mycobacterium tuberculosis complex family in any part of the body and that is in an 
active state as determined by either: 
1) A smear or culture taken from any source in the person’s body tests positive for tuberculosis 
and the person has not completed the appropriate prescribed course of medication for active 
tuberculosis disease. 
2) Radiographic, current clinical, or laboratory evidence is sufficient to support a medical 
diagnosis of tuberculosis for which treatment is indicated.” (CDC 2011) 
Adherence: The extent to which patients follow the instructions they are given for taking their 
prescribed medications (Haynes et al 2008)  
Catastrophic health expenditure: “… when a household must reduce its basic expenditure over 
a period of time to cope with health costs” with reductions of between 5% and 20% being used 
as illustration in various studies (Xu et al 2003) 
Chronic poverty: “when an individual experiences significant capability deprivations for a period 
of five years or more” (Hulme and Shepherd 2003)  
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Conditional cash transfers: “regular, predictable amounts of money given to households and 
individuals by governmental or non-governmental agencies” (Forde et al 2011). 
 
Deprivation: “the effects of poverty on one’s life”, similar in meaning to the term “multi-
dimensional poverty” which acknowledges the multi-faceted nature of poverty as being more 
than lack of material goods (Friedman and Bhengu 2008: 201) 
DOTS supporters (Directly Observed Treatment Supporters): community-based lay health 
workers who assist the TB Control Programme in various ways; most importantly in the context 
of this trial, DOTS supporters observed treatment taking and verified patients’ adherence (Dick 
et al 2005) 
DOTS Strategy: The Directly Observed Treatment, Short Course Strategy is the strategy 
recommended by the World Health Organisation internationally for TB control. It consists of 
five components: Sustained political and financial commitment; Diagnosis by quality ensured 
sputum-smear microscopy; Standardized short-course anti-TB treatment (SCC) given under 
direct and supportive observation (DOT); A regular, uninterrupted supply of high quality anti-TB 
drugs; and Standardized recording and reporting. (WHO 2006) 
Economic incentive (see also material incentive): An incentive that makes a positive economic 
impact on the patient’s life, and that can be quantified in monetary terms; for example, cash, 
vouchers or food. Economic incentives can be direct, such as the former examples, or indirect, 
such as the provision of a service for free, for which the patient would otherwise have had to 
pay.  
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Economic shock: A “sudden and substantial decline in the level of economic activity” (Weeks 
and Drengacz 1982) 
Enabler: Financial or material assistance to help patients overcome barriers to accessing and 
completing treatment (Lutge et al 2012)  
Food security: “access to food, adequate in quantity and quality, to fulfill all nutritional 
requirements for all household members throughout the year” (Jonsson and Toole 1991).  
Household: “a person or group of persons who usually live and eat together, sharing the same 
housing unit, facilities and food” (Nzimande 2010: 13). 
Incentive: “any financial or material reward that patients and/or providers receive, conditional 
on their explicitly measured performance or behaviour” (Beith et al 2007). 
Latent tuberculosis: “the presence of Mycobacterium tuberculosis bacteria in the body as 
evidenced by a significant reaction to a Mantoux tuberculin skin test or positive interferon 
gamma release assay. A person with latent TB infection does not have an illness nor is he or she 
infectious” (CDC 2011) 
Material incentive (see also economic incentive): a physical incentive that has monetary value 
and can be quantified in economic terms.  
Poverty alleviation: Bringing people closer to the poverty line (Booysen 2004) 
Poverty eradication: Lifting people out of poverty (Booysen 2004) 
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Poverty gap: “… the difference between each poor household’s income and the poverty line. 
Thus, it measures the depth of poverty of each poor household. The aggregate poverty gap is 
calculated by summing the poverty gaps of each poor household. Therefore, it is equivalent to 
the total amount by which the incomes of poor households need to be raised each year to bring 
all households up to the poverty line and, hence, out of poverty” (SARPN 2004) 
Poverty headcount ratio: The “proportion of the poor in the total population” (Subramanian 
2005) 
Poverty line: a level of income or expenditure below which people are considered poor (Bhorat 
et al 2011).  
Poverty rate: The percentage of people who lived in poverty in one calendar year (US Census 
Bureau 2012).  
Pragmatic trial: “A trial that aims to test a treatment policy in a 'real life' situation, when many 
people may not receive all of the treatment, and may use other treatments as well.  This is as 
opposed to an explanatory trial, which is done under ideal conditions and is trying to determine 
whether a therapy has the ability to make a difference at all (i.e. testing its efficacy)” (MRC 
2012) 
Relative poverty: When “individuals, families and groups….lack the resources to obtain the 
types of diet, participate in the activities and have the living conditions and amenities which are 
customary…in the societies to which they belong” (Alcock 2006: 64). 
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Results-based financing: “the transfer of money or material goods conditional on taking a 
measurable action or achieving a predetermined performance target”. Also known as “pay-for-
performance, performance-based funding, and output-based aid.” (Oxman and Fretheim 2009)  
 
Social protection: “the public actions taken in response to levels of vulnerability, risk and 
deprivation which are deemed socially unacceptable within a given polity or society” (Norton et 
al 2001)  
Unemployment, strict (official, narrow) definition: “those people within the economically active 
population who: did not work during the seven days prior to the interview; want to work and 
are available to start work within two weeks of the interview; and have taken active steps to 
look for work or to start some form of self-employment in the four weeks prior to the 
interview”. (Lehohla 2004) 
Unemployment, expanded definition: “those people within the economically active population 
who: did not work during the seven days prior to the interview; want to work and are available 
to start work within two weeks of the interview” but have given up on looking for work. 
(Lehohla 2004). 
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Chapter 1:  
Background to and rationale for this thesis 
 
Introduction 
 
In this chapter, the background to and rationale for this thesis are described and discussed. 
Firstly, the evidence for the relationship between poverty and TB, which forms the foundation 
for this thesis, is presented. This evidence describes the possible “causal pathways” for the 
effect of poverty on the development of TB disease and on the outcomes of patients on TB 
treatment. In light of the strong association between TB and HIV, and the high co-infection rate 
in South Africa, I also discuss the effects of poverty on HIV epidemiology and clinical outcomes, 
and how this might relate to TB. The models for our intervention are described, and the use of 
similar interventions in South Africa (in the form of social grants) is discussed. Finally, the 
structure of the thesis and the contents of the succeeding chapters are outlined.  
Background 
 
It is generally accepted that poverty and ill health are closely related. Much of the literature 
converges on a consensus opinion  that income poverty, with its multiple dimensions, is 
detrimental to health (Biggs et al  2008, Harris 2004, Benzeval and Judge 2001, Fulton 1980). 
Indeed, the World Health Organisation’s Commission on the Socio-Economic Determinants of 
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Health found that there is sufficient evidence supporting this relationship to justify action 
(WHO 2008: Note from the Chair).  
 
Tuberculosis (TB) is one of the diseases whose relationship with poverty seems to be 
particularly strong (Hargreaves et al 2011, Lonnroth et al 2010, Lancet 2005).  There is a large 
body of work, dating back over a century, that emphasizes the close relationship between 
poverty and TB (Farmer 2001). Indeed, Robert Koch himself described the disease as “the 
outcome of social misery” (quoted in Farmer 2001: 202). Rene and Jean Dubois, in their seminal 
book “the White Plague: Tuberculosis, Man and Society” called tuberculosis “a social disease”, 
which emphasizes the importance of social context in the development and course of TB 
(Dubos and Dubos: xv).  
The way in which poverty impacts on TB has been outlined in various “causal pathways”.  Food 
insecurity, with consequent under-nutrition, is one of the fundamental features of poverty 
(ASSAF 2007), and poor nutrition is a powerful determinant of TB disease (Cegielski et al 2012, 
ASSAF 2007, Van Lettow et al 2004, Tverdal 1986, Edwards et al 1971). Under-nutrition 
undermines the functioning of the immune system, even leading to secondary 
immunodeficiency, which in turn increases the risk of developing disease from new and latent 
TB infections (Gupta et al 2009).  Protein appears to play an important role (Bates et al 2004), 
with low consumption of dietary protein (Strachan et al 1995) and low albumin levels (Cegielski 
et al 2012) both increasing the risk of TB. Similarly, under-nutrition increases the risk of death in 
patients on treatment for TB (Zachariah et al 2002). Although a recent systematic review of 
trials found insufficient evidence to judge the effectiveness of nutritional supplements in 
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improving the outcomes of patients on treatment for tuberculosis (Sinclair et al 2011), other 
studies suggest that various micronutrients are important in the pathophysiology of TB.  Low 
plasma ferritin is an independent risk factor for treatment failure in patients with pulmonary TB 
(Isanaka et al 2012), and low levels of vitamin A are associated with increasing severity of the 
disease (Pakasi et al 2009). Vitamin D, an important immunonodulator, may also play a role in 
the development and prognosis of TB disease (Battersby et al 2012). Other micronutrients 
which may influence the risk and course of TB are zinc, vitamins C and E, selenium and copper 
(Gupta et al 2009). Other conditions of poverty, such as overcrowding and poor ventilation, are 
also important in the spread of the infection (Baker et al 2008, Bates et al 2004) but fall outside 
the scope of this thesis.  
The prevalence of TB is higher in poorer countries (Ploubidis et al 2012) and among poorer 
communities in wealthy countries (Bates et al 2004). Indeed, in South Africa, a country of 
profound income inequality (Coovadia et al 2009), TB has been called a “barometer of poverty” 
(Andersson 1990).   
Tuberculosis and poverty in South Africa 
 
Tuberculosis has a long history in South Africa and like many other diseases in this country, its 
distribution is highly racialised (Coovadia et al 2009). Little is known of the prevalence of the 
disease or its effect on mortality prior to the eighteenth century, and the experience of African 
populations of tuberculosis before the advent of Europeans is debatable (Van Rensburg et al 
2005: 12, Packard 1990: 25). It is likely though that it was not an important cause of morbidity 
and mortality because the conditions that favour the spread of the disease were largely absent 
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(Van Rensburg et al 2005: 12). Initially, tuberculosis was spread from early European colonists 
in the late eighteenth and early nineteenth centuries and the disease was concentrated in the 
more highly colonised Cape (Van Rensburg et al 2005: 12). However, the deliberate engineering 
of poverty among indigenous people to generate labour for South Africa’s growing economy 
(Terreblanche 2002: 6) and in particular the use of migrant labour in the mines, with their 
overcrowded living conditions, poor wages and inadequate diets, resulted in a massive increase 
in the incidence of TB and the mortality due to the disease in African miners (Coovadia et al 
2009, Packard 1990: 3).1 These miners facilitated the spread of TB to rural populations, by 
frequent return to their homes in rural areas; indeed, miners who were ill were often forcibly 
repatriated because they were less productive (Packard 1990: 11). The impoverishment of rural 
people due to the imposition of taxes and the erosion of traditional diets increased their 
susceptibility to the disease (ibid). Rapid urbanization of Africans in the 1920s and 1930s and 
their squalid living conditions in peri-urban settlements further fuelled the disease in this 
group, where rates of TB remained much higher than in the white population which enjoyed far 
better living conditions (Packard 1990: 16). Apartheid and its defining policies of segregation 
and exploitation further exacerbated rates of disease and death in African populations 
(Coovadia et al 2009), including from tuberculosis (Packard 1990: 17). The continued 
impoverishment of black and rural populations, the fragmented and highly inequitable health 
care system and the emphasis on hospital-based and doctor-driven health care were all 
characteristics of the Apartheid era that facilitated the spread of TB and undermined its control 
(van Rensburg et al 2005: 22). 
                                                          
1
 Because the living and working conditions of white miners were superior, rates of TB were much lower in this 
group (Packard 1990: 5). 
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Since the advent of democracy in 1994, the inequalities in income and health that existed 
between race groups in South Africa have persisted and income inequality within race groups 
has increased (SARPN 2004).2 Although there has been some debate on whether or not poverty 
in the country has decreased since 1994 (Aguero et al 2007, du Toit 2005), there is general 
consensus that income inequality has increased (Coovadia et al 2009, Aguero et al 2007, SARPN 
2004). This inequality in income is reflected in inequalities in health across the country, both 
within and between provinces (Coovadia et al 2009), including in tuberculosis prevalence and 
outcomes. The prevalence of tuberculosis is highest in KwaZulu-Natal, which is also one of the 
poorest provinces in the country (Barron et al 2007), and the average TB cure rate in the most 
deprived districts of South Africa is 55.3% , whilst in the least deprived it is 71.4% (Day et al 
2009:10).  
The effect of poverty on tuberculosis epidemiology and clinical outcomes 
 
The association between poverty and TB exists over the entire course of the disease, from 
initial infection to final outcome (Hargreaves et al 2011). Although effective treatment is 
available for drug-susceptible TB, and this is provided free of charge in public sector clinics in 
South Africa, there is a wealth of research that shows that the effect of poverty on TB outcomes 
is due, at least in part, to the costs of accessing and adhering to treatment (Ukwaja et al 2012, 
Munro et al 2007a, Zhang et al 2007, Rowe et al 2005, Yach 1988).  
                                                          
2
 The racial classification of South Africans into “Africans”, “Coloureds”, “Indians” and “Whites” was central to the  
Apartheid system and was legalized in the Population Registration Act of 1950 (Posel 2001). Because the racialised 
inequality of the country remains prevalent today, the terms are still used to describe population groups.    
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Poverty may cause delays in accessing initial treatment for TB, thus delaying the detection and 
treatment of TB and its complications. Even after the initiation of treatment, the limitations 
that poverty imposes on access to treatment may also reduce the likelihood of treatment 
success (Bates et al 2004).  In South Africa, deprivation is an important determinant of the use 
of primary health care services (the level at which most TB care is delivered). The primary 
health care utilization rate is lowest (between 2.0 and 2.1 visits per person per year) in the most 
deprived districts of the country and highest (3 visits per person per year) in the least deprived 
(Day et al 2009: 8). Interestingly, some of the lowest primary health care utilization rates occur 
in South Africa’s biggest cities, contradicting the assumption that access to health care in South 
Africa is worse in rural than in urban areas (ibid).  
Having made the initial clinic visit for diagnosis and treatment, ongoing clinic access is further 
undermined by conditions of poverty. The costs of transport to the clinic, and of forgoing a day 
of economic activity, may be difficult if not impossible for patients to meet (Munro et al 2007a).  
It has been shown in several countries, that patients may have to sell assets or take out loans to 
pay for their treatment (Bates et al 2004);  even in settings of general poverty, poorer patients 
are more severely affected than those who are less poor.  For example, in Malawi, the costs of 
TB treatment for patients who were most poor amounted to 248% of their monthly 
expenditure, whereas for those who were less poor, it accounted for 124% of monthly 
expenditure (Bates et al 2004). In Tajikstan, the costs incurred during an episode of TB were 
two and a half times greater than the per capita GDP (Aye 2010) and in Swaziland, patients 
themselves identified two aspects of poverty as highly important in undermining adherence to 
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TB treatment: insufficient funds to attend the clinic for ongoing treatment, and lack of food 
whilst on TB treatment (Escott and Newell 2007).  
In South Africa, financial constraints have been found to be major obstacles to the completion 
of TB treatment (Lutge et al 2009, Naidoo et al 2009, Yach 1988) and TB preventive therapy 
(Rowe et al 2005). In Rowe’s qualitative study, financial limitations were universally reported by 
patients as general barriers to adherence, and cited again as preventing access to the clinic 
because of the expense of transport. In a survey of TB patients in KwaZulu-Natal, which served 
as a foundation for the work done in this thesis, it was shown that financial constraints were 
important factors in a patient’s failure to complete TB treatment,  even in populations where 
knowledge of TB was generally good (Lutge et al 2009). The majority (two thirds) of patients 
interviewed in this foundational work said it was “very expensive” to get to the clinic, with most 
(75%) using taxis as their main form of transport to the clinic. These expenses were incurred 
against a backdrop of high unemployment. Over half of all patients surveyed felt that the costs 
of accessing TB treatment over the course of the disease had had an important negative effect 
on their household finances (ibid). In addition, food security amongst these TB patients was 
low, with 42% of patients cutting the size of their meals and 31% cutting the size of their 
children’s meals due to lack of food in the six months prior to the study (ibid).  
The effect of poverty on HIV epidemiology and outcomes on treatment 
 
It is crucial to include HIV in any discussion of TB in South Africa.  The co-infection rate of these 
diseases is as high as 80% in some clinics in KwaZulu-Natal, and both the incidence and the 
geographical distribution of TB in the country have been profoundly affected by HIV.  
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Importantly, under-nutrition, TB and HIV also seem to act synergistically, thus creating the 
“perfect storm” for rampant epidemics in South Africa (ASSAF 2007). In addition, there has 
been “unparalleled” (Hargreaves et al 2011) research on the association between poverty and 
HIV, both globally and in South Africa, which is important both because of the influence of HIV 
on the epidemiology of TB, but also because it informs the relationship between poverty and 
TB, which has been less intensively researched.  
The prevalence of HIV in South Africa is highest among Africans (13·3%), whilst Whites and 
Indians have very low prevalences of the disease (0·6% and 1·9%, respectively) (Coovadia et al 
2009). Also, like TB, the prevalence of HIV in KwaZulu-Natal (one of the poorest provinces) is 
the highest in the country (Day et al 2012: 89; UNAIDS 2008). However, the role of income 
poverty in the transmission of HIV is controversial, with some studies showing that risk of 
infection increases with wealth (Barninghausen et al 2007), and others showing the opposite 
(Shisana and Simbayi 2002, quoted in Booysen 2004). What is clear though is that households 
affected by HIV are likely to be impoverished as a result of HIV and AIDS, both in terms of loss 
of income (Collins and Leibbrandt 2007, Booysen 2004) and in terms of increased expenses due 
to the illness. Burying a member who has died of HIV is an important cost for families. The 
majority (61%) of households in South Africa do not have insurance to cover funeral costs, 
which may cost up to seven months of income for poor households (Collins and Leibbrandt 
2007). Since TB is the most important cause of death in patients with HIV in Africa (WHO 2012), 
these findings may also apply to families affected by TB.  
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As in TB, under-nutrition has been associated with poor prognosis in HIV infection (ASSAF 
2007). Food insecurity has been associated with increased HIV transmission (Anema et al 2009) 
and is an important reason for non-adherence to anti-retroviral treatment. Patients who are 
food insecure are less likely to adhere to treatment, have lower baseline CD4 counts, 
incomplete virological suppression and are less likely to survive (Anema et al 2009, Weiser et al 
2009).   The side effects of antiretroviral drugs (ARVs) are exacerbated by the absence of food, 
and because these drugs can increase appetite, patients may experience “intolerable hunger in 
the absence of food” (Weiser et al 2009). Lack of food may therefore lead patients to skip doses 
if they cannot afford to eat (Yoder et al 2009: 50). The choice of either eating or getting their 
medicines, if money is limited, may lead some patients to choose food over accessing clinics in 
order to get their treatment (Weiser 2010). In addition, dietary diversity in HIV infected children 
in South Africa is significantly lower than in uninfected children living in the same areas, and 
this may be an important contributor to poor outcomes of infected children, even those on 
anti-retroviral treatment (Mpontshane et al 2008).  
Anti-retroviral treatment programmes in sub-Saharan Africa retain an average of 60% of their 
patients, with a range of 46-85% (Rosen et al 2007). Although rates of adherence to ARVs have 
been shown to be as high or higher among patients in South Africa compared to those in high 
income countries (Orrell et al 2003), these high rates come at a cost. Patients have been shown 
to make “impossible choices” in order to obtain and take their treatment, such as borrowing, 
begging and doing without other necessities of life (Ware et al 2009). Money for transport to 
the clinic is considered an important factor in patients’ inability to attend the clinic for their 
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appointments and to collect their medicines, with missed appointments leading to missed 
doses (Tuller et al 2010).  
Rationale for this trial 
 
South Africa has one of the highest burdens of tuberculosis in the world (Abdool Karrim et al 
2009) and the outcomes of patients on TB treatment remain below the targets set by the World 
Health Organisation. In the context of 40% smear positivity, the national cure rate around the 
time of the trial was 67.5%, the treatment completion rate was 76.5% and the default rate was 
7.5% (Day and Gray 2010). Although these outcomes represent improvements over the last 
decade, the transmission rate of TB has increased dramatically over this time and it has been 
suggested that the current national strategy for TB control, based on the DOTS Strategy, is 
insufficient to control the epidemic (Wood et al 2010).  
Although the association between poverty and TB is well documented, there are very few 
programmes which directly address this relationship with economic interventions, and even 
fewer research studies which evaluate them (Hargreaves et al 2011). This is in part because 
such research is difficult to do. Because of the scale on which poverty occurs, and because of 
the complex relationship between different aspects of poverty and disease, such studies may 
be  difficult to design and enormously costly to conduct. In the words of the Commission on the 
Socio-economic Determinants of Health, “Countries do not lend themselves to randomization. 
Interventions such as the development and implementation of laws  .....  cannot be randomized 
across countries” (WHO 2008: 42). However, the Commission also states that, in spite of the 
growing body of evidence to support action in this field, “there is a pressing need to invest in a 
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great deal more research, bringing together different disciplines and areas of expertise, to work 
out how social determinants create health inequity, and how action on these determinants can 
produce better, fairer health” (WHO 2008: 27). Indeed, the third principle of action of the 
Commission is to “Measure the problem, evaluate action, expand the knowledge base” (WHO 
2008: 2).  
 
This call for research in the field has been echoed by some recent reviews (Lutge et al 2012, 
Boccia et al 2011, Lagarde et al 2009). In addition, a recent expert consultation on Social 
Protection for TB control, held at Chatham House in London in February 2012, concluded that 
“a) despite the indirect evidence gathered in a recent review...[ ]..., the actual impact of social 
protection on TB indicators (e.g. incidence, mortality, case finding, TB treatment adherence) 
remains unknown; b) it is unclear how social protection initiatives may be best integrated with 
current TB control activities and which forms of social protection are most likely to be 
successful, depending on the objectives posed”.  
 
Given the complexity of poverty as a phenomenon, and the depth and extent of poverty in 
South Africa, it is very difficult for small studies to investigate the effect of its alleviation on 
disease. Indeed, although “social Injustice is killing people on a grand scale”, (WHO 2008: 
Executive summary), the scale is too vast for small intervention studies to meaningfully 
interrogate the multiplicity of interventions to alleviate poverty and the effects of these on 
health. It is, however, important to view the research around the eradication of such social 
injustice in a similar way to the injustice itself. As Amartya Sen says in “The Idea of Justice” 
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(2009:ii), “What moves us, reasonably enough, is not the realisation that the world falls short of 
being completely just, which few of us expect, but that there are clearly remediable injustices 
around us which we want to eliminate”. Just as it is important to address these “clearly 
remediable injustices” instead of being weighed down by their enormity, it is important in 
research to start somewhere, by focussing on one or two links in the chain binding poverty and 
disease and testing interventions that weaken these links.  
 
Models for our intervention: conditional cash transfers and economic 
incentives 
 
Improving health by enabling or rewarding healthy behaviour is an area of increasing interest 
worldwide (Hargreaves et al 2011), and the idea can be encapsulated in the umbrella terms 
“results-based financing” or “pay-for-performance, performance-based funding, and output-
based aid” (Oxman & Fretheim 2009). These terms include the two specific types of 
interventions of interest in this thesis: conditional cash transfers and economic incentives. 
Although the emphases of conditional cash transfers and economic incentives are different, 
they share many common features, and when incentives are used in low and middle income 
countries (which is where the largest conditional cash transfer programmes are run), the 
distinctions between them may become blurred. The major features of each, and the 
commonalities between them, are discussed further below.  
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Conditional cash transfers 
 
The reduction of poverty and the improvement of access to health care are among the explicit 
aims of conditional cash transfer programmes. Such transfers are intended to increase 
household income and in so doing, improve household food security and overcome the barriers 
that poverty imposes on access to health care (Lagarde et al 2009). They compensate 
households for the indirect or opportunity costs associated with accessing health care (ibid) and 
protect them from the economic shocks that may be associated with illness. In addition, they 
serve to re-distribute wealth in society and because of their broader educational and 
developmental goals, also try to break inter-generational cycles of poverty (ibid). Conditional 
cash transfers have demonstrated potential in improving health outcomes by improving 
household economies (Boccia et al 2011; Lagarde et al 2009; United Nations 2009: 139). The 
best known examples of cash transfer programmes are those implemented in Latin America 
during the 1980s and onwards (Lagarde et al 2009). These cash transfers are conditional on 
certain behaviours on the part of recipients (ibid). Thus not only do conditional cash transfers 
help households cope with the costs of accessing health care (such as transport and treatment 
costs), and compensate participants for income lost when attending the health facility, they 
also create a demand for health services because of the need to meet the conditions of the 
transfer (Lagarde et al 2009). Patients and households are “rewarded” for practicing healthy 
behaviour and in this sense, conditional cash transfers can be seen to have an incentivising 
function, as well as a more developmental one. Many cash transfer programmes have indeed 
been shown to improve household economic well-being, household food security and access to 
health care (Boccia et al 2011), as well as health outcomes in terms of improved nutritional 
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status, fewer episodes of diarrhoea and reduction in the probability of illness in children of 
various age groups  (Lagarde et al 2009). However, these findings are not uniform across all 
transfer programmes nor do they occur across all age groups (ibid). Of note, there are currently 
no studies of cash transfer programmes that have explicitly addressed tuberculosis (Boccia et al 
2011).  
Economic incentives 
 
Economic or material incentives to encourage adherence to TB treatment are similar to 
conditional cash transfers in that the provision of the incentive also depends on a patient’s 
compliance with a prescribed behaviour. However, the scope of the incentive is much more 
limited than that of the conditional cash transfer: where the cash transfer aims to address 
household poverty and factors associated with it (such as lack of access to education), the 
incentive focuses exclusively on a single health outcome, such as to reduce substance misuse 
(Burton et al 2010), encourage smoking cessation (Cahill and Perera 2011), promote adherence 
to the hepatitis B vaccination schedule (Seal et al 2003) and increasingly, to prevent HIV 
infection (World Bank 2011).  
Although not specifically used to overcome barriers of poverty in accessing health care and 
adhering to treatment, economic incentives have been used among patients with tuberculosis 
to encourage adherence to treatment (Lutge et al 2012, reported in Chapter 2). It is possible 
that incentives may be more effective among patients in low and middle income countries, 
because they represent larger proportions of patients’ generally low incomes (Oxman and 
Fretheim 2009). In such contexts, it might be more appropriate to refer to economic incentives 
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as “enablers” since, although their effect on poverty is lower than that of conditional cash 
transfers, they do assist patients in overcoming the obstacles to health care and health that are 
imposed by poverty. Thus in this thesis, the terms “incentive” and “enabler” are used together 
to emphasise the dual and often indistinguishable effect of economic interventions in the 
improvement of TB outcomes. For the sake of simplicity, and in order to capture both meanings 
in one word, the term “economic support” is most often used in this thesis.3  
To date, there is very little evidence available to inform a decision on whether to use economic 
incentives or enablers among patients with active TB in low and middle income countries (Lutge 
et al  2012, reported in Chapter 2).  
Difficulties in the delivery of conditional cash transfers and economic incentives 
 
Although the conditionalities inherent in both conditional cash transfers and economic 
incentives have clear potential benefits, they also have potential drawbacks. Conditional cash 
transfers have been criticised as being paternalistic in their imposition on households of 
priorities for expenditure (Forde et al 2011). They may also be difficult to monitor and enforce, 
with many low income countries lacking the administrative capacity to do so (United Nations 
2009: 140). The enforcement of conditions may also generate corruption, with the possibility 
that officials may be offered bribes to certify that conditions are being met (ibid) or recipients 
may report changes in behaviour but not actually practice them (Oxman and Fretheim 2009). 
Transfers or incentives may also be stolen or forged (ibid). They may have a perverse incentive 
                                                          
3
 The title of this thesis has been changed to replace the term “economic incentives” with which this PhD was first 
registered in 2009, with the term “economic support”. The change reflects the evolution of ideas around the 
interventions that are the subject of this thesis and was accepted by both the Postgraduate and Health Research 
Ethics Committees of the University of Stellenbosch.  
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effect, with patients behaving in a way opposite to that intended by the programme in order to 
continue receiving the transfer or incentive. For example, women may increase their fertility 
because pregnant women are the targets of a particular transfer (ibid). They may also generate 
dependence on the transfer or incentive (ibid). Very poor families may struggle to meet the 
conditions in spite of the transfer, and so be excluded from the programme, resulting in a 
failure to assist those most in need (United Nations 2009: 140). Finally, targeting of certain 
households may generate conflict in communities where some are excluded from the 
programme (ibid). In spite of all these potential drawbacks, the conditionalities associated with 
cash transfers have been cited by some as the sole reason for their success in improving health 
and other outcomes (Forde et al 2011).  
Both conditional cash transfers and economic incentives are possible to implement on a small 
(sub-national) scale, which makes them amenable to small-scale research projects, and both 
are attractive options for exploring ways to intervene in the cycle of poverty and TB. 
Cash transfer programmes in South Africa  
 
South Africa has an extensive programme of social protection for poor and vulnerable groups, 
in the form of cash transfers (known in this country as social grants). These grants have been 
shown to have a positive impact on the depth of poverty in the country (Armstrong 2008) and 
in terms of government expenditure, are the largest form of assistance to poor households in 
South Africa. The grants available in South Africa include: the old age pension (also known as 
the older person’s grant), child support grant, disability grant, care dependency grant and foster 
care grant. The old age pension and the child support grant have the greatest coverage of all 
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these grants, and have increased dramatically in value since democracy (Booysen 2004). In 
addition, the number of beneficiaries of these grants has increased since 1994, with the age 
cut-off for the old age pension decreasing steadily, and the age cut off for the child support 
grant increasing steadily since then (Friedman and Bhengu 2008: 108).  
Like conditional cash transfer programmes, the two most common social grants in South Africa 
(the old age pension and the child support grant) have important developmental effects. The 
old age pension has been shown to dramatically improve household finances and, in so doing, 
also improve the family’s food security, and children’s school enrollment (Case and Menendez 
2007). In addition, in households where there is a recipient of an old age pension, it is easier for 
younger adults in the household to leave the area to find work elsewhere, and further improve 
the financial status of the household (Ardington et al 2009). Similarly, the Child Support Grant 
has reduced the number of children living in extreme poverty (Rispel 2009). Like the old age 
pension, the child support grant confers a measure of financial stability on the household that 
allows members to look for work “more intensively, extensively, and successfully than workers 
in comparable households without social grants” (ibid). Children living in households where the 
child support grant is received are also more likely to attend school, and have better nutritional 
status, than in households where no grants are received (ibid).  
The only cash transfer programme in South Africa that is specifically related to an illness is the 
disability grant for TB or HIV. Patients with TB and/or HIV in South Africa may qualify for this 
grant if they are judged to meet certain criteria by attending doctors. The disability grant is an 
income replacement grant and, in the case of TB, is given for the duration of treatment. The 
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grant is generous and at the time of the trial, was valued at R1080.00 per month (the same 
value as the old age pension and about four times higher than the Child Support Grant). 
Although the disability grants for TB or HIV are not conditional on any behaviour on the part of 
the patient, they have been deemed to be very important, especially for patients with HIV, in 
order to integrate issues of food security with antiretroviral treatment programmes  (Weiser 
2010, Anema 2009).  However, the determination of eligibility for these grants in South Africa is 
neither clear nor standardised and varies both between and within provinces (Whitworth et al 
2006). In KwaZulu-Natal, the administrative processes required to access the grants are 
onerous and lengthy (personal experience of the principal investigator). Perhaps in part 
because of this, the grants have been shown to have relatively low coverage. In a study 
conducted in the Eastern Cape, only 35% of patients infected with HIV were receiving the 
disability grant, and a further 13% had previously received the grant but it had been stopped 
(Peltzer and Phaswana-Mafuya 2008). In the survey conducted in KwaZulu-Natal that informed 
this trial, only 21% of TB patients received a disability grant for either TB or HIV (Lutge et al  
2009).   
The  possibility that the disability grant for TB or HIV may act as a disincentive for the 
completion of treatment must be kept in mind (Oxman and Fretheim 2009). In a qualitative 
study investigating adherence to anti-retroviral treatment  in KwaZulu-Natal, patients with HIV 
reported that the disability grants were very helpful, attributing the improvement in their 
health to the food they were able to buy with the grant money (Yoder et al 2009: 44). However, 
termination of the grant (done when a patient’s CD4 count returns to a certain level) was seen 
as problematic for patients (Yoder et al 2009: 61). Some of the patients cited in this report said 
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that they had stopped taking treatment because their grants had been stopped. For example, 
one had stopped treatment when his grant was terminated, but had returned to the clinic when 
his CD4 count was low enough to warrant a grant again (Yoder et al 2009: 62).  
In addition to a disability grant, patients with TB in South Africa may be eligible to receive 
nutritional support from the clinic (Department of Health 2009). This may take the form of food 
supplements, such as powders that are re-constituted with milk or water, or food such as 
packets of beans, rice or porridge. However, in the research that informed this trial, it was 
shown that the supply of food parcels to the clinics has decreased over time, and for TB 
patients the provision can be erratic (Lutge et al 2009). Nurses may not be able to provide 
nutritional support to all patients who need it, and may have to ration it. In addition, the 
storage of such foodstuffs at clinics can be problematic as space is often limited and the foods 
attract rats and cockroaches. 
In South Africa, all cash transfer programmes are unconditional. Neither the disability grants for 
patients with TB or HIV nor the nutritional support is tied to any conditions on the part of the 
patient. Although unconditional cash transfers are easier to administer (del Ninno 2005), it may 
be that if a transfer is intended to improve health outcomes, for example by improving a 
specific health behaviour, a conditional transfer would be more effective.  
Development of our intervention 
 
We reasoned that an economic transfer to patients with TB in South Africa could improve 
household economic well-being, and in so doing increase access to health care, improve 
household food security, improve patient adherence and thus improve outcomes on TB 
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treatment. We felt that research investigating the feasibility of delivering such a transfer and its 
effect on TB outcomes would be acceptable in the South African setting because: 
 Cash transfer programmes are already well established in South Africa, and have 
demonstrated important effects in alleviating poverty 
 Such transfers are already available to patients with TB (although their distribution is 
suboptimal) 
 Conditional cash transfers have demonstrated improvements in access to health care,  
nutrition and certain health outcomes in other settings.  
In developing the protocol for this research, we spoke to many stakeholders in the field of TB 
management and policy development in South Africa, including TB programme managers at all 
levels (district, provincial and national), local traditional leaders and local political 
representatives. We wanted to make sure that these stakeholders would support this research 
and, if our intervention was found to be effective, would be amenable to rolling it out on a large 
scale. In the course of these discussions, and as a result of the inputs we received, we decided 
to offer a voucher for foodstuffs instead of cash. This was preferred by the majority of 
stakeholders for the following reasons: 
 It was a security risk to hold large sums of cash at clinics in KwaZulu-Natal 
 If the cash were stolen from patients it would be impossible to verify the theft or 
replace the cash 
 Most patients at public sector clinics did not have bank accounts, thus making electronic 
transfers difficult 
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 Cash could be spent on any items, and patients may have chosen to spend it on 
unhealthy or damaging items such as cigarettes or alcohol 
 The expenditure of vouchers could be more easily monitored. 
Managers in the TB programme were also concerned about potential adverse effects, such as 
generating dependence on the voucher, and a perverse incentive effect. To avoid this (and to 
remain within the limited budget of the trial), we decided to offer an amount significantly 
smaller than the disability grant for TB, but which we hoped would be enough to meaningfully 
assist poor patients. The R120.00 per month at which the voucher was valued was less than the 
food poverty line of R226.00 at the time of the study (Oosthuizen 2008), and was about a fifth 
of the value of the median per capita monthly income in KwaZulu-Natal around the time of the 
trial (Hall et al 2010). However, it was hoped that the voucher would allow households to 
increase expenditure on food stuffs. The amount offered in the voucher was sufficient to 
purchase a number of food stuffs commonly used in South African households (Table 1), which 
we hoped would improve household food security and the nutritional status of the index 
patient.  
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Table 1: Prices of selected food stuffs in January 2010 (mid-way through trial) 
Commodity Rural price in 
ZAR 
Urban price in 
ZAR 
Full cream long 
life milk 1 litre 
10.28 9.72 
Loaf of brown 
bread 700g 
7.00 6.97 
Loaf of white 
bread 700g 
7.56 7.83 
Maize meal 5kg 29.09 22.93 
Margarine 500g 14.61 12.88 
Peanut butter 
400g 
16.59 15.48 
Rice 2kg 28.58 23.14 
Sunflower oil 
750ml 
17.20 12.81 
Ceylon/black 
tea 62.5g 
7.06 7.02 
White sugar 
2.5kg 
19.73 18.15 
Source: Food Price Monitor 2011; available at 
http://www.namc.co.za/dnn/LinkClick.aspx?fileticket=r7dfjbWctLg%3D&tab. Accessed on 14th February 
2013. 
 
We also hoped that the voucher would free up money spent on food stuffs to meet other 
essential expenditure, such as transport to the clinic. In the research that informed this trial, 
patients in KwaZulu-Natal reported spending an average of R16.64 on transport to the clinic 
(with a range of R0 for those who walked, to R140.00) (Lutge et al 2009). We reasoned that the 
amount provided in the voucher could free up sufficient funds to facilitate clinic access.  
Although it has been suggested that a once-off voucher on completion of TB treatment might 
be a stronger incentive for patients in South Africa to adhere to their treatment (Abdool Karrim 
et al 2009), and although we did expect that our voucher would have some incentivising effect, 
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our rationale for providing support was more to enable adherence than to reward it. We 
therefore decided to give the voucher on a monthly basis to assist patients with food and other 
expenditures during their treatment.  
A simple logic model describing the postulated mechanisms of action of the voucher is 
illustrated in Figure 1 below (Anderson et al 2011).  
Figure 1: Postulated mechanisms of action of the voucher 
 
 
In addition to investigating whether the voucher would improve TB patients’ outcomes on 
treatment, an important question to be answered in this trial was the feasibility of 
administering this voucher at public sector clinics in the province. A process evaluation was 
conducted alongside the trial, in order to best answer questions of feasibility, and to 
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interrogate the extent to which the mechanism of action of the voucher corresponded to our 
hypothetical model. As discussed above, it has been noted in previous research that the 
disability grant for patients with TB is seldom received and entails a lengthy and difficult 
application process (Lutge et al 2009, Whitworth et al 2006). The provision of food parcels to 
patients with TB is uneven because of an erratic supply (Lutge et al 2009). The feasibility of 
administration of material or economic support to TB patients is thus an important area of 
research. Even if an economic intervention were found to be effective in improving the 
outcomes of patients with TB, its impact would be limited if it were not feasible to administer it. 
Given the administrative difficulties demonstrated in the provision of other forms of economic 
support to TB patients in South Africa, it was important that this trial provide evidence that 
could be used by policy makers in the real-world South African setting (Treweek and 
Zwarenstein 2009). Our trial therefore had a “pragmatic attitude” (ibid) and tended towards 
the pragmatic domains of the Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) 
tool  (Thorpe et al 2009) which are described in more detail in Chapter 3.  
 
Accordingly the pragmatic trial forming the central component of this thesis aimed to 
investigate the following: 
 The feasibility of delivering a voucher to TB patients in KwaZulu-Natal and of integrating 
this with routine TB treatment 
 The effectiveness of this voucher in improving the outcomes of patients on TB 
treatment 
 The effect of the voucher on the patients’ household expenditure.  
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Structure of the thesis 
The structure of this thesis is as follows: 
 Chapter 1: A discussion of the rationale for the thesis and the models on which we based 
our intervention 
 Chapter 2: A report of the findings of a Cochrane systematic review, collating the existing 
evidence around the use of economic incentives and enablers in patients with TB (the 
Cochrane review was published in the Cochrane library in February 2012 (Lutge et al 2012)) 
 Chapter 3: A report of the conduct and findings of the pragmatic, cluster randomized 
controlled trial of economic support to improve TB treatment outcomes in South Africa (an 
abridged version of this report was published in the journal “Trials” in June 2013 (Lutge et al 
2013)). 
 Chapter 4: Part one of the process evaluation of the trial, reporting on the responses of 
nurses, managers, patients and shop keepers to the voucher 
 Chapter 5: Part two of the process evaluation of the trial, reporting on the effect of the 
voucher on patients’ household expenditure, and the goods on which the vouchers were 
spent 
 Chapter 6: A summary of evidence that informed the trial, the findings of the trial and their 
implications 
 Chapter 7: Suggested questions for further research in the field of economic interventions 
for the improvement of TB outcomes, and the ethical rationale for pursuing this research.   
Stellenbosch University  http://scholar.sun.ac.za
26 
 
Cochrane systematic review: Material 
incentives and enablers in the management of 
tuberculosis 
 
Introduction 
 
This chapter describes a Cochrane systematic review which aimed to assess the evidence for 
the use of material incentives and enablers in the management of TB. This review complements 
the evidence available for the use of other forms of economic support, specifically conditional 
cash transfers, for improving patients’ outcomes on TB treatment. This review was lead by me 
and was published in the Cochrane library in February 2012 (Lutge et al 2012). The review as 
presented in this thesis largely follows the format for Cochrane reviews of effects, conforming 
to requirements for the structure and content of these reviews. However, to improve the flow 
of this thesis, the format of the review has been altered slightly (primarily by excluding the 
abstract, and moving explanatory tables and figures to the appendices for this chapter).  
Background  
Description of the condition  
 
Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis 
which spreads from person to person by inhalation of respiratory droplets. The burden of 
disease is highest in low- and middle-income countries where it is associated with poverty, 
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overcrowding, and lowered immunity (due to poor nutrition or infection with the human 
immunodeficiency virus (HIV)) (WHO 2009a). 
Following the initial infection, most people do not develop symptoms as the bacterium is 
completely controlled by the immune system, and lies dormant in a state known as “latent TB”. 
Active TB, where the bacterium is no longer controlled by the immune system, can occur at any 
time following infection and most commonly affects the lungs, causing a chronic cough (which 
acts to spread the disease), loss of weight, loss of appetite, and general malaise (Harries 2006). 
The most widely used method of diagnosing latent TB is the tuberculin test (also known as the 
Mantoux test), which involves injecting a small amount of a purified M. tuberculosis protein 
under the skin, usually of the forearm. If the person has previously been exposed to TB, a small 
swelling occurs due to a localised immune response, and the size of this response is measured 
48 to 72 hours later (CDC 2010). Treatment of latent TB, often called TB prophylaxis, aims to 
prevent the later development of active disease, and reduce transmission. 
Effective treatment for both active and latent TB requires regular medication to be taken for six 
to twelve months; non-adherence to this difficult and prolonged schedule is the most common 
cause of treatment failure (Narayanan 2003; Volmink 2000) and one of the most important 
obstacles to TB control globally. Non-adherence, with prolonged infectiousness, constitutes a 
health risk to close family and community contacts, and can lead to the development of drug 
resistant organisms which are more difficult and more expensive to treat (Lam 2002). 
Adherence is not the sole responsibility of the patient, nor of the health system, but some 
combination of the two (Garner 2007), and consequently interventions aimed at reducing non-
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adherence may need to target both. These interventions may be classified as: technical (making 
the medications simpler to take, such as reducing doses and personalising packaging); 
behavioural (establishing a pattern of behaviour through stimuli or positive reinforcement); 
educational (improving patients' capacity to manage their diseases, often through a cognitive 
didactic approach); structural (improving the accessibility and acceptability of TB programmes); 
or complex (a combination of these) (Haynes 2008; Munro 2007b; van Dulmen 2007; WHO 
2003c). A review of direct observation has been completed indicating little added effect of 
direct observation (Volmink 2007), and a review of patient reminders and prompts is also 
available showing mixed effects (Liu 2008). A further review on patient education has recently 
been completed, showing potential benefits of educational interventions (M'Imunya 2012). 
Description of the intervention  
 
Incentives and enablers are interventions targeted at the patient which seek to either promote 
or assist improved adherence (WHO 2003a; WHO 2003b; WHO 2003c). They may be given 
directly as cash or vouchers (for example for groceries), or indirectly as the provision of a 
service for which the patient would otherwise have had to pay (for example transport to and 
from the clinic). 
A recent overview of reviews found that material incentives improved adherence and outcomes 
for a number of health problems, and also increased the utilisation of health services for 
prevention programmes (Sutherland 2008). Conditional cash transfers, used primarily in Latin 
America, can be regarded as economic incentives used on a large scale to promote healthy 
behaviour in poor families and individuals (Lagarde 2007). They have been particularly 
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successful in promoting the use of health services and in improving nutritional and 
anthropometric outcomes in certain groups (Lagarde 2007). 
How the intervention might work  
 
Incentives are based on behavioural theories of reward for “good” behaviour (van Dulmen 
2007), and may be defined as “any financial or material reward that patients and/or providers 
receive, conditional on their explicitly measured performance or behaviour” (Beith 2007). 
Alternatively, “enablers” assist patients to adhere by overcoming the financial barriers to 
treatment. In a recent qualitative review, economic constraints due to absences from work to 
attend appointments, or the direct and indirect costs of accessing treatment, were commonly 
cited by patients as important barriers to completing TB treatment (Munro 2007a). 
As well as potential benefits, the use of material incentives may also have unintentional 
negative consequences. Patients who receive incentives to adhere to one health behaviour may 
be reluctant to adhere to others if they are not also accompanied by incentives (Malotte 1999). 
This might be especially important where incentives are offered in one of several possible 
stages in a multi-stage treatment process such as screening for and treating TB. Further 
possible negative effects include: resentment in patients who do not receive the incentive 
(Malotte 2001); fraud and corruption, with patients manipulating the incentive system to gain 
more; the creation of “ghost” patients allowing health staff to steal incentives from the system 
(White 1998); or the “perverse incentive” effect, where the incentive induces exactly the 
opposite behaviour to that intended; for example, patients who want to continue receiving the 
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incentive may deliberately not take medications in order to remain ill (Department of Social 
Development 2006). 
Why it is important to do this review  
 
In light of the increased risk of TB posed by HIV infection (Stop TB Partnership 2010), and the 
development of epidemics of drug-resistant forms of TB (Yang 2011; Wells 2007), efforts to 
help patients complete therapy are of paramount importance. If material incentives and 
enablers improve adherence rates amongst patients with TB, they should be used far more 
widely than they are currently. 
Objectives  
 
To evaluate the effects of material incentives or enablers given to patients undergoing 
diagnostic testing for TB, or receiving drug therapy to prevent or cure TB. 
Methods  
Criteria for considering studies for this review  
Types of studies  
 
Randomized controlled trials, where the unit of allocation was either an individual or cluster. 
Types of participants  
 
People receiving curative treatment for TB 
This included smear positive cases, smear negative cases, new cases, and re-treatment cases. 
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People receiving preventive therapy for TB 
This included patients at risk of developing active TB and taking anti-TB chemoprophylaxis (i.e. 
isoniazid preventive therapy). 
People suspected of TB undergoing, and collecting the results of, diagnostic tests 
Diagnosis of TB infection (using tuberculin skin tests) and disease (using sputum microscopy and 
culture) often requires the patient to return to the health facility a few days after the test is 
performed to receive the results. Incentives have been used to encourage patients to do this. 
Children, adolescents and adults 
Although it was originally intended to include only studies focusing on adults of 16 years and 
over, we decided to drop this age limitation as a few trials were found that investigated 
children or adolescents. 
Types of interventions  
 
Interventions included any form of material inducement to return for TB test results, or adhere 
to or complete anti-TB preventive or curative treatment. These may have been direct such as 
cash or vouchers, or indirect such as the provision of a service for which the patient would 
otherwise have had to pay (for example transport to and from the clinic). Non-material 
incentives, such as praise from a health worker, were not considered in this review, because 
their economic value is difficult to quantify and the form of the incentive is difficult to 
standardise. 
In those trials where incentives were combined with other interventions, studies were only 
eligible for inclusion in a meta-analysis if disaggregation of the effect of the incentive was 
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possible. Other interventions that could be combined with incentives include health 
information and education, and increased access to health workers through home visits, or 
additional appointments. 
Trials were only included if the standard TB curative or preventive treatment were the same 
across the control and treatment arms. 
Control groups 
 
Controls were those patients receiving standard TB treatment or preventive treatment, or 
undergoing testing for suspected TB, who had no incentive or an alternative incentive or 
intervention. 
Types of outcome measures  
 
Primary: 
For treatment of active TB 
Cure and/or completion of treatment, using the following World Health Organization (WHO) 
definitions (WHO 2009b): 
Cured: A patient who was initially smear-positive and who was smear negative in the last 
month of treatment and on at least one previous occasion.  
Successfully treated: A patient who was cured or who completed treatment. 
For prophylaxis 
Cases of TB. 
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For diagnostics 
Number returning to collect test results within the appropriate time frame for that test. 
Secondary: 
Percentage of treatment completed, appointment keeping, presence of urinary markers, and 
certification by direct observation of treatment. 
Adverse effects 
Adverse events reported in trials, such as expenditure of cash or vouchers on unhealthy items. 
The latter were defined as commodities that undermine the patient’s chance of cure, such as 
tobacco products or alcohol. 
Costs 
Cost effectiveness of the intervention; where costs include the direct and indirect costs 
incurred by patients, and costs to the health system of providing and administering the 
incentives/enablers. 
Search methods for identification of studies  
 
We attempted to identify all relevant trials regardless of language or publication status 
(published, unpublished, in press, and in progress).  
Databases 
 
We searched the following databases using the search terms and strategy described in 
Appendix 2A: Cochrane Infectious Diseases Group Specialized Register (22 June 2011); 
Cochrane Central Register of Controlled Trials (CENTRAL: 22 June 2011); MEDLINE (1966 to 22 
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June 2011); EMBASE (1974 to 22 June 2011); LILACS (1982 to 22 June 2011); and Science 
Citation Index (EXPANDED) and Social Sciences Citation index (SSCI) (1956 to 22 June 2011). 
We also searched the metaRegister of Controlled Trials (mRCT) using 'tuberculosis', 'incentive', 
'cash transfer', 'adherence', 'compliance', and 'concordance' as search terms (1998 to 22 June 
2011). In addition, we searched the WHO International Clinical Trials Registry Platform 
(http://www.who.int/ictrp/search/en/) for ongoing trials (22 June 2011). The detailed search 
strategies are presented in Appendix 2A.  
Researchers and organizations 
 
We contacted researchers and other experts in the field of TB and adherence research, for 
unpublished and ongoing trials. 
Reference lists 
 
We checked the reference lists of related reviews (Garner 2007; Haynes 2008; Lagarde 2007; 
Sutherland 2008; Volmink 2000) and all full-text articles reviewed for inclusion in this review. 
Data collection and analysis  
Selection of studies  
 
Elizabeth Lutge (EL) and Stephen Knight (SK) independently screened all citations and abstracts 
identified by the search strategy for potentially eligible studies. The full text articles of 
potentially relevant studies were independently assessed by the two authors using the pre-
specified trial inclusion criteria. Disagreements were resolved by discussion and consensus. 
When a disagreement could not be resolved we sought arbitration from a third author (Charles 
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Shey Wiysonge (CSW) or Jimmy Volmink (JV)). We excluded studies that did not meet the 
inclusion criteria and documented the reasons for exclusion in the table of “Characteristics of 
excluded studies”.  
Data extraction and management  
 
Using a pre-designed data extraction form, EL and CSW independently extracted information 
from the selected trial reports on study methods used, participant characteristics, 
interventions, and outcomes. For all outcomes, we extracted the number of participants 
randomized and the number analysed. The trials identified and included in this review all 
randomized individual participants and reported only dichotomous outcomes. For each study, 
we extracted the number of participants with an outcome of interest in each group as well as 
the number of participants randomized to each group, and the number analysed. 
Disagreements were resolved through discussion and consensus between EL and CSW initially, 
and with SK or JV if the disagreement was not resolved. 
Assessment of risk of bias in included studies  
 
EL and CSW independently assessed the risk of bias in each included study using the The 
Cochrane Collaboration's tool for this purpose (Higgins and Green 2011). The authors followed 
the guidance to assess whether adequate steps were taken to reduce the risk of bias across six 
specific domains, namely, random sequence generation; allocation concealment; blinding of 
participants, personnel and outcome assessment; incomplete outcome data; selective outcome 
reporting; and “other issues”. For each included study, the two authors independently 
described what the trial authors reported that they did for each domain and then made a 
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decision relating to the risk of bias for that domain by assigning a judgement of “Low risk” of 
bias, “High risk” of bias, or “Unclear risk” of bias. The authors compared the results of their 
independent assessments of risk of bias and resolved any discrepancies by discussion and 
consensus. Any differences in opinion between the two authors was resolved by discussion and 
consensus, with arbitration by a third author (JV). 
Assessment of reporting biases  
 
If at least 10 studies were included in the meta-analysis for any outcome, we would have 
evaluated the likelihood of publication bias and other sources of bias by examining the degree 
of asymmetry of funnel plots. We chose this number because it has been shown that when 
there are fewer than 10 studies in a meta-analysis the power of funnel plot asymmetry tests is 
too low to distinguish chance from real asymmetry (Higgins and Green 2011). 
Data synthesis  
 
We analysed data using Review Manager 5. We analysed trial participants in the groups to 
which they were randomized, regardless of how much of the intended intervention they 
actually received. 
All studies reported only dichotomous data, so we have expressed study results as the risk ratio 
(RR) with its 95% confidence interval (CI) for each outcome. We used the fixed-effect model for 
the primary analysis. When significant statistical heterogeneity was present and it was 
appropriate to combine the data, we used the random-effects model. We stratified analyses 
according to the type of incentive and control intervention, i.e. incentive versus routine care, 
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immediate versus deferred incentive, cash versus non-cash incentive, and incentive versus any 
other intervention. 
In addition, we used the GRADE approach to summarise the quality of the evidence on the 
effects of material incentives or enablers on each outcome (Guyatt 2008). In the GRADE system, 
randomized trials without important limitations constitute high quality evidence. However, the 
system considers five factors that can lower the quality of the evidence, i.e. study limitations, 
inconsistent results across studies, indirectness of the evidence, imprecision, and publication 
bias. Overall, the GRADE system classifies research evidence into four categories ie high, 
moderate, low, or very low quality. High quality evidence implies that we "are very confident 
that the true effect lies close to that of the estimate of the effect", while very low quality 
evidence implies that the "true effect is likely to be substantially different from the estimate of 
effect" found in the review (Balshem et al 2011). 
Subgroup analysis and investigation of heterogeneity  
 
The presence of statistical heterogeneity across trials was determined by visually inspecting the 
forest plots to check for overlapping confidence intervals and by means of the chi2 test for 
heterogeneity with a P value of < 0.10 indicating statistical significance. Further, the I2 statistic 
was used to quantify the amount of heterogeneity as low (I2 value of 25% or less), moderate (I2 
value between 25% and 75%), or high (I2 value of 75% or more). If we had at least 10 studies in 
any meta-analysis that showed significant statistical heterogeneity, we would have explored 
the possible sources of heterogeneity by performing subgroup analyses; with subgroups 
defined by age, gender, socioeconomic status, and risk of bias (ie low versus high/unclear). 
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Results4  
Description of studies  
 
We obtained 733 titles and abstracts from the electronic search of databases, and no additional 
articles from contacting researchers or screening reference lists. After removal of duplicates, 
225 records remained. Following discussion and consensus, we obtained 21 potentially eligible 
articles. Five of these articles were not randomized controlled trials (Cheng 1997; Filho 2009; 
FitzGerald 1999; Morisky 1990; Yao 2008), three were published reports of a trial of nurse case-
management of latent TB in which both study arms received the same material incentive 
(Nyamathi 2006), and one was a trial of community health worker delivered TB treatment 
combined with food supplements (Jahnavi 2010). All these articles were excluded. Eleven 
randomized controlled trials met our inclusion criteria (Chaisson 2001; Malotte 1998; Malotte 
1999; Malotte 2001; Martins 2009; Morisky 2001; Pilote 1996; Tulsky 2000; Tulsky 2004; White 
1998; White 2002), and were included in the review. The final article (Kominski 2007) was a 
cost-effectiveness analysis of an included study (Morisky 2001). The search and selection of 
studies is shown Figure 1 below. 
 
 
 
 
 
                                                          
4
 Additional tables, figures and summaries are presented as appendices for this chapter at the end of the thesis. 
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Figure 1: PRISMA diagram showing the search for and selection of studies
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Included studies  
 
Ten of the 11 included trials were conducted in the USA, and only one was from a low- or 
middle-income country (Martins 2009: Timor-Leste). 
Studies varied in size from 79 to 1078, with a mean of 430 participants, and most studies 
focused on very specific patient subgroups. Four studies were conducted among injection drug 
or cocaine users (Malotte 1998; Malotte 1999; Chaisson 2001; Malotte 2001), three on 
homeless or marginally housed adults (Pilote 1996; Tulsky 2000; Tulsky 2004), two studies on 
prisoners (White 1998; White 2002), and one assessed incentives given to adolescents aged 11 
to 19 years (Morisky 2001). Only one study involved members of the general adult population 
with TB, and this focused on malnourished men living close to the study clinics (Martins 2009). 
The studies assessed adherence to different stages of TB management. Some investigated the 
use of incentives in improving return for reading of tuberculin skin test results (Malotte 1998; 
Malotte 1999) while others focused on improving attendance at the clinic for initiation of 
treatment (Pilote 1996), adherence to preventive TB treatment (White 1998; Tulsky 2000; 
Chaisson 2001; Malotte 2001; Morisky 2001; White 2002; Tulsky 2004) and just one looked at 
adherence to treatment for active TB (Martins 2009). 
The trials investigated various types of incentives, and several trials had multiple study arms 
receiving different forms of both material and non-material incentives. Eight studies included a 
study arm given cash in values of US $5 or US $10 (Pilote 1996, Malotte 1998, White 1998, 
Malotte 1999, Tulsky 2000, Chaisson 2001, Malotte 2001, Tulsky 2004). Three studies gave 
vouchers which could be redeemed for groceries, food, transport, meals at fast food outlets or 
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phone calls (Malotte 1999, White 2002, Tulsky 2004), and one study gave food as a hot daily 
meal (Martins 2009). In one study, adolescent patients negotiated the incentive they received 
from their parents (Morisky 2001). Common choices included special meals at home, going to a 
movie or renting a video. 
These material incentives were compared with routine care, and in multi-arm trials also with 
motivational education (Malotte 1998; Malotte 1999), peer counselling (Morisky 2001; Pilote 
1996; Tulsky 2000), and standardised education sessions (White 1998; White 2002). In addition, 
one study compared different levels of incentive (Malotte 1998), one study compared an 
immediate incentive, given monthly throughout treatment, with a lump sum given on 
completion (Chaisson 2001), and two studies compared different forms of incentive (Malotte 
1999; Tulsky 2004).  
Characteristics of included studies with their risk of bias tables are presented in Appendix 2C.  
Excluded studies  
 
One study was excluded because in both arms of the trial, patients were given the same 
incentive (Nyamathi 2006). Two other trials were excluded from this review because they were 
quasi-randomized; in one, randomization was done by day of the week (Cheng 1997) and in the 
other it was done by the last digits in the participants' clinic record numbers (Morisky 1990). 
Three trials were excluded because they were cross sectional studies where one group was 
given the incentive and the other was not (Filho 2009, FitzGerald 1999, Yao 2008), and another 
was excluded because the main intervention was community health-worker delivered TB 
treatment combined with food supplements (Jahnavi 2010). 
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Characteristics of excluded studies are presented in Appendix 2D. 
Risk of bias in included studies  
 
Our judgements about the risk of bias in each included study are summarised in Appendices 2E 
(Risk of Bias Graph) and 2F (Risk of Bias Summary).  
Allocation (selection bias)  
The generation of the randomization sequence was judged to be adequate in eight trials (Pilote 
1996; White 1998; Tulsky 2000; Chaisson 2001; Malotte 2001; White 2002; Tulsky 2004, 
Martins 2009) and unclear risk in the remainder (Malotte 1998; Malotte 1999; Morisky 2001). 
The allocation concealment was judged to be adequate in four trials (White 1998; Malotte 
2001; White 2002, Martins 2009) and unclear risk in the rest. 
Blinding (performance bias and detection bias)  
The blinding of outcome assessors was adequate in three trials (White 1998; White 2002; 
Tulsky 2004) and unclear in the rest. 
Incomplete outcome data (attrition bias)  
All the included trials addressed incomplete outcome data adequately. 
Selective reporting (reporting bias)  
It was unclear to us if any of the included studies were free of selective outcome reporting, 
since the study protocols were not available and there was no earlier methods paper listing the 
pre-specified outcomes for any of the studies. 
Other potential sources of bias  
Our assessment indicated that studies were free of other biases, except Tulsky 2004. This trial 
compared the effects of cash and non-cash incentives among homeless adults on adherence to 
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treatment for latent TB infection as well as the length of time needed to look for participants 
who missed their dose of medications. Although the participants were described as homeless, 
the study groups were not the same with respect to their primary housing in the year prior to 
the study. In the cash incentive arm, 23% had lived in a shelter or on the street, whilst 41% of 
the non-cash incentive arm had done so (Tulsky 2004). This baseline difference had the 
potential to introduce systematic differences in study outcomes. 
Effects of interventions  
 
Analyses for each comparison are presented in Appendix 2G, and forest plots for each analysis 
in Appendix 2H. However, because of its importance for this thesis, the forest plot illustrating 
the effect of incentives in patients on treatment for active TB is presented below. 
Incentives versus routine care 
 
Return to clinic for tuberculin skin test reading 
Two studies in drug users from the USA compared material incentives ($5-$10) with routine 
care alone (Malotte 1998; Malotte 1999). 
Material incentives significantly increased the proportion of people who returned for reading of 
the tuberculin skin test (two trials, 1371 participants: RR 2.16, 95% CI 1.41 to 3.29; Analysis 1.1). 
Although there was significant heterogeneity between these studies (I2 = 86%), the 
heterogeneity relates to the magnitude of the observed effect, and not the direction or 
significance of the result. Both studies demonstrated a clinically important benefit. 
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Return to clinic for initiation or continuation of TB prophylaxis 
Three studies from the USA compared material incentives with routine care alone (Pilote 1996; 
White 1998; White 2002). Pilote 1996 gave $5 to homeless people on return to a clinic after a 
positive tuberculin skin test, White 1998 gave $5 when recently released prisoners attended a 
community clinic for continuation of TB prophylaxis, and White 2002 gave recently released 
prisoners food or transportation vouchers worth $25 upon presentation at a TB clinic. 
Incentives significantly increased clinic attendance for initiation or continuation of treatment 
for latent TB infection (three trials, 595 participants: RR 1.58, 95% CI 1.27 to 1.96; Analysis 1.2). 
Although heterogeneity between the relative effects was low (I2 = 0%), there was a wide 
variation in the absolute benefit achieved with incentives. In the two trials in prisoners, 
attendance at clinic remained lower than 25% even in the intervention groups. 
Completion of TB prophylaxis 
Three studies, again from the USA, examined the effect of incentives on completion of TB 
prophylaxis. Malotte 2001 gave a $5 cash incentive to drug users on attendance for twice 
weekly directly observed treatment, White 2002 gave recently released prisoners 
transportation vouchers worth $25 upon first presentation at a TB clinic, and Morisky 2001 
established an incentive agreement between adolescents aged 11 to 19 years and their parents, 
where parents provided cash or treats at various stages in the treatment process. 
Incentives had no statistically significant effect on the completion of TB prophylaxis (three 
trials, 869 participants: RR 1.79, 95% CI 0.70 to 4.58, Analysis 1.3). However, there was 
significant heterogeneity in these results (I2 = 90%). Malotte 2001 found a statistically 
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significant benefit with incentives (RR 14.53, 95% CI 3.64 to 57.98), but adherence in the control 
group was extremely low (3.6%). In Morisky 2001 completion of treatment was reasonable in 
the control group (77.8%), and did not significantly change with the incentive (76.4%), while in 
White 2002 completion remained low in both groups despite the intervention (13.8% control vs 
14.1% intervention). 
Completion of treatment for active TB 
One trial compared incentives given as food (in the form of hot meals at the clinic during the 
intensive phase of treatment followed by monthly food parcels) to nutritional advice alone 
(Martins 2009). Both arms received usual TB care. 
There was no significant difference in treatment completion rates between participants given 
nutritional supplements and those receiving nutritional advice alone (one trial, 265 participants, 
RR 0.98, 95% CI 0.86 to 1.12, Analysis 1.4). Treatment completion was below 80% in both the 
control (77.5%), and intervention groups (75.7%).  
Figure 2: Completion of treatment for active TB 
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Immediate versus deferred incentive 
Completion of TB prophylaxis 
One study, (Chaisson 2001) compared the effects of an immediate incentive ($10 for each 
monthly appointment attended) with the promise of a deferred lump sum ($10 for each 
appointment attended) on completion of TB prophylaxis. 
The participants who received the immediate incentives completed treatment more often than 
those whose incentives were deferred (83% vs 75%), but the difference was not statistically 
significant (one trial, 300 participants: RR 1.11, 95% CI 0.98 to 1.24; Analysis 2.1). 
Cash versus non-cash incentives 
Return to clinic for tuberculin skin test reading 
One study amongst injection drug and crack cocaine users (Malotte 1999), directly compared a 
cash incentive ($10) with non-cash incentives (grocery store coupons, bus tokens and fast food 
coupons equivalent in value to $10). 
The cash incentive was significantly more effective at increasing return for reading of tuberculin 
skin tests than any of the non-cash incentives (one trial, 651 participants: RR 1.13, 95% CI 1.07 
to 1.19; Analysis 3.1). 
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Completion of TB prophylaxis 
One study among homeless and marginally housed adults with latent TB infection (Tulsky 2004) 
compared a cash incentive ($5), with non-cash incentives (patients could choose between fast 
food or grocery store coupons, phone cards or bus tokens equivalent to $5). 
Again, the cash incentive was significantly more effective than the non-cash incentives (one 
trial, 141 participants: RR 1.26, 95% CI 1.02 to 1.56; Analysis 3.2). 
Different values of cash incentive 
Return to clinic for tuberculin skin test reading 
One trial (Malotte 1998), also compared different values of cash incentive ($10 versus $5). 
The $10 incentive significantly increased the proportion of patients returning to the clinic to 
collect their diagnostic TB test result compared to the $5 incentive (one trial, 404 participants: 
RR 1.08, 95% CI 1.01 to 1.16; Analysis 4.1). 
Incentives versus any other intervention 
Return to clinic for tuberculin skin test reading 
The two trials among drug users in the USA (Malotte 1998; Malotte 1999), also had a treatment 
arm which received 5 to 10 minutes of motivational education. The material incentives ($5 to 
$10) significantly increased the rate of return for tuberculin skin test reading compared to 
motivational education alone (two trials, 1366 participants:RR 2.16, 95% CI 1.56 to 3.00; 
Analysis 5.1). 
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Return to clinic for initiation or continuation of TB prophylaxis 
Two trials assessing return to clinic for TB prophylaxis compared material incentives with 
education or counselling. Both were from the USA; Pilote 1996 used peer counsellors to 
encourage homeless men and women to attend clinic after a positive test result, and White 
2002 gave education sessions every two weeks to prison inmates to encourage attendance at a 
community clinic upon release. 
There was no significant difference between material incentives and education or peer 
counselling (two trials, 535 participants: RR 1.10, 95% CI 0.92 to 1.31; Analysis 5.2). 
Completion of TB prophylaxis 
Three trials also used peer counselling or education sessions to promote completion of TB 
prophylaxis: one among prison inmates (White 2002), one amongst homeless adults (Tulsky 
2000), and one among adolescents (Morisky 2001). 
The results were mixed. In adolescents, completion rates were high in both groups and with no 
significant difference between groups (one trial, 387 participants: RR 0.95, 95% CI 0.86 to 1.06). 
Among the homeless, the cash incentive appeared more effective than counselling but 
completion remained low in both groups (one trial, 80 participants: RR 2.34, 95% CI 1.11 to 
4.93), and among prison inmates the trend was towards a benefit with counselling (one trial, 
370 participants: RR 0.58, 95% CI 0.31 to 1.09). 
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Potential effect modifiers 
 
The only potential effect modifier to be reported was educational status. Six trials assessed this 
and no effect on outcomes was noted (Pilote 1996; Malotte 1998; Malotte 1999; Malotte 2001; 
White 2002; Tulsky 2004). 
None of the studies reported their results subgrouped by HIV status. In three studies it was 
noted that HIV positive patients were included (Malotte 1998; Malotte 1999; Malotte 2001), in 
one study it was noted that the population from which the study sample was drawn had a 
generally low prevalence of HIV (Martins 2009), and in a further three trials HIV positive 
patients were actively excluded (Tulsky 2000; White 2002; Tulsky 2004). 
Adverse events 
 
Although adverse events due to the anti-TB drugs administered (such as isoniazid) were noted, 
adverse effects of the incentives/enablers themselves were not. No study documented what 
patients chose to purchase with the cash or vouchers, and no study recorded incidents of theft, 
fraud or a perverse incentive effect. 
Cost effectiveness 
 
We found one paper reporting a cost analysis (Kominski 2007), which related to an included 
trial (Morisky 2001). This trial involved the administration of an incentive to adolescents with 
latent TB (in the form of a "contingency contract" with their parents). 
As this trial failed to demonstrate any clinical benefit with the use of incentives, any further 
appraisal of the cost component was not considered useful. 
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Discussion  
Summary of main results  
 
When given as cash, incentives/enablers may increase the return rate for reading of tuberculin 
skin test results compared to normal care (low quality evidence), and will probably improve 
clinic re-attendance for initiation or continuation of anti-TB prophylaxis (moderate quality 
evidence). 
Cash incentives may also be more effective than non-cash incentives (low quality evidence), and 
higher amounts of cash may be more effective than lower amounts (low quality evidence). 
We currently don't know if material incentives/enablers can improve long-term adherence and 
completion of anti-TB treatment for active disease. Only one trial has assessed this and the 
incentive, given as a daily hot meal, was not well received by the population due to the 
inconvenience of attending the clinic at midday (very low quality evidence). 
Material incentives/enablers may be more effective than motivational education at improving 
return tuberculin skin test results (low quality evidence), but may be no more effective than 
peer counselling, or structured education at improving continuation or completion of 
prophylaxis (low quality evidence). 
Overall completeness and applicability of evidence  
 
In line with Cochrane methodology, the evidence reviewed for this chapter consisted only of 
randomised controlled trials. Whilst such studies are considered to provide the highest quality 
evidence on the effectiveness of interventions, it is important also to consider other study types 
which may also provide insight into other questions, such as the acceptability of an 
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intervention. Such studies are discussed in more detail in the discussion section of Chapter 3, 
and in the final review of evidence presented in Chapter 6.  
All but one of the studies included in this review were conducted in the USA, and in all but one 
the participants belonged to special groups (injecting drug users, homeless people, prison 
inmates, and adolescents). The applicability of these results to the broader adult population, 
especially in low- and middle-income countries where the burden of TB is highest, is therefore 
questionable. It is possible that these subpopulations have different relationships with material 
incentives than the general population, and a greater potential for misuse. 
Another important consideration in extrapolating these results to other populations is HIV. It is 
possible that HIV co-infection may affect adherence to anti-TB medications, either positively 
(for example through adherence education received in the HIV programme), or negatively (for 
example because illness prevents patients from attending the clinic, or because patients are 
already taking a number of medications for HIV). However, HIV was not considered in most of 
these studies. Since the risk of developing TB among patients with HIV is far higher than in 
those who are HIV negative (WHO 2009a), future studies on incentives/enablers for TB should 
specifically investigate the effect of HIV status on outcomes. 
In some settings, health workers and managers may be concerned about giving cash to 
patients. Indeed, this was the rationale for the inclusion of non-cash incentives in one of the 
trials in this review (Malotte 1999). The reason for this concern was not described in the trial, 
but could be related to the expenditure of cash on unhealthy purchases. Vouchers for specified 
goods cannot be spent on such items and in fact were demonstrated by this trial to have a 
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beneficial effect on return for tuberculin skin testing. None of the studies however investigated 
what purchases were made with cash or vouchers. 
A further objection to the use of incentives/enablers may be to the rationale of “paying the 
patient” to behave in a healthy way (when it is considered the patients' responsibility to do so). 
However, in poor settings, it may be difficult, if not impossible, for the patient to access the 
clinic or pay for medicines (McIntyre 2006). This acknowledgement underlies conditional cash 
transfer programmes in Latin America, where patients are assisted financially in return for 
behaviours that will promote the health of families (Lagarde 2007). In these programmes, the 
economic transfer may act more to enable, than to incentivise, a certain health behavious. Such 
programmes have been shown to have benefits in a poor population (Lagarde 2007), as well as 
in groups of vulnerable patients in wealthier settings (such as homeless people in the USA) 
(Pilote 1996). However, the ethics of "paying patients" who are not poor or vulnerable is 
beyond the scope of this review. 
Quality of the evidence  
The quality of evidence provided by this review has been assessed using the GRADE approach, 
and is presented in five summary of findings tables (Appendix 2I). The evidence is generally 
considered to be of low or very low quality which indicates that further research is very likely to 
change these estimates of effect. 
The main reason for downgrading quality was the indirectness of the evidence, with only one 
trial recruiting from the general adult population in low and middle income countries. 
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Potential biases in the review process  
We minimised potential biases in the review process by adhering to the guidelines of the 
Cochrane Collaboration (Higgins and Green 2011). We conducted comprehensive searches of 
both peer-reviewed and grey literature, without limiting the searches to a specific language. 
Two independent authors assessed study eligibility, extracted data, and assessed the risk of bias 
in each included study. 
Agreements and disagreements with other studies or reviews  
Consistent with the findings of relevant previous reviews (Lagarde 2007; Haynes 2008; 
Sutherland 2008), we found that material incentives/enablers may promote the uptake of 
health services in certain settings, although the evidence is of low to very low quality. To the 
best of our knowledge, our review is the most comprehensive synthesis of existing evidence on 
the effects of material incentives/enablers in patients undergoing diagnostic testing for TB or 
receiving drug therapy to prevent or cure TB. 
Authors' conclusions  
Implications for practice  
There is some evidence to support the use of material incentives/enablers to improve return 
rates for TB diagnostic test results and adherence to anti-TB preventive therapy. The data is 
currently limited to trials among predominantly male drug users, homeless, and prisoner 
subpopulations in the USA, and therefore the results are not easily generalised to the wider 
adult population, or to low- and middle-income countries, where the burden of TB is highest. 
Implications for research  
Further high-quality studies are needed to assess the effects and costs of incentives/enablers to 
improve adherence to the long-term treatment of active TB. 
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Future studies should specifically investigate the role of HIV and socioeconomic status in 
modifying the effects of incentives/enablers for TB treatment. The possible adverse effects of 
incentives/enablers such as misuse, fraudulent practices, the effect of incentives/enablers on 
non-recipients, and the perverse incentive effect, should also be considered. 
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Chapter 3 
Does economic support improve TB 
treatment outcomes in South Africa? 
Findings from the randomised controlled 
trial 
 
Introduction 
 
This trial centred on two related questions, namely whether it was feasible to deliver economic 
support in the form of a voucher to patients with TB in public sector clinics in South Africa, and 
whether this support was effective in improving the treatment outcomes of those patients.  
This chapter reports primarily on the effectiveness findings of the trial. The question of whether 
it is feasible to deliver this form of economic support in South Africa is answered primarily in 
Chapter 4 (process evaluation); however, elements related to the feasibility of distributing our 
voucher impacted on our findings of its effectiveness, and so are introduced in this chapter.   
The report of the conduct and findings of this trial was published in the journal “Trials” in June 
2013 (Lutge et al 2013). 
Background 
 
The randomised controlled trial is generally accepted to be the gold standard for generating 
evidence regarding the effectiveness or otherwise of an intervention. This is because 
Stellenbosch University  http://scholar.sun.ac.za
56 
 
randomisation ensures that comparison groups are very similar in terms of known and 
unknown factors that are related to trial outcomes.  Any effect demonstrated in a randomised 
controlled trial is more likely to be due to the intervention rather than to any confounding 
factor (Kirkwood 1988: 184). This was thus the design chosen to test our voucher.  
Because we felt it would be logistically easier for nurses to administer the voucher to all of their 
patients with pulmonary TB (as opposed to certain patients within the clinic who were 
randomised to receive the voucher) (Weijer et al 2011), and because we hoped to avoid 
creating resentment among patients who did not receive the voucher, we decided to use a 
cluster rather than an individually randomised design. The cluster design allowed nurses to 
deliver the voucher to all eligible patients in the same way that they would do if this were a 
routine programme of the Department of Health. This trial design was therefore considered not 
only the most appropriate for answering the question of effectiveness, but also for assessing  
the feasibility of voucher administration in public sector clinics in South Africa. 
Although the cluster design of this trial was the best way of achieving the trial’s aims, the 
design is more demanding than that of an individually randomised trial, both in terms of the 
sample size (which needs to be larger than in individually randomised trials because of the 
correlation between participants within clusters), and the statistical analysis (Campbell et al 
2004). In addition, issues of informed consent are more complex for cluster than for individually 
randomised controlled trials.  
For a trial where the unit of randomisation is the cluster, but the intervention is applied at the 
individual level (like this one), the description “individual-cluster” trial is used and consent for 
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participation can be taken at both the cluster and the individual level (Edwards et al 1999). At a 
cluster level, consent for participation can be given by a “guardian” (someone who has the 
authority to act on behalf of a cluster, and who will have the best interests of the cluster at 
heart) (Edwards et al 1999). Such a person may be democratically elected, or may occupy this 
position by virtue of their employment or position in society. At an individual level, patients 
within a cluster can, and some argue should, give their informed consent for participation 
(Weijer et al 2011). However, in cases where the research is very low risk, and/or obtaining 
informed consent from each individual might make the project unfeasible, individual-level 
consent in an individual-cluster trial may be waived (Weijer et al 2011).  
In order to test whether the administration of the voucher was feasible in the real world setting 
of public sector clinics in South Africa, this trial was pragmatic in design (Treweek and 
Zwarenstein 2009). The description of trials as pragmatic or explanatory was first made by 
Schwartz and Lellouch in 1967 (Schwartz and Lellouch 1967). Where pragmatic trials measure 
effectiveness (“the benefit the treatment produces in routine clinical practice”), explanatory 
trials measure efficacy (“the benefit a treatment produces under ideal conditions”) (Eldridge 
2010). Pragmatic trials are said to “help users choose between options for care” and 
explanatory trials, to “test causal hypotheses” (Thorpe et al 2009). Often, trials are not either 
“purely” pragmatic or explanatory but exist on a continuum where elements of both may be 
present (Thorpe et al 2009). The pragmatic-explanatory continuum indicator summary (PRECIS)  
tool describes 10 dimensions or domains which are building blocks in the design of a trial and 
which can sit anywhere along the pragmatic-explanatory continuum (Chaldikou et al 2012). 
These factors are: 
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 “Participant eligibility criteria 
 Amount of flexibility with which the experimental intervention is applied 
 Level of expertise practitioners have in using the experimental intervention 
 Selection of the comparison arm and the amount of flexibility with which it is applied 
 Level of expertise practitioners have in using the control intervention 
 Intensity of follow up 
 The nature of the primary trial outcome  
 Use of strategies to maintain compliance among participants and the measurement of 
patient compliance 
 Use of strategies to maintain compliance among practitioners and the measurement of 
practitioner compliance 
 Type of analysis used to evaluate the data” (Chaldikou et al 2012).  
 
These domains help to situate the trial on the pragmatic-explanatory continuum both in the 
design phase and once the trial has been completed (Chaldikou et al  2012). The Consolidated 
Standards for Reporting Trials (CONSORT) Statement guides the reporting of pragmatic trials 
(Zwarenstein et al 2008). The PRECIS tool is used to describe this trial (see Appendix 3A) and 
both the PRECIS tool and the CONSORT statement are used to discuss the trial and its findings. 
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Aim of the trial 
 
To evaluate the feasibility and effectiveness of economic support for improving treatment 
outcomes in patients with pulmonary TB in a province of South Africa 
Objectives of the trial 
 
 To design and conduct a pragmatic, cluster randomised controlled trial in public sector 
clinics in KwaZulu-Natal in consultation with managers of the national and provincial TB 
Control Programme 
 To develop a voucher which was recognised as legal trade by all stakeholders 
 To minimise potential misuse of the voucher by features of its design and administration 
 To train nurses in the delivery of the vouchers 
 To establish contracts with local shops for the redemption of the vouchers 
 To identify potential problems in the delivery of the vouchers as a routine part of the TB 
Control Programme of the Department of Health 
 To identify problems in the redemption of the vouchers at participating shops 
 To collect data on the outcomes on TB treatment of all participating patients, using 
routine Department of Health reporting systems 
 To compare the outcomes of patients in intervention clinics with those of patients in 
control clinics. 
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The specific objectives of the process evaluation accompanying the trial are outlined in 
Chapters 4 and 5.  
 
Study setting 
 
This study was conducted in KwaZulu-Natal, one of South Africa’s poorest and most populous 
provinces. The province has the second highest population and the second highest population 
density of the country, including the highest number of children under the age of one year (Day 
et al 2012: 202). Development indicators for the province remain poor, with 11.8% of adults 
over the age of 20 having had no schooling at all and a further 17.4% having had only some 
primary school education (Nzimande 2010: 22). The unemployment rate in the province (strict 
definition) is 29.2% (Gow et al 2007: 7) with over 50% of the unemployed having been without 
work for over three years (Gow et al 2007: 6).  
KwaZulu-Natal has the highest incidence of TB in the country (1142 per 100 000) (Day et al  
2012: 89) as well as the highest HIV prevalence rate  (39.5%) (Day et al 2012: 203; UNAIDS 
2008).  Probably due to its high burden of HIV (Day et al 2012: 90), the province has for several 
years had the dubious honour of having the highest number of TB patients in the country (120 
421 cases of all types of TB in 2010) (Day et al 2012: 202). Tuberculosis is the most important 
cause of death in the province, causing 16.2% of all deaths in 2009 (Statistics South Africa 2011: 
81).  
At the request of a senior TB programme manager, our trial included one urban district 
(eThekwini, also known as the city of Durban) and one rural district (Uthungulu). Uthungulu has 
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the fifth highest and eThekwini the sixth highest TB incidence of the 52 districts in the country 
(Day et al 2012: 90). Cure rates in these districts are low, however; both fall below the national 
average, with eThekwini ranked 41st, and Uthungulu 36th out of 52 districts (where first is best 
and 52nd is worst) (Day et al 2009: 101).  In both eThekwini and Uthungulu, TB is the most 
important cause of death, causing 14.9% and 17.4% of all deaths in these districts in 2009 
respectively (Statistics South Africa 2011: 94). At 46.4%, Uthungulu has the highest prevalence 
of HIV in the country, as measured by the annual Antenatal HIV Prevalence Survey (Day et al  
2012: 203).  
The poverty rate amongst individuals in KwaZulu-Natal is the second highest in the country, at 
58.5%, and just over a quarter (25.5%) of all poor individuals in the country live in the province 
(Armstrong et al 2008). In a deprivation ranking of all South African districts, eThekwini lies 
within socio-economic quintile 4, and Uthungulu in socio-economic quintile 2 (where quintile 5 
is least deprived, and quintile 1 is most deprived) (Day et al  2009: 2). Within eThekwini 
however, are large areas of deep poverty, such as informal settlements and former townships. 
It is in these areas of the city that the study was conducted.  
 
 
 
 
 
Stellenbosch University  http://scholar.sun.ac.za
62 
 
Figure 1: Map of KwaZulu-Natal 
 
(Source: GIS Unit, KwaZulu-Natal Provincial Department of Health, August 2012).  
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Methods 
 
Trial design 
 
This was a pragmatic, open, two-arm cluster randomized controlled trial, using primary health 
care clinics as clusters. 
Nested within the controlled trial was a process evaluation, which consisted of two parts: an 
assessment of how participants responded to the vouchers (reported in Chapter 4), and an 
assessment of the impact of the voucher on patients’ household economies (reported in 
Chapter 5).  
Study setting and participants 
Clinics 
 
Public sector (government-funded) primary care clinics were chosen for this study, since these 
treat the majority of patients with TB in South Africa. These clinics are managed by professional 
nurses, and staffed by nurses of all grades.   
Clinics with cure rates of between 40% and 70% for the year preceding the trial were eligible for 
inclusion in the study. The upper limit was set because demonstrating a clinically meaningful 
effect in clinics with cure rates higher than 70% would have required a very large sample size. 
The lower limit was set to reduce between-clinic variability and to exclude clinics where poor 
service provision and systemic weaknesses may have contributed to poor treatment success 
rates. In addition, only clinics seeing between 20 and 150 new smear positive TB patients per 
year were eligible for inclusion. The lower limit was set in order to meet the sample size 
Stellenbosch University  http://scholar.sun.ac.za
64 
 
requirements of the trial, and the upper limit was set because implementing the intervention in 
very large clinics would have exceeded the limited budget of this trial.  
Patients 
 
All patients diagnosed with pulmonary TB that was considered to be sensitive to routine TB 
treatment, and attending intervention clinics within the period 01/07/2009 to 31/03/2010 were 
recruited into the trial; however, only patients who started TB treatment within this 
recruitment period were eligible for analysis. Patients were followed up to the end of their 
treatment (which is a maximum of six months in new cases and eight months in re-treatment 
cases). Both adults and children were included in the analysis because, as a high burden 
country, there are a significant number of children receiving treatment for TB in South Africa 
(Marais et al 2006).  
Intervention 
 
A voucher, valued at ZAR 120 (approximately $US 14.60 at the start of the trial) was offered to 
patients by nurses every month on collection of their treatment, to a maximum of eight 
months. A copy of a voucher is presented in Appendix 3B. 
The vouchers were redeemable at specific general stores, chosen by the nurses at each 
participating clinic on the basis of their proximity to the clinic and the relative costs of their 
goods. At the request of TB programme managers, patients were advised by clinic nurses to 
spend the vouchers on healthy foodstuffs; however, nurses did not monitor their expenditure 
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and the stores were asked to allow patients to purchase any goods up to the value of the 
voucher.  
Patients at control clinics received usual TB care.  
Pilot study 
 
The voucher and its administration were piloted in two clinics (one rural, one urban) prior to 
the trial. On the basis of the pilot study, minor modifications to the trial methodology were 
made. Specifically, since it was found during the pilot that many patients did not possess 
identity documents (ID books), the recording of a patient’s identify number on the voucher was 
no longer mandatory in the main trial. However, the presentation of a patient’s clinic book5 was 
made mandatory, to confirm the patient’s identify and eligibility for receipt of the voucher.  
Support from study team for voucher delivery 
 
Prior to the inception of the trial, the principal investigator and her assistant showed the TB 
nurses at each intervention clinic how to administer the voucher. Each nurse was given a study 
information sheet containing this information (see Appendix 3C). If nurses were replaced, 
outgoing nurses explained the process to new nurses and this was reinforced by an additional 
visit from the principal investigator. Nurses were able to telephone the principal investigator at 
any time to discuss queries about the voucher or its delivery. The principal investigator and her 
                                                          
5
 The patient’s clinic book is a patient-held document that lists his or her diagnosis, treatment, clinic visits and, in 
the case of TB, number of doses of medication taken as verified by a DOTS supporter (a community-based lay 
health worker who supports TB treatment adherence).  
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assistant visited each intervention clinic every four to six weeks to collect the voucher receipts 
from the TB nurses and to discuss any problems that might have arisen in the trial.  
Similarly, managers of participating shops were shown how the voucher was to be used at the 
outset of the study. Managers were responsible for training cashiers in the use of the voucher. 
Shops were visited by the principal investigator and her assistant every four to six weeks and at 
these visits, any problems with the administration of the voucher were discussed.  
Logistics of voucher delivery 
 
Nurses at intervention clinics were supplied with voucher books consisting of 100 vouchers 
each. In order to receive a voucher, patients were required to come to the clinic on the dates 
stipulated by the nurses, and also to present their clinic books with verification of adherence by 
their DOTS supporters. Pill counts were done by nurses if adherence was in doubt.  
Each voucher had a unique number and consisted of three copies (pink, yellow and green).   The 
vouchers were carbonised so that the information entered by the nurse onto the top copy 
would appear on two other copies below. The nurse entered the patient’s name, gender, ID 
number and clinic number on the voucher, signed it and stamped the top copy with the clinic 
stamp. A unique sticker was placed on each voucher, without which it could not be redeemed, 
to minimise the risk of fraudulent copies of vouchers being made and used. The nurse gave the 
patient the top two copies of the voucher and kept the third copy at the clinic.  
The patient took the two copies of the voucher to the designated shop and exchanged these for 
goods. Both copies of the voucher were retained by the shop. Every four to six weeks, the 
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principal investigator collected one copy of the vouchers from the shop, and used these to 
calculate the amount owed to the shop for goods purchased. This amount was deposited into 
the shop’s bank account by electronic transfer. The shops kept one voucher copy for their own 
records. 
In order to prevent “leakage” of vouchers to patients who were not eligible to receive them 
(Lagarde et al 2009), patients were asked to present their ID books, if available, and clinic books 
on redemption of the vouchers; these were presented on the patients’ behalf if relatives or 
friends redeemed vouchers for very sick patients. Vouchers had to be redeemed within one 
month of acquisition, and could not be exchanged for cash. No change was given by the shops if 
the full amount was not spent, although patients could supplement the vouchers with their 
own cash. The till slips, or written lists,  indicating the purchases made and their prices, were 
attached by cashiers to the redeemed vouchers and collected with the vouchers by the 
principal investigator.  The vouchers collected from the shops were tallied with those collected 
from the clinics. Each voucher received from the clinics and redeemed from the shops was 
linked with individual patient data, so that for each patient the number of vouchers received 
and redeemed was ascertained.  
The data on patient purchases was analysed and is reported in Chapter 5.  
Ethics and consent 
 
Ethical approval for the trial and its process evaluation was received from the Committee for 
Human Research at the University of Stellenbosch (reference N07/10/245) (see Appendix 3D). 
Permission to conduct the trial was received from the KwaZulu-Natal Provincial Department of 
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Health, the eThekwini and Uthungulu District Offices, the Health and Safety Sub-Committee of 
elected City Counsellors and the Research Committee of the eThekwini Municipality, the 
traditional leaders of the isigodi (wards) where rural clinics were situated, and the sisters in 
charge at individual intervention clinics. Although all participants in the main trial were 
informed verbally and in writing of the study, individual written consent from patients in 
intervention clinics was not sought, as acceptance of the voucher was interpreted as consent. 
Waiver of written informed consent from patients in intervention clinics was sought from and 
approved by the Committee for Human Research at the University of Stellenbosch before the 
trial started.  
Individual written informed consent was obtained for all participants in the process evaluation 
sub-studies of the trial, in the language of their choice (either isiZulu or English) (see English 
versions in Appendices 3E and F).  
Registration 
 
This trial is registered with Current Controlled Trials (reference ISRCTN50689131), the South 
African Clinical Trials Registry (reference DOH-27-0409-2791), the Wellcome Trust Register of 
Clinical Trials (reference 083619), and the Pan African Clinical Trials Registry (reference 
PACTR2010010001275437).  
The trial protocol is presented in Appendix 3G.  
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Outcomes 
 
The primary outcome was TB treatment success, defined as the sum of those patients cured 
and those completing treatment. Secondary outcomes were default and treatment failure 
rates. Data on other routine TB treatment outcomes were also collected, as described below.  
The World Health Organisation definitions for these outcomes, which are used in South African 
clinics and were used for the purposes of this study, are as follows:  
 
TREATMENT SUCCESS: “A patient who was cured or who completed treatment” (WHO 2009b) 
CURED:  “A patient who was initially smear-positive and who was smear negative in the last 
month of treatment and on at least one previous occasion” (WHO 2009b) 
COMPLETED TREATMENT: “A patient who completed treatment but did not meet the criteria 
for cure or failure”. This definition applies to pulmonary smear-positive and smear-negative 
patients and to patients with extra-pulmonary disease (WHO 2009b) 
TREATMENT INTERRUPTION: “Cessation of treatment for less than two months” (WHO 2007) 
TREATMENT FAILURE: “A patient who was initially smear-positive and who remained smear-
positive at month 5 or later during treatment” (WHO 2009b) 
DEFAULTED:  “A patient whose treatment was interrupted for 2 consecutive months or more” 
(WHO 2009b) 
DIED: “A patient who died from any cause during treatment” (WHO 2009b) 
TRANSFERRED OUT: “A patient who transferred to another reporting unit and for whom the 
treatment outcome is not known” (WHO 2009b) 
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MDR TB: Infection with bacilli resistant to at least rifampicin and isonizid treatment (WHO 
2007b). 
 
TB treatment outcomes were ascertained by participating clinics using their usual procedures. 
In smear positive patients, this was done through sputum microscopy and culture after six or 
eight months of treatment (in the cases of new and re-treatment patients respectively). In 
smear negative patients, where initial diagnosis is based on chest x-rays and clinical signs, cure 
cannot be determined and treatment completion is the outcome used (Department of Health 
2009). In keeping with its pragmatic nature, no additional clinical investigations were 
performed for the purposes of this trial.  
Data on factors that have been shown to impact on adherence to treatment (Kipp et al 2011, 
Munro et al 2007a) were also collected. These factors were age, gender, employment status, 
type of TB and HIV status (determined by PCR or ELISA tests).  
Clinic TB registers and individual patient files (held at the clinics) were the main sources for all 
these data. Patient files are completed by the consulting nurse, and clinic registers are 
completed in many cases by a clerk attached to the TB programme in the clinic. The latter are 
checked by the nurse or sister in charge of TB at the clinic. In a few small clinics, where clerks 
are not available, this record keeping is done by the nurse working in TB. In this study, the clinic 
register was the primary source of data. Patient files were used to fill in missing data for any 
patients whose information in the clinic registers was incomplete.  Data obtained from clinic 
registers was checked for accuracy by comparing the outcomes obtained with those in a sample 
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of individual patient files. A ten percent random sample of data from the total trial population 
was checked. This was done by randomly identifying a starting point on the trial database, and 
retrieving every tenth patient file for those patients from the clinic.  
Statistical methods 
 
Sample size 
 
At the time of the study, there were a total of 144 clinics in the urban, and 68 clinics in the rural 
district, providing TB care. A list of those clinics meeting the inclusion criteria was constituted. 
Twenty one clinics in the urban and five in the rural district were eligible for inclusion. 
An intra-cluster correlation co-efficient (ICC) of 0.03 was calculated based on pre-trial data from 
the clinics. To detect a 15% difference in treatment success rates (which we felt would be the 
minimum required to influence policy), based on a power of 90%, at a significance level of 5% 
(two sided test) and an average cluster size of 100, 18 clinics were necessary. Twenty clinics 
were however included in the sample, to allow for clinic drop out during the trial.  
Randomisation 
 
The 20 study clinics were randomly selected from the 26 eligible clinics stratified by district (21 
in eThekwini and 5 in Uthungulu). Sixteen study clinics were selected in the urban and 4 in the 
rural district. Within the two districts the study clinics were randomly assigned in a 1:1 ratio, 
using a randomisation list generated by the study statistician.  
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 Clinics were allocated to intervention or control groups by the study statistician and no 
changes were made to this allocation. Staff in all clinics were aware that they were part of a 
trial to test the effectiveness of a voucher.  
Clinics were enrolled by the principal investigator, and participants within the clinics were 
enrolled by the nurses in charge of TB care at each clinic.  
Blinding 
 
Because of the nature of the intervention, no blinding was possible in this study. Data 
extractors were not blinded as it was considered neither practical nor feasible to conceal from 
them the intervention status of the clinics from which they collected data.  
Analysis 
 
Analysis was by intention to treat (ITT) and patient level data was used for this purpose.  
For the binary study outcome (treatment success achieved, not achieved) a generalised linear 
model (GLM) was used to evaluate the intervention effect with adjustment for the stratification 
of clinics at randomisation. The clustering effect of clinics was taken into account through 
cluster robust variance estimation. 
An exploratory analysis was also done for the primary outcome, in order to assess the effect of 
the voucher on patients in intervention clinics who actually received it.  This analysis was based 
on a “per protocol” analysis. Although in a strict per protocol analysis, only patients who 
received a voucher every month in their treatment period would be included, in this 
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exploratory analysis we included all patients in the intervention group who had received at 
least one voucher.  The control group remained unchanged.  
 
As an ancillary analysis of the ITT study population, a multiple regression model (GLM) was used 
to investigate the impact of adjusting for selected covariates on the estimated intervention 
effect. The covariates included in this model were employment status, whether the participant 
was a minor, whether the TB type was smear positive or diagnosed clinically or on x ray, and 
gender. The model was evaluated for interaction effects between the intervention and any of 
the covariates.  
 
A further secondary analysis was done to test for a dose-response effect in the intervention 
arm. The study outcome was evaluated against the number of months the participant had 
received a voucher. The GLM approach was used for this purpose (McCullagh and Nelder 1989). 
Results 
 
Participant flow 
 
As seen in the following flow chart, there was no loss of clinics in the trial, and all eligible 
patients in each clinic were included in the analysis. Loss to follow up was small, with outcome 
data unavailable on 0.2% of patients in intervention clinics and 0.7% of patients in control 
clinics.  
Figure 2: Participant flow diagram 
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212 TB clinics assessed 
for eligibility
. 
10 Clusters received 
the intervention 
(planned sample 
size: 900 patients). 
10 Clusters 
assigned control
(planned sample size: 900 
patients). 
Outcome data collected on  
2107 
TB patients post-
randomisation  (outcome 
data not available for 5 
patients). 
Outcome data collected on  
1984 
TB patients post-
randomisation (outcome 
data not available for 13 
patients). 
26 Clinics eligible (21 
in urban area and 
5 in rural area). 
20 Clusters 
randomised
20 Clinics randomly 
selected
Clinics not included in the trial
Urban 
district
Rural 
district
Total facilities 174 74
Hospitals 30 9
Results not available 25 15
Cure rate too high and 
too small
0 8
Cure rate too low and 
too small
49 3
Cure rate too low 13 1
Cure rate too high 1 0
Clinic too small 24 31
Clinic too big 11 2
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Recruitment 
 
Recruitment of patients took place over eight months (July 2009 to March 2010 inclusive). 
Patients who started treatment during this period were followed up to the end of their 
treatment. The trial ended on 30/09/2010, when the last recruited patients completed their full 
course of treatment.  
Numbers analysed 
 
A total of 4091 patients were included in this study, 1 984 in the control arm and 2 107 in the 
intervention arm. The number of patients enrolled by clinics varied between 68 and 335.  
Baseline data  
 
The baseline characteristics of the two groups are presented in a comparative table (Table 1).  
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Table 1: Baseline characteristics of trial cohorts* 
 Intervention clinics Control clinics 
Total number of trial 
participants 
2 107 1 984 
Minimum number of 
participants per  clinic 
122 68 
Maximum number of 
participants per  clinic 
335 335 
Mean age of participants 29 years 32 years 
Number (percentage) of male 
participants 
1058 (50.2%) 1069 (53.9%) 
Number (percentage) of 
participants in rural district 
266 (12.6%) 167 (8.4%) 
Number (percentage) of HIV 
positive participants 
910 (68.0%) (1338 patients for 
whom a record of HIV testing 
was available) 
1106 (73.0%) (1515 for whom a 
record of HIV testing was 
available)  
Number (percentage) of 
unemployed participants 
1 081 (60.2%)  1 228 (66.2%) 
Number (percentage) of child 
participants (less than 13 years) 
386 (21.5%) 251 (13.5%) 
Number (percentage) of smear 
positive participants 
903 (42.9%) 882 (44.5%) 
* Data on HIV status and employment were not available for all patients. 
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Primary Outcomes  
 
Intention to treat analysis showed a small and non-significant improvement in treatment 
success rates in the group receiving the vouchers.  Exploratory analysis6 however showed a 
significant improvement in treatment success rates in the intervention arm (Table 2).  
Table 2: Primary outcome (treatment success) – intention to treat and exploratory analyses 
Outcome Intervention group 
(%) 
Control group 
(%) 
Risk 
difference (%) 
(95% 
confidence 
interval) ‡ 
p-value 
Treatment 
success: 
Intention to 
treat  analysis 
1 606/2107 
(76.2) 
1 402/1984 
 (70.7) 
5.6%  
(-1.2; 12.3%) 
0.107 
Treatment 
success: 
Exploratory 
analysis 
1 051/1294 (81.2) 1 402/1984 
(70.7) 
10.6% 
(3.7; 17.5%)         
0.003 
† The estimated ICC for our study for the primary outcome was .033. This is very close to the ICC 
assumed in the sample size calculation (.03). 
‡ Estimate from GLM model. 
There was greater variability in the outcomes of clinics in the control arm compared to the 
intervention arm. There were four clinics in the intervention arm with treatment success rates 
of more than 80%, compared to only two in the control arm, and three clinics in the control arm 
with treatment success rates of less than 65% compared to none in the intervention arm (Table 
3). 
                                                          
6
 The exploratory analysis was a modified per protocol analysis, where all patients who received at least one 
voucher were compared to the control group.  
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Table 3: Treatment success per clinic for intervention and control clinics (intention to treat 
analysis) 
Intervention clinics Control clinics 
Clinic Treatment 
success (%) 
Other TB 
outcome (%) 
Clinic Treatment 
success (%) 
Other TB 
outcome (%) 
1 202 (80.16) 50 (19.84) 1 88 (89.80) 10 (10.20) 
2 238 (78.55) 65 (21.45) 2 99 (52.66) 89 (47.34) 
3 198 (68.99) 89 (31.01) 3 112 (58.03) 81 (41.97) 
4 198 (68.99) 89 (31.01) 4 240 (71.64) 95 (28.36) 
5 83 (68.03) 39 (31.97) 5 204 (73.81) 72 (26.09) 
6 274 (81.79) 61 (18.21) 6 159 (68.24) 74 (31.76) 
7 82 (66.67) 41 (33.33) 7 140 (72.16) 54 (27.84) 
8 183 (81.33) 42 (18.67) 8 233 (77.67) 67 (22.33) 
9 106 (83.46) 21 (16.54) 9 85 (85.86) 14 (14.14) 
10 104 (74.82) 35 (25.18) 10 41 (60.29) 27 (39.71) 
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Secondary outcomes  
 
The treatment completion rates of patients in the intervention arm were almost ten percent 
higher than those in the control arm; however, the cure rates of patients in the intervention 
arm were slightly lower than those in the control. Default, treatment interruption and 
treatment failure rates were all lower in the intervention arm (Table 4).7  
Table 4: TB treatment outcomes for patients in intervention and control clinics 
Treatment outcome Intervention group (%) 
(n=2107) 
Control group (%) 
(n=1984) 
Total (%) 
Treatment completed 911 (43.2) 694 (35.0) 1605 (39.2) 
Cured 695 (33.0) 708 (35.7) 1403 (34.3) 
Defaulted 158 (7.5) 202 (10.2) 360 (8.8) 
Treatment interrupted 0 (0.0) 15 (0.8) 15 (0.4) 
Treatment failure 79 (3.8) 113 (5.7) 192 (4.7) 
MDR TB  1 (0.1) 3 (0.2) 4 (0.1) 
Died 151 (7.2) 137 (7.0) 288 (7.0) 
Moved/transferred 107 (5.1) 99 (5.0) 206 (5.1) 
No outcome data available 5 (0.2) 13 (0.7) 18 (0.4) 
 
                                                          
7
 Because most data were extracted from clinic registers, the reasons for default and the causes of death were not 
available. 
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Ancillary analysis 
 
All patients were included in this analysis, although data on HIV status were missing for 1252 
patients.  
 
The intervention effect shown (4.2%) is slightly smaller than in the unadjusted intention to treat 
analysis (of 5.6%). Thus about 1.5% of the intervention effect in the unadjusted analysis can be 
explained by differences in the intervention and control clinics.  
 
Patients who were unemployed had significantly lower treatment success rates than those who 
were employed. Children under the age of 13 had significantly better treatment success rates 
than those over 13 years, and women had better rates than men. Patients with smear positive 
TB had significantly better treatment success rates than those with smear negative TB, whilst 
patients on re-treatment (after default, completion or failure) had significantly lower treatment 
success rates than new patients. HIV positive patients had significantly lower treatment success 
rates compared to those who were HIV negative. No significant interactions between any of 
these sub-groups were found (Table 5).  
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Table 5:  Regression model showing patient characteristics associated with treatment success 
(GLM model) 
 
Patient characteristic Number Risk difference 95% confidence interval P-value 
Intervention group indicator 4091 0.042 -0.024; 0.109 0.211 
Unemployed  3650 -0.052 -0.094; -0.009 0.017 
Child  3650 0.058 0.008; 0.107 0.024 
Smear positive TB  3614 0.043 0.01; 0.076 0.011 
Re-treatment (versus new cases) 4084 -0.110 -0.16; -0.076 <0.001 
HIV positive (versus HIV negative) 2839 -0.052 -0.083; -0.021 <0.001 
Female 4076 0.043 0.023; 0.063 <0.001 
Intercept*  0.718   
*The intercept represents the outcome in the control arm when all other covariates = 0.  
Adherence to the intervention 
 
Of all 2076 patients who were eligible to receive a voucher for the six to eight months of their 
treatment, 813 (36.2%) did not receive a voucher at all, and 671 (32.3%) received a voucher for 
between one and three months. The remainder received a voucher for four to eight months of 
treatment. In many cases, nurses in intervention clinics gave vouchers to those patients they 
considered more needy (process evaluation, reported in Chapter 4). This preference for giving 
vouchers to patients who were relatively more deprived is illustrated in an analysis of eligible 
patients who received at least one voucher, compared to eligible patients who didn’t receive 
any vouchers at all (Table 6). There were significantly more unemployed patients in the group 
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that received vouchers (p = 0.04), whilst there were significantly fewer children in the group 
that received vouchers (p = 0.03). In addition, women were more likely to receive vouchers 
than men (p = 0.026).  
Table 6: Comparison of eligible patients who received vouchers with eligible patients who did 
not8 
Received at least 
one voucher 
Employed 
(%) 
Children 
(%)  
Pensioner 
(%) 
Student 
(%) 
Unemployed 
(%) 
Total 
(%) 
No 117 (17.06) 178 
(25.95)        
12 
(1.75) 
2 
(0.29) 
377 
(54.96) 
686 
(100) 
Yes 172 
(15.82) 
202 
(18.58)        
16 
(1.47) 
6 
0.55 
691 
(63.57) 
1,087 
(100.00) 
 
Another reason for the failure of eligible patients to receive a voucher every month may have 
been that nurses did not always give patients vouchers on the days that they came to collect 
their TB tablets. In some cases, this was because new voucher books had not yet been delivered 
to the clinics by the investigators, and in other cases it was because nurses preferred to give all 
vouchers out at month end (process evaluation, reported in Chapter 4).  
 
 
                                                          
8
 The patients analysed in this table represent the sub-set of trial patients for whom data on employment status 
was available.  
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Dose-response analysis 
 
There was a strong dose-response effect (p<0.001) (Figure 2).  The treatment success rate of 
patients who did not receive any vouchers was 68.3%, compared to a rate of more than 90% in 
patients who received a voucher for five months or more.  
Figure 3: Effect of increasing frequency of vouchers on treatment success rate 
 
 
Adverse events 
 
The adverse events investigated in this study were those related to the voucher, and not to the 
clinical consequences of TB or its treatment.  Specifically, there were very few reports of 
patients spending the vouchers on alcohol or cigarettes (assessment of expenditure of 
vouchers, reported in Chapter 5), very few reports of leakage of vouchers, and no reports of 
coercion of staff by patients to give them a voucher (process evaluation, reported in Chapter 4).  
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Other adverse events are discussed in more detail in the first part of the process evaluation 
(reported in Chapter 4) but are outlined briefly here. Some patients reported in interviews that 
when relatives or friends had redeemed vouchers on their behalf, the relatives had not given 
them (the patients) the goods. Finally, those patients who did not receive the vouchers (that is, 
those with extra-pulmonary TB) expressed varying degrees of anger about this, both to clinic 
nurses and to the principal investigator (process evaluation, reported in Chapter 4).  
Discussion 
 
This was the first trial in Africa to investigate the effect of economic support (a monthly 
voucher) on TB outcomes. The trial found a 5.6% improvement in treatment success rates 
among patients who received the voucher, meaning that for every 1000 patients who received 
the voucher, an additional 56 would have achieved treatment success. This was lower than the 
15% difference that the study was powered to detect, which explains in part, the failure of the 
trial to achieve a significant result. This failure may be further explained by low fidelity to the 
intervention, which is discussed further in the process evaluation described in Chapter 4. The 
exploratory analysis, which compared patients who had received at least one voucher in 
intervention clinics to the control group, showed significantly higher treatment success rates in 
intervention compared to control clinics. A powerful dose-response effect was also 
demonstrated, with patients who received vouchers more frequently being more likely to 
complete treatment.  These analyses are discussed further below.  
 Although we expected that the voucher would incentivise patients’ clinic visits, our main aim in 
providing it was to make adherence easier by ameliorating two features of poverty which are 
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commonly associated with TB: under-nutrition and limited access to health care (Hargreaves et 
al 2011). We hypothesised that the voucher (if used for purchasing food) could have improved 
patients’ food security and released household funds for use elsewhere, such as for transport 
to the clinic (Munro et al 2007a). In 2008, 71% of the households in KwaZulu-Natal lived on less 
than 40% of the median per capita income of R569.00 per month (Hall 2010). Thus, like 
conditional cash transfers, it would have served both as an incentive and as an enabler to 
access TB care. 
Some randomised controlled trials have tested the effects of economic incentives in the context 
of TB. However, in the Cochrane review reported in Chapter 2, only one included trial focused 
on participants with active TB. In that study (conducted in a low income country), nutritional 
(food) support to patients on TB treatment had no effect on treatment completion rates 
(Martins et al  2009). Other non-randomised studies investigating the use of financial incentives 
in patients with active TB have had varying results. One such project in China where both 
patients and providers received cash incentives, showed no impact on TB outcomes (Yao et al  
2008). A second project in Cambodia, where patients with TB received nutritional 
supplementation and participated in a microfinance programme, showed improved cure rates 
in the intervention group (Thim et al 2004). Although several large conditional cash transfer 
programmes show positive effects on household food security and access to health care, their 
effect on TB outcomes has not been measured (Boccia et al 2011). To our knowledge, no 
studies have tested the impact of economic support on TB outcomes in Africa, where the 
burden of TB is among the highest in the world and where poverty is extensive.  
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Social and economic interventions to strengthen TB control are rare (Hargreaves et al 2011). In 
South Africa, patients with TB may be given food parcels when they collect their treatment, and 
may also be eligible to receive a disability grant. Although data on receipt of food parcels and 
disability grants are not recorded in the TB registers at South African clinics, and were therefore 
not collected in this trial, we expect that, due to randomisation, the proportions of patients 
receiving them would be the same across intervention and control clinics. 
In our study, the lack of a statistically significant effect in the intention to treat analysis may be 
due in part to the low fidelity to the intervention. It is likely that eligible patients who did not 
receive any vouchers at all were considered by nurses not to need them. Nurses in the trial, 
who are used to rationing food supplements to those patients whom they consider most needy, 
tended to give vouchers out in the same way (process evaluation, reported in Chapter 4). This is 
supported by the finding that unemployed patients in intervention clinics were more likely to 
receive vouchers than patients who were employed. Interestingly, eligible children were less 
likely to receive vouchers than adults, and although this seems surprising, it must be noted that 
the majority of these children would have been in receipt of a child support grant. One of the 
criteria reported by nurses for not giving vouchers to eligible patients was their receipt of other 
forms of state grants (process evaluation, reported in Chapter 4). 
Eligible patients who received the vouchers only sometimes (as opposed to every month of 
treatment) may have been asked to make an additional visit to the clinic to collect the 
vouchers, either because the new voucher books had not yet arrived at the clinics, or because 
nurses preferred to give vouchers out at the end of the month (process evaluation, reported in 
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Chapter 4). This may have been difficult for some patients, either because they were too sick or 
too busy to travel or could not afford to travel. More rigorous monitoring of our intervention 
may have improved fidelity, and made it easier for a trial of this size to detect a significant 
effect (Oxman et al 2009). However, an important aim of this pragmatic trial was to assess the 
feasibility of administering such vouchers under normal public sector clinic conditions (process 
evaluation, reported in Chapter 4) (Zwarenstein et al 2008).  
In a similar way to a per protocol analysis, the exploratory analysis attempted to estimate what 
effect the voucher might have had, if it had been administered closer to the way in which it was 
intended (Thorpe et al 2009). The patients in intervention clinics who received a voucher at 
least once were likely to be systematically different from the patients in intervention clinics 
who received no vouchers, and so not only is the potential bias in this exploratory analysis 
acknowledged, it can also to a certain extent be described (Zwarenstein et al 2008). The 
patients who received the vouchers were more likely to be unemployed and more deprived, 
than those who did not, because of the nurses’ sense that it was unjust to give the vouchers to 
patients who needed them less (process evaluation, reported in Chapter 4). The analysis 
suggests that, in patients who received them, the vouchers did have a significant effect on 
treatment outcomes. Although the intention to treat analysis is presented as the main and 
most important finding of this trial, the exploratory analysis is included because it adds possible 
explanatory detail to the trial, and because it raises questions for further research. These 
questions, and others arising from this trial, are discussed in Chapter 6.  
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The findings of the dose response analysis support those of the exploratory analysis by 
suggesting that these vouchers have the potential to significantly improve outcomes on TB 
treatment. The fact that the sub-groups of patients who received the vouchers more frequently 
achieved significantly better TB outcomes than those who received it less frequently, implies 
that higher fidelity to the intervention, with delivery of the voucher to all eligible patients, may 
produce a significant benefit. In addition, the dose-response analysis argues against a perverse 
incentive effect of the voucher. If patients did try to remain ill in order to continue receiving the 
voucher, treatment success rates would have fallen with frequency and duration of receipt. This 
is an important finding, given the local and global concern about this unintended consequence 
of conditional cash transfers, economic incentives and results-based financing (Oxman and 
Fretheim 2009). However, a caveat to the interpretation of this dose reponse analysis is that it 
is possible that patients who attended clinics more regularly were more likely to receive 
vouchers, making it difficult to differentiate cause and effect. The possibility of reverse causality 
cannot be ruled out here and should be investigated in further trials in this field.  
In this study, the conditionality (of adhering to TB treatment) appeared not to be difficult to 
enforce. Nurses were able to confirm that patients were indeed taking their tablets (and not 
just collecting them) by checking their clinic books, which DOTS supporters notated every time 
patients took their tablets. Although this method is not fool-proof, the data on TB outcomes 
support the idea that the conditionality of the trial was adhered to. This finding is an important 
contribution to the debate around the provision of social grants in South Africa. Concerns have 
been raised that the child support grant encourages teenage girls to fall pregnant in order to 
receive the grant (Makiwane et al 2006), and that the disability grant for HIV leads patients to 
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try to remain ill in order to continue receiving the grant (Yoder et al 2009). Such behaviour was 
not seen in this study. Although other studies of incentives programmes in health care have 
shown a range of adverse events (Oxman & Fretheim 2009), many of these were not found in 
this study (process evaluation, reported in Chapter 4).  
Sub-group analysis showed that treatment success rates were better in women, patients who 
were employed, children under 13 years of age, and smear positive patients. Although such 
results are not found in all settings, they do reflect the findings of many other studies in Africa 
and elsewhere.  In the African (Mature et al 2011) and South African contexts (Brust et al 2010), 
women have been shown to have better adherence to TB treatment than men. However, 
women in some settings may need to seek permission to attend clinics and may therefore have 
poorer adherence than men (Munro et al 2007a). In our study, employed patients were better 
off financially than those who were unemployed (assessment of patient poverty, reported in 
Chapter 5). The poorer outcomes of unemployed patients are reflected in the findings of 
several studies in Africa and elsewhere, where low income has been shown to be associated 
with poorer adherence to TB treatment (Munro et al 2007a, Muture et al 2011). In our study, 
children younger than 13 years had better outcomes on treatment than those older than 13. 
Although in some contexts adherence of children to TB treatment is low (Alperstein et al 1998, 
Guwatudde et al 2003), in South Africa, adherence of children has been shown to be high (van 
Zyl et al 2006). Finally, smear positive TB was associated in our study with better outcomes on 
treatment. A possible explanation for this is that these patients are less likely to be infected 
with HIV, which has been identified as an independent risk factor for default from TB treatment 
(Muture et al 2011, Brust et al 2010).  
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Limitations of the trial 
 
This was a pragmatic trial, and so adherence to the intervention was not rigorously controlled. 
This resulted in approximately one third of eligible patients not receiving a voucher at all. An 
important limitation of the trial is that the contribution of various factors to this low fidelity was 
not quantified. These factors included the preference of nurses to give vouchers to patients 
who were more deprived, as well as the logistical issues involved in giving eligible patients their 
vouchers on their clinic appointment days. It was important for this trial to have a pragmatic 
nature because it answered questions relating to the feasibility of implementing economic 
support for patients with TB in South Africe. However, future research should investigate the 
extent to which different variables impact on the delivery of such support, and quantify their 
individual impact.  
Adherence to treatment in this trial was measured by public sector clinics in their usual 
manner. Although DOT supporters indicated on patients’ clinic books each time tablets were 
taken, no intermediate objective measures of adherence were made by the investigators, with 
the result that it is not known whether patients actually took their tablets as prescribed. 
However, given that the primary outcomes of the trial were dependent on adherence to 
treatment during the trial, additional measures of adherence are unlikely to have added much 
value to the findings.  
At the time of the trial, TB and HIV services were run in separate parts of the clinic and 
significant numbers of TB patients were either not tested for HIV or their test results were not 
recorded in the TB register. Since a high proportion of TB patients in this trial and in KwaZulu-
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Natal are also infected with HIV (Corbett et al 2003), and since the effects of poverty on 
adherence may be compounded by HIV (Weiser et al 2010, Anema et al 2009), this was an 
important limitation of the study.  
We are not sure of the mechanism of action of the voucher in improving patient outcomes. 
Analysis of the impact of the voucher on patients’ household expenditure (reported in Chapter 
5) suggests that it did not significantly improve the economic well-being of patients’ 
households. However, qualitative analysis (reported in Chapter 4) suggests that it did enable 
patients to buy more food with which to take their tablets, which many described as very 
helpful.  An additional limitation of the trial however, is that the nutritional status of patients, 
and the effect of the voucher on this, were not assessed.  
Most clinics and patients in the trial were situated in urban areas because relatively few rural 
clinics met the trial’s inclusion criteria. Thus the extent to which the results of this trial can be 
generalised to rural areas may be limited.  
Conclusions 
 
This pragmatic cluster randomised trial which compared economic support for TB patients 
against usual care and was conducted in the real world setting of public sector clinics in South 
Africa, found no significant difference in treatment success rates between intervention and 
control clinics.  Our findings suggest that factors related to the administration of such support 
may undermine its effectiveness. The low fidelity to the delivery of this voucher meant that 
only a third of all eligible patients received it for four months or more. However, among 
patients in intervention clinics who received the voucher at least once, treatment success rates 
Stellenbosch University  http://scholar.sun.ac.za
92 
 
were significantly improved compared with rates in the control group. Further, in the 
intervention arm the more frequently the vouchers were received by patients, the higher their 
probability of treatment success. Further operational research is needed to explore how best to 
ensure the consistent and appropriate delivery of such support to those eligible to receive it, 
and to investigate whether, under conditions of higher fidelity, the extent of the benefit on 
treatment outcomes found in this study can be increased.  
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Chapter 4 
Process evaluation (part one): A qualitative 
analysis of participants’ responses to the 
voucher and its administration 
 
Introduction 
 
This chapter presents the findings of the first part of the process evaluation of this trial. It 
reports on the conduct and analysis of qualitative, in-depth interviews with all groups of 
participants in the trial: patients, nurses at intervention clinics, shop personnel, and managers 
of the TB programme at district, provincial and national level. This chapter is central to the 
assessment of the feasibility of delivering economic support to patients with active TB in public 
sector clinics in South Africa, and provides important information that helps to explain the 
findings of the main trial. 
Background 
Although randomised controlled trials provide high quality evidence for the efficacy or 
effectiveness of an intervention, they do not provide contextual information that might explain 
the findings of the trial. Such information is particularly important in pragmatic trials, where the 
real world settings in which interventions are delivered may have a profound impact on the 
conduct and the findings of the trial.  This information may be provided by qualitative research 
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conducted alongside trials of such interventions (Lewin et al 2009). Such research can provide 
insight into issues which are not amenable to quantitative investigations, and which may be 
important for the replicability of trials, or for  the large-scale implementation of the 
interventions tested therein (ibid). However, in spite of the recognition of the value that 
qualitative research adds to the conduct of a trial (Oakley et al 2006), such research is seldom 
conducted. In a recent review, it was found that less than a third of recently completed trials in 
the Cochrane Effective Practice and Organisation of Care register had a qualitative component, 
and all of those that did had been conducted in high income countries (Lewin et al 2009).  
The importance of investigating the complexities of the context within which interventions are 
implemented is also reflected in the discipline of policy analysis. A linear or “top-down” 
approach to the assessment of the implementation of a policy or intervention views the process 
of delivery as a rational one influenced only by a set of centrally determined conditions 
(Sabatier and Mazmanien 1979, quoted in Walker and Gilson 2004). However, the “bottom-up” 
perspective sees such implementation as a dynamic and complex process which is directly and 
significantly affected by those who are required to implement the policy (Walker and Gilson 
2004). Indeed, the bottom up approach sees the gap between the policy as planned and the 
policy as implemented not so much as policy failure but as a demonstration of how policy is 
“recreated through the process of implementation” (Hill 1997, quoted in Walker and Gilson 
2004). 
 
Process evaluations attempt to view the implementation and receipt of an intervention from 
the perspective of the implementers and the recipients, and use both qualitative and 
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quantitative methods to analyse the contributions of a variety of factors to the effectiveness, or 
otherwise, of an intervention (Oakley et al 2006). Importantly, where an intervention is not 
effective, process evaluations can help to ascertain whether it is the intervention itself that is 
inherently flawed, or whether the way in which it was delivered undermined its effectiveness 
(Rychetnik et al 2002). The following two chapters of this thesis (Chapters 4 and 5) constitute a 
process evaluation of the delivery and receipt of the voucher. The current chapter is a 
qualitative analysis of interviews conducted with a sample of participants in the trial, including 
patients, nurses, managers of the TB programme and shop personnel. Chapter 5 is an analysis 
of the economic status of patients’ households and the effect of the vouchers on their 
expenditures.  
As various models show, health behaviours such as adherence are complex phenomena, 
particularly for chronic conditions, and are dependent on both individual and contextual factors 
(Munro et al 2007b). Changing health behaviour by offering economic incentives or enablers is 
not necessarily a linear process, even in patients who are poor (Adato et al 2011). The 
responses of patients to economic support is affected by a multiplicity of social, cultural, 
political and economic factors and may not conform to theories of rational economic behavior 
(ibid). For example, although conditional cash transfers have had positive effects on health 
seeking behaviour and some aspects of health itself (Boccia et al 2011, Lagarde et al 2009) 
these effects have not been uniform and in some communities, uptake of certain health 
services remain poor in spite of the transfers. Qualitative research aims to explain why this may 
be so (Adato et al 2011).  
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The provision of economic support or incentives to promote health is controversial. In South 
Africa, where our trial was carried out, there is some opposition to social assistance in general, 
and in particular to social assistance for those who are ill, because of the fear that such grants 
will lead to a “culture of dependency” (Surender et al 2010). Concerns have also been 
expressed over recipients’ use of social grant monies; many of the politicians and TB managers 
who were consulted in the planning phases of this trial felt that individuals might spend their 
vouchers on frivolous or even damaging items, such as alcohol or cigarettes. A final concern is 
that economic support for vulnerable people may constitute a perverse incentive; that is, it may 
encourage people to behave in ways that ensure the continuation of such support (Oxman and  
Fretheim 2009). Where concerns about an intervention are so prevalent, it is crucial that these 
are explored in studies that extend beyond assessments of effectiveness, to include 
assessments of how an intervention is implemented and used, and factors that impact on this.  
As discussed in Chapter 3, the results of this trial were not significant. It is important to explore 
the reasons for this, because the level of effectiveness we found may have been influenced at 
least in part, by the context in which the intervention was delivered (Hawe et al 2004) and by 
the process of implementation itself. Factors that may have affected the implementation of our 
voucher include levels of programme support, and the prevailing beliefs and attitudes of health 
care providers and recipients.   
Aim: 
To explore the views and experiences of stakeholders regarding the voucher system and to 
examine contextual factors affecting its implementation.  
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Objectives: 
 To investigate the administrative processes involved in delivering the vouchers 
 To investigate the opinions of participants on the possible positive and negative aspects 
of the vouchers 
 To investigate which contextual factors affected the implementation of the vouchers 
 To investigate whether the vouchers assisted some patients to adhere better to 
treatment, and if so, how. 
Methods 
Study design  
 
This was a qualitative study which used in-depth interviews as a tool to gather data.  
Qualitative research aims to interpret or understand the world “from the point of view of 
participants in it” rather than to explain an objective “reality” (Green and Thorogood 2004: 13). 
It is based on the premise that the external “reality” that governs human behaviour is to a large 
extent socially constructed (ibid), so that the context in which people live and work affects and 
is affected by, their attitudes, beliefs and perceptions. Qualitative research is a vital tool for 
understanding how health is achieved (or not achieved) through, among others, healthy 
behaviours and the implementation of health systems.  
These interviews describe, from the perspective of participants in the trial, the “reality” in 
which the trial took place and explain, at least in part, how this context influenced its conduct. 
They enable an understanding of how the participants in the trial perceived and experienced 
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the voucher, and its role in poverty alleviation and TB control, and explain to some extent how 
these perceptions and experiences affected their responses to the voucher and so influenced 
the results of the trial itself.   
In this study, semi-structured in-depth interviews were conducted with patients who had 
received vouchers; nurses who had administered vouchers at intervention clinics; shop owners, 
managers and cashiers at the shops where vouchers were redeemed; and managers of the TB 
Control Programme at district, provincial and national level who had been involved in or were 
well informed about the trial. The research process was iterative, in that follow up interviews 
were conducted with selected participants to clarify issues raised in the initial interviews, or to 
discuss new issues that arose during implementation of the voucher system.  
Population and sampling 
 
Interviews were conducted with patients and nurses at intervention clinics. Clinics were 
selected purposefully to represent the range of settings in the trial, so that large and small and 
urban and rural clinics were included. Nurses in charge of the TB programme at seven out of 
ten participating clinics were interviewed. At the same clinics, patients were approached to be 
interviewed if they were receiving the voucher, and if they were attending one of the seven 
selected clinics on the day on which interviewers were present. Two fieldworkers stayed at the 
clinics all day, and each interviewed one or two patients every day. A month was spent at clinics 
conducting patient interviews. Interviews with patients were conducted until thematic 
saturation was reached. 
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Seven out of eight shops were included in this sub-study. This ensured that the range of stores 
participating in the trial, which included large chain stores as well as small owner managed 
shops, from both urban and rural areas, were represented. Personnel in management positions, 
who had been involved in the administration of the vouchers, were invited to participate. Four 
administration managers, one general manager, one owner and one cashier were interviewed.  
Three senior TB managers from the two districts and one from the province in which the trial 
was conducted were interviewed, as well as one senior TB manager from the national level. 
These managers were selected because of their role in the running of the TB Control 
Programme, their awareness of the study from its inception, and because they were involved in 
policy formulation for TB management.  
No participants refused to be interviewed.  
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Table 1: Participant demographic information 
Group (number interviewed) % 
urban 
% 
female 
Median 
age 
Median level of 
education 
Patients (29) 62 76 35 Grade 10 
Nurses (7) 71 71 40 All professional nurses 
Managers in the TB Control 
Programme (5) 
 60 49 Data not collected 
Shop personnel (7) 71 71 30 Data not collected 
 
All nurses interviewed were professional nurses, with a median nursing experience of 15 years. 
Patients’ median level of education was Grade 10. Sixty nine percent of patients were 
unemployed, 14% worked in the informal sector, 3% in the formal sector and 14% were too 
young to work.  
Data collection 
 
Interviews with nurses, TB Control Programme managers and shop personnel were conducted 
face to face, between one researcher and one interviewee. Interviews with patients, which 
were also face-to-face, were conducted by one research assistant and attended by a second 
research assistant who managed the audio recorder and took additional notes. Interviews with 
patients were conducted in their first language, which was isiZulu for all patients participating 
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in this study. Interviews were audio recorded, transcribed verbatim and translated into English, 
with the translation checked by the second person who attended the interview. Interviews with 
nurses, shop personnel and TB managers were conducted in English (the language of training 
and reporting in KwaZulu-Natal), audio recorded and transcribed verbatim. 
Interviews with managers of the TB Control Programme were conducted by the principal 
investigator, whilst interviews with nurses, shop personnel and patients were conducted by 
research assistants. This was because it was felt that the latter group of interviewees might feel 
obliged to give the principal investigator positive responses about the voucher and its system of 
implementation, given her involvement in the project. Although such constraints were possible 
in the interviews conducted with managers, they were less likely since TB managers held more 
senior positions in the health services and so would be on a more equal footing with the 
principal investigator.   
Interviews with patients took place in the clinic grounds, away from the clinic building, or else in 
an unused room within the clinic, to preserve patient privacy. Interviews with nurses took place 
in unused consulting rooms or offices at the clinics, whilst those with shop owners, managers 
and cashiers took place in the administration offices of the shops. Interviews with TB 
programme managers took place in their offices or at a designated public meeting place.  
Research assistants introduced themselves as such to all participants, emphasising that they 
were from an independent research organisation and not affiliated to the health services. 
Research assistants transcribed and translated (where necessary) the interviews they had 
conducted, and assisted in the analysis by providing their impressions of issues that were 
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important to interviewees and by applying these impressions in the identification of important 
codes and themes.   
The subjects covered in the interviews are summarised in Table 2 below. Full interview guides 
are presented in Appendices 4A - D.  
Table 2: Summaries of main questions put to participants 
Patients were asked mainly about their adherence to TB treatment, and what factors 
(specifically those related to poverty) made adherence more difficult. They were also asked 
about their experiences of the voucher, and how it had helped them, if at all.  
 
Nurses were asked about the administration of the voucher, and what if any problems they 
encountered in this regard. They were asked whether they thought the voucher had impacted 
on patient adherence, and whether they thought that financial support in general was an 
acceptable and viable way of improving patients’ outcomes on TB treatment.  
 
Shopkeepers were primarily asked about the administration of the voucher, and its impact on 
their workload and cash flow.  
 
Managers in the TB Control Programme were asked about the administration of the voucher, 
potential benefits and challenges of its delivery, and about their perceptions of financial 
support for health outcomes.   
 
Data Analysis 
Interviews were analysed thematically. Transcripts were coded manually, and from these 
codes, themes were built up, both within the groups of interviewees (patients, nurses, TB 
managers and shop personnel) and across these groups.  Both similarities and differences 
between interviewees’ responses were noted and discrepant views were described (these were 
views that did not fit with the general trend of the findings, but that needed to be considered 
and accounted for in the final explanation) (Green and Thorogood 2004: 177).  Transcripts of 
interviews were read and re-read so that recurring ideas (meaning units) could be identified. 
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Abstractions (codes) of these meaning units were developed, and categories of codes built up 
into sub-themes and themes (Green and Thorogood 2004: 177-180). For each key analytic 
theme, data extracts were identified on the basis of being representative and/or interesting 
illustrations of an emerging issue. The process of data analysis is illustrated in Table 3. Analysis 
was undertaken by the principal investigator and one of the co-investigators, with contributions 
from the research assistants who were involved in data collection.   
Analysis was informed by the principal investigator’s knowledge of the setting and of TB care. 
However, no formal theoretical stance was taken. This qualitative aspect of the process 
evaluation focused on how people experienced the voucher and the trial, and so was informed 
by a set of specific research questions, which in turn shaped the interview guides and the 
analysis.  
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Table 3: Example of analytic process 
Meaning unit Code Sub-theme Theme 
“It helps me as I say that 
when I receive the 
voucher  I am able to 
buy food and take my 
tablets on the right time; 
I have to eat before I 
swallow my tablets that 
is how the voucher is 
helping me” 
Voucher 
helps with 
buying food 
with which to 
take tablets  
Important role of 
voucher is to prevent 
having to take tablets 
on empty stomach 
Role of voucher in 
improving aherence 
“... you know that you 
can only get the voucher 
while you are on 
treatment. The minute 
you are out, it’s back to 
square one, and those 
needs that were catered 
for by those vouchers 
are now left hanging and 
the patient might be 
tempted to default 
treatment so that to 
continue getting these 
vouchers”. 
Patients may 
want to 
remain ill in 
order to 
continue 
receiving 
voucher 
The voucher may act 
as a perverse 
incentive 
Negative effects of 
voucher 
 
Ethical considerations 
Written informed consent was obtained from all participants in all interviews in the language of 
their choice (either isiZulu or English) (see Appendix 3E). Patients were assured that non-
participation in these interviews would not impact on the treatment they received from the 
clinic, nor on their continued participation in the trial. All participants were assured of 
confidentiality, and no participants were paid for taking part in these interviews. 
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The hard copies of interviews and participants’ consent forms were stored by the principal 
investigator, in locked drawers. Electronic copies of interviews were stored on the computer of 
the principal investigator which is password protected.  
Results 
These results explain both the implementation of the voucher (with implications for its 
operational feasibility and its effectiveness) and the views of trial participants regarding the 
voucher, including their opinions on the principle of social assistance for people who are ill. 
Specifically, the results cover the issues of the operational feasibility of implementing the 
voucher system, the leakage and misuse of vouchers, the fidelity to the prescribed process of 
voucher implementation, the perceived effects of the voucher on adherence to treatment and 
on household poverty, and views on the continuation of the voucher scheme.  
Operational feasibility of voucher 
The perceptions of participants were that it was operationally feasible to administer the 
voucher to patients as a routine part of the TB Control Programme. Both nurses and shop 
personnel who were responsible for administering the voucher, said that it was simple to do. 
For example, clinic nurses noted that: 
“In administering we had no problems…” (Nurse, Clinic 8 page 2).  
“…on my side it was easy to issue the voucher… It was getting more easier because I was used to 
issuing the voucher and it was just an ID number or date of birth, my signature and a stamp of 
the clinic. It was more easier as the time goes on – I was used to issuing it” (Nurse, Clinic 9 page 
1). 
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The manager of a shop expressed a similar view: 
“Easy … The whole control of it, the way it’s being controlled it’s very easy to actually do …” 
(Manager, Shop 6 page 1).  
In addition, managers suggested that there were no significant additional costs or increases in 
workload incurred by the shops as a result of the administration of the voucher.  
“No, there was no cost on my side and it wasn’t time consuming at all so there was no problem 
on my side” (Manager, Shop 1 page 2).  
Patients also found the process of receiving the voucher from the clinics and redeeming it at 
the shops to be problem-free.  
“There is nothing that I can say is bad, it is all good…Yes it is easy… There (are) no problems” 
(Patient, Clinic 4 page 2).  
“It’s easy, there is no problem” (Patient, Clinic 7 page 6). 
However, in spite of the general sense that the vouchers were not difficult to administer, two 
important administrative problems did occur and are discussed in the section “Logistical 
problems that impacted on fidelity to trial procedures” below.  
Leakage and misuse of the vouchers 
The terms “leakage” and “misuse” of vouchers are used variably by studies investigating the use 
of vouchers to incentivise behaviour change (Hanson et al 2008). In this thesis, the term 
“leakage” refers specifically to the receipt of the voucher by groups not eligible to receive it, 
whilst “misuse” is a broader term which encapsulates the concept of leakage and includes the 
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theft or fraudulent acquisition of a voucher, as well as the inappropriate expenditure of the 
vouchers.  
Issues relating to the “leakage” of vouchers (to those for whom they were not intended) were 
closely monitored in this study. The investigators were able to correlate all vouchers issued by 
the clinics with those redeemed from the shops. Other cases of misuse of vouchers were not 
reported during the trial and did not impact on its conduct. Nevertheless, cases of “leakage” 
were described by interviewees and are reported here.  
Generally, patients, nurses and shop personnel were happy that, on some occasions, relatives 
or friends of voucher recipients redeemed the vouchers on their behalf. However, there were 
three reports from interviewees of cases where patients were not given their vouchers, or the 
goods redeemed with their vouchers, by the people who had collected them.  
“… we have the Nompilo’s (lay DOT supporters) … there is a lot of cruelty going on, they act like 
they are coming to get it (the voucher) for you when they take it themselves and you will feel 
bad, so it’s better to come and get it yourself” (Patient, Clinic 7 page 6).  
“only exceptional …  case where I discovered that one patient complained that some of the 
family members were taking the food … but only one patient … we could rectify that mistake”  
(Nurse, Clinic 9 page 1). 
One shop owner said that a stolen voucher had been brought in to be redeemed.  
“One case happened when a voucher was stolen but we managed to sort that one out ….I can’t 
remember clearly what happened but the story from the cashiers was that someone came even 
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before the voucher was redeemed and said his voucher has been stolen and told them his name. 
When the person who stole the voucher came through he was asked his name and proof of that 
name and he left the voucher there and never came back” (Owner, Shop 5, page 2).  
These were the only such incidents reported however, in over 2 000 patients who received 
vouchers over the study period. There were no occasions where the theft or loss of a voucher 
had to be investigated, or where the issuing of vouchers had to be stopped due to such 
problems. 
Fidelity to trial procedures for implementation of the voucher system 
In spite of their overall satisfaction with the administration of the voucher, patients, nurses and 
shop personnel discussed problems with the principle of giving vouchers only to patients who 
met the trial’s eligibility criteria. 
Some nurses expressed their belief that vouchers should not be given to patients who were 
relatively better off financially. This impacted on the proportion of eligible patients who 
received the voucher, as outlined in Chapter 3. At most clinics, nurses appear to have given 
vouchers to patients whom they considered more deprived.  Nurses noted that it seemed unfair 
not to give vouchers to patients who were more deprived, even if they did not meet the clinical 
eligibility criteria, and equally unfair to give to those who, for example, were employed or in 
receipt of a social grant but did met the eligibility criteria. Nurses commented that: 
 “The malnourished patients I would give even though it’s not PTB (pulmonary TB), sometimes I 
would use my discretion” (Nurse, Clinic 8 page 2).  
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 “I would decide by looking at who is needy, considering their social problems, then I will give 
(to) extra pulmonary (patients);9 like if they do tell me they can’t take pills on an empty stomach 
then I will give considering their background…but those who are working I wouldn’t give … “ 
(Nurse, Clinic 7 page 3). 
 Nurses felt that it was not difficult to assess the patients’ levels of need:  
“It’s easy (to decide who is needy)… By history taking I can ask them, how many members of the 
family, who is a breadwinner, who is working, then I can assess from there” (Nurse, Clinic 8 page 
4). 
The patients themselves felt that this was fair – if they were doing well financially that month, it 
was better that someone else received the voucher that they might have taken: 
“When I am here I get it if I ask for it” (Patient, Clinic 5 page 4). 
“Sometimes I do not ask for it, if I see that I do have something” (Patient, Clinic 5 page 2). 
The nurses also felt that asking for the voucher meant that the patient needed it, and so were 
justified in receiving it:  
“As I told you the ones who are working they don’t even ask for anything, it’s for those who are 
not working” (Nurse, Clinic 4 page 2). 
                                                          
9
 Nurses did not record the distribution of vouchers to patients with extra-pulmonary TB in the TB registers, thus it 
was not possible to verify statements such as these.  
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Furthermore, patients, nurses and shop personnel were concerned that only certain patients 
(i.e. those with pulmonary TB) were eligible to receive the voucher. They felt that this was 
unfair, given the depth of deprivation experienced by some patients.  
“I do hear them saying that the voucher is given to those with PTB only … They are complaining - 
you know people they also want to get the voucher, they are not happy that some people are 
receiving it while others don’t” (Mother of 5 year old patient, Clinic 7 page 4).  
Even one cashier was distressed by this exclusivity:  
“If you could also try and help the others not just the TB patients. We also have people sick 
besides (those) diagnosed with TB” (Cashier, Shop 4 page 5).  
Managers of the TB programme also perceived this as a problem, not for the reasons of equity 
cited by patients and nurses, but because they feared that it would act as a perverse incentive.  
“If you target for example the TB patients, then people see that TB patients have better or get 
things for just being TB patients. So now everyone will want to have TB to get those things 
especially if they are in need, like food and all those things” (TB Manager page 4).  
 “... you know that you can only get the voucher while you are on treatment. The minute you are 
out, it’s back to square one, and those needs that were catered for by those vouchers are now 
left hanging and the patient might be tempted to default treatment so that to continue getting 
these vouchers” (TB manager, page 2).   
It was clear from the interviews that all participants found the exclusivity of giving vouchers 
only to a select group of patients to be problematic. Nurses’ further objections to this 
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exclusivity are raised under the section “The impact of the voucher on the nurse-patient 
relationship” below. The targeting of economic support to certain groups to the exclusion of 
others, is discussed further in the discussion section of this chapter, and in Chapter 6.  
Logistical problems that impacted on fidelity to trial procedures 
Administrative reasons for patients not receiving vouchers every month were that the vouchers 
were either not available (because they had not been delivered timeously to the clinic by 
investigators) or because nurses only gave them out at the end of the month.  
Although the investigators visited clinics every four to six weeks, clinics would sometimes run 
out of vouchers before these visits. Sometimes nurses would only notify the investigators of 
this problem on the day that the vouchers ran out, and it was not always possible to deliver 
voucher books to clinics quickly enough to prevent some patients from leaving the clinic 
without vouchers. Patients commented that:  
“Sometimes it happens that you come for the voucher and find there are no vouchers. They say 
come on the following or the third day” (Patient, Clinic 7 page 3) 
Some nurses preferred to issue all vouchers in one batch at the end of the month, because they 
found it logistically easier to do this “in bulk”. Patients were required to return to the clinic at 
the end of the month to get their vouchers.  
 “They tell us that we get them when it is month end” (Patient, Clinic 5 pg 2). 
Travelling to the clinic on another day to collect their vouchers would have imposed additional 
costs on patients, and very poor patients may not have been able to afford this additional trip. 
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Similarly, patients who were working may not have been able to take time off work for an 
additional clinic visit, and patients who were very ill may not have been able to visit the clinic a 
second time in a month. Although the proportion of patients affected by these factors was not 
quantified in the trial, this qualitative part of the process evaluation suggests that at least some 
patients were affected by them.  
Perceived effects of the voucher on adherence to treatment 
Both nurses and patients felt that the voucher had improved adherence to treatment, as the 
following data extracts suggest:  
“The adherence was excellent! Even if you check their files they were coming monthly now, 
there was no need to keep on phoning them to come forward for more treatment, they come 
monthly because they knew that they will get the voucher …” (Nurse, Clinic 9 page 1).  
“I saw that it was bringing back the patients, because patients were informing others about the 
voucher and the defaulters were coming back to the clinic…Adherence has increased even on 
the strepto (streptomycin) patients, knowing that they’ll get the voucher every month…. Since 
the voucher we haven’t had a case where someone (was) stopping treatment and then coming 
back. We haven’t had patients defaulting” (Nurse, Clinic 8 pages 1 and 2). 
Patients also said that the voucher enabled better adherence to treatment, through addressing 
barriers to adherence that were related to poverty:  
“Yes, having no money can have an effect (on adherence). Since in the clinic we are given a 
specific date to collect our treatment, if one does not have money on that day that will be the 
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problem…(Also) If you have TB you must take nutritious food and (if) you don’t have money you 
can’t take that kind of food” (Patient, Clinic 3 page 1).   
The voucher alleviated some of these problems, as the following data extracts show:   
 “Yes it has made it better for me to take my pills, we were so happy about receiving it, food is a 
problem” (Patient, Clinic 7 page 5).  
“It’s very important and needed. Some times at home I don’t have food so I am able to use the 
voucher for that. It helps a lot” (Patient, Clinic 8 page 2).  
“It truly made it easier. I get motivated to take my treatment and I can’t wait for my date to go 
to the clinic for my treatment.”  (Patient, Clinic 8 page 1).  
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How the voucher may have affected links between poverty and TB treatment outcomes 
Many patients, nurses and shop personnel noted that the value of the voucher was small:  
“It does help me for the time being. I think food for R120 is too small, but I appreciate what they 
are giving me … the vouchers are small, the voucher is for us to eat for few days, and it’s 
finished” (Patient, Clinic 5 pages 1 and 5).  
From the perspective of patients, the main value of the voucher lay in providing food with 
which to take their TB medication. A major theme that emerged from patient interviews was 
that it was very difficult to take TB tablets on an empty stomach. Doing so made many patients 
feel very hungry and it made others feel ill. For others, eating before taking their tablets 
increased the efficacy of the treatment.  
“… most of the time the tablets are making you hungry you need to get food right away” 
(Patient, Clinic 7 page 8)  
“Just imagine as I have said how difficult it is to take them on an empty stomach. In fact it 
seems as if they are not helping you here but they are killing you!” (Patient, Clinic 7 page 6).  
 “If you take the tablet without eating anything that tablet will not work - where is it going to 
stay? It’s better if you got something to eat first” (Mother of 5 year old patient, Clinic 7 page 4).  
The voucher enabled patients to buy food so that they could take their tablets on a full 
stomach. 
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“It helps me as I say that when I receive the voucher I am able to buy food and take my tablets 
on the right time; I have to eat before I swallow my tablets that is how the voucher is helping 
me” (Patient, Clinic 4 page 7).  
In many cases, patients shared the food purchased with their vouchers with their families, as it 
was considered to be against the norms of family behaviour to eat it alone:  
“Yes I have to share with them I cannot be able to eat alone … We are a family I cannot be able 
to eat by myself, I wasn’t taught like not to share” (Patient, Clinic 7 page 4).  
However in some cases, especially in the case of children or the elderly, the food was reserved 
for the index patient alone.  
“It’s for the child … This money is hers, the voucher belongs to her as she is taking the 
treatment” (Mother of 5 year old patient, Clinic 7 page 5). 
In other cases, members of the household protected the index patient’s superior claim to the 
food. 
 “What I can say is that at home I stay with people who knows the rules of a sick person. That is 
why they say I must not share it”  (Patient, Clinic 5 page 3). 
The fact that the voucher enabled patients to buy more food with which to take their tablets 
was a powerful one, echoed by many patients. However, the practice of sharing this food may 
have impacted on the benefit that the index patient could derive from it. If the economic 
support intended for one patient only is shared with family or community members, the 
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efficacy of that support may be diluted. The targeting and sharing of economic support for TB 
patients is discussed further in the discussion section of this chapter and in Chapter 6.  
The impact of the voucher  on the nurse-patient relationship 
Although this was not specifically asked about in any participant interviews, many nurses noted 
spontaneously that the voucher had improved their relationships with patients. This, they 
suggested, was because nurses were doing something active and out of the ordinary for 
patients by giving out the vouchers, and the patients appreciated this.  
“Otherwise our relationship with the patients has improved and patients are always asking for 
Sister .... (me)” (Nurse, Clinic 8 page 2). 
“The relationship has grown very much… between us sisters and patients because they come 
here and get helped” (Nurse, Clinic 3 page 2).   
An improved relationship with nurses was not raised by patients in their interviews, which 
suggests that they either did not experience this at all, or that it was not important enough for 
them to raise.  
Conversely, the relationship between nurses and patients who were not eligible for the voucher 
suffered some strain as a result of this trial because nurses had to justify to them why some 
patients were allowed to receive vouchers and they were not.  
 “… it should be given to all the patients (at this clinic) not just some because people think that 
it’s our own agenda that some people are given while others are not“ (Nurse, Clinic 10 page 5).  
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“Now as a sister I have to explain why the other patient got the voucher and why the vouchers 
don’t go to everyone who is sick…. you find that they are neighbours -  the other neighbour got 
it and the other one did not and they now don’t like each other” (Nurse, Clinic 3 page 4). 
Continuing the voucher scheme: addressing poverty or creating dependency? 
 
As opposed to managers in the TB Programme, who saw both benefits and drawbacks to the 
voucher, patients, nurses and shop personnel expressed almost universal support for its 
continuation. 
“What I can say is that it does help because there are people who got real problem and bigger 
than my problem. You find that they really do not have food to eat - some end up not taking 
their pills because they do not have food to eat. At least this voucher is helping … they help, they 
do help a lot” (Patient, Clinic 7 page 4) 
“I wish the vouchers can continue because it helps the patient very much and that most of the 
times TB patients don’t work - they don’t know where to get food because they don’t have jobs 
and we give them porridge but nobody can survive with porridge only. With the voucher the 
patient can get real food after the porridge” (Nurse, Clinic 3 page 4).  
Shop personnel were interested in participating in further trials of programmes involving similar 
voucher schemes, because their turnover and profit had increased without a commensurate 
increase in workload or costs. 
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In addition to its practical benefit, nurses did not see as problematic the principle of “paying 
patients” to behave in a healthy way. In the context of widespread poverty, the vouchers were 
not seen in this light.  
“It’s like we are supporting them (the patients) and it’s a good thing because people don’t have 
jobs so I don’t see it as paying them, rather as supporting needy people” (Nurse, Clinic 8 page 3). 
Managers of the TB programme had a rather more complex approach to the continuation of 
the voucher. On the one hand. they were supportive in principle of the idea of financial support 
for TB patients and also felt that it was important to address poverty in patients with TB.  
“If we just leave those patients (i.e. don’t materially support them) chances are we will get them 
coming back again with the disease… I think if we address poverty, if we improve the living 
conditions of people, then we will go a long way towards addressing TB” (Senior TB Manager 
page 2). 
However, on the other hand, they were concerned about creating dependency on the vouchers 
and providing a perverse incentive to remain ill.  
“We have had cases where patients will sell their sputum… Ja, we’ve had cases where they will 
sell their TB counts and cards and move into other clinics so that they can be considered to be on 
treatment and then, so that they can get (the disability) grant. So it does create dependence and 
there are loops within the system that make it vulnerable to misuse…” (Senior TB Manager page 
3).  
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Although it did not seem to detract from her support of the continuation of the voucher, one 
nurse echoed this fear. “The way people are depending on the money, some want to be sick” 
(Nurse, Clinic 8 page 3). 
A related concern of one senior TB manager was that receipt of the voucher would make it 
unnecessary for patients to work.  
“The reason why people go for those grants is to get something to support their families….. So I 
see it as perpetuating the culture of not working because they’re relying on the grant maybe… 
we don’t want to create a situation where people are dependent on some monetary incentive 
somewhere” (Senior TB Manager page 2). 
These complex views reflect both the perceptions of the widespread and deep poverty which 
prevails in KwaZulu-Natal and the effect of poverty on illness, as well as ideas on how poverty 
should be addressed. These views echo age-old debates over social support for the poor and 
are further discussed in the discussion section of this chapter, and in Chapter 6.   
Stellenbosch University  http://scholar.sun.ac.za
120 
 
Discussion 
 
This qualitative analysis provides contextual and process information which goes beyond the 
trial design and methodology to explain why our results were achieved (Rychetnik et al 2002). 
This type of information is important in all studies, but may be particularly so in trials with 
negative or inconclusive results like ours, because it helps to differentiate between 
interventions that failed because they were inherently flawed, and those that failed because 
they were poorly delivered (Rychetnik et al  2002). Placing trial findings in context also helps to 
gauge the transferability of interventions, and their possible effects in different settings (ibid).  
Summary of findings 
In this qualitative study, participants noted that it was operationally feasible to deliver the 
voucher to patients as an integrated part of the TB Control Programme in public sector clinics in 
KwaZulu-Natal. However, the study also found that there were two important factors which 
prevented the delivery of the voucher to all eligible patients, for every month of their 
treatment. Firstly, many nurses felt that the vouchers should be withheld from eligible patients 
who were better off financially; this meant that approximately one third of eligible patients did 
not receive a voucher at all (Lutge et al 2013, reported in Chapter 3). Secondly, the logistical 
issues involved in delivering a supply of vouchers to all intervention clinics before they ran out, 
and the preference of some nurses to give vouchers out in one batch at the end of the month, 
meant that vouchers were sometimes not given to eligible patients on their clinic appointment 
dates. Patients who were unable to make return trips to the clinics to collect their vouchers 
may have missed out on vouchers for some months of their treatment. This poor fidelity to the 
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guidance for implementation of the voucher explains in part the non-significant findings of the 
intention to treat analysis (Lutge et al 2013, reported in Chapter 3).  
This study found further that there were few cases of “leakage” or misuse of vouchers, and that 
both nurses and patients felt that the voucher had helped to improve adherence to treatment. 
Specifically, patients appreciated the voucher because it enabled them to buy food with which 
to take their tablets. Although most participants felt that the value of the voucher was very 
small, patients, nurses and shop personnel generally felt that the voucher system should be 
continued. Managers in TB Control Programme, however, were ambivalent about this; although 
they acknowledged the importance of addressing poverty in order to improve TB control, they 
were also concerned about creating dependency on the voucher, and that the voucher might 
become a perverse incentive for patients to remain ill.   
Feasibility of implementing the voucher system 
 
Nurses, shop personnel and patients found that the voucher was generally easy to administer 
and use. This is contrary to administration of the disability grant for TB which sometimes 
involves a waiting period of a few months before it is disbursed, and additional visits to clinics 
and government offices to fill in and drop off forms.  However, the low fidelity to the 
intervention meant that only one third of eligible patients received the vouchers for most 
months of their treatment. This low fidelity occurred for reasons of both principle (equity and 
social justice) and process (logistics of administration).  
Nurses felt that giving vouchers to patients who were financially better off was unfair, and 
tended to exclude such patients even if they were eligible to receive the vouchers in terms of 
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the trial protocol. This approach impacted on the delivery of the vouchers, and reaffirms the 
importance of the “street level bureaucrat” as implementer (Walker and Gilson 2004). The term 
“street level bureaucrat” was first coined by Michael Lipsky (Lipsky 1980) and refers to public 
service workers who have important roles in delivering government services, have constant 
interaction with members of the public and are able to use their own discretion in carrying out 
their activities (ibid). Lipsky suggests that the implementer of a policy or intervention is not a 
passive medium, through which the policy or intervention passes from the designers to the 
recipients. On the contrary, implementers can be seen as active in interpreting and, if 
considered necessary, modifying that policy or intervention, to the extent that they can 
represent a level of policy-making themselves (ibid).  
 
The nurses in our trial modified the delivery of these vouchers in a few ways, but perhaps most 
importantly for this trial, they rejected the eligibility criteria as being unjust. Working in a 
context of widespread and deep poverty, it seemed unfair to them to give vouchers only to 
those who met the eligibility criteria, when some of those who met the criteria needed the 
voucher less, and some who didn’t meet the criteria needed it more. Nurses are confronted 
with similar issues in the distribution of food parcels at clinics (Lutge et al 2009). Because there 
are usually not enough food parcels for all those who need them, nurses must give to those 
who need them more. They seemed to use similar principles in the allocation of vouchers in this 
trial. Nurses’ reluctance to adhere to the eligibility criteria of the trial can be explained by the 
complexity of the ways in which service providers make decisions and implement new policies 
(Walker and Gilson 2004), based on the social, cultural and historical contexts in which they 
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operate (Adato et al 2010).  Although the eligibility criteria for receipt of a voucher (which did 
not include socio-economic status) were clearly outlined to nurses at the start of the trial, the 
imperative to ration the vouchers was stronger.  
 
Many nurses expressed the wish that they could give the vouchers to all patients at their clinics.  
Their reasoning was not based on a fear of stigmatising people by labelling them as “the 
poorest of the poor” as was the case for some recipients of conditional cash transfers in Turkey 
(Adato et al 2011) but rather because they felt that all patients needed them, to a greater or 
lesser degree. Interestingly, patients who felt that they did not need the voucher at a particular 
point in time would not take it, feeling that others who needed it more could benefit from it. 
The same feeling is echoed in a qualitative study amongst recipients of the Child Support Grant 
in KwaZulu-Natal; caregivers would not apply for the grant if they had other regular sources of 
material support (Hunter and Adato 2007). For communities with high levels of poverty, these 
feelings are extraordinarily altruistic.  
Logistical problems also impacted on the fidelity to the intervention. In some clinics, it was 
administratively easier for nurses to give out all the vouchers at month end, but this required 
patients to come back to the clinic at this time to receive them. Because the study team was 
small, there were also logistical difficulties with delivering vouchers to all clinics on time. 
Voucher books were personally delivered to all clinics and collected from all shops by the 
principal investigator and one assistant, with staff at clinics and shops required to sign proof of 
delivery or collection. This meant that vouchers were sometimes not available for patients on 
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their appointment dates, which necessitated another visit to the clinic to collect them. 
Although the frequency of these occurrences were not quantified, they were raised by some 
interviewees in this process evaluation.  
These issues of logistics are important considerations for the replication of this intervention in 
other settings. The co-ordination of delivery of vouchers to clinics and collection of vouchers 
from shops requires considerable organization and a dedicated staff complement. Setting up 
the infrastructure to manage the voucher system may be difficult where health systems are 
weak and resources very limited.  
Like patients in Mexico’s conditional cash transfer programme (Adato et al 2011), we found 
that many patients shared their voucher purchases with their families, and that this was 
consistent with their social values. Although this may have diluted the effect of the vouchers for 
the index patients, for many it was inconceivable that they should keep the voucher to 
themselves. Like other social grants in South Africa, the material benefits of the grant are 
generally distributed throughout the household, so that the household is the unit that benefits, 
rather than the individual recipient (Case and Menendez 2011). For this voucher therefore, as 
for other social grants, it is important to note that the impact of policies targeted at individuals 
will be mediated by household dynamics (Rosenzweig 1986). If the value of the voucher had 
been larger, the dispersion of this benefit may have improved the nutritional status of other 
household members and so reduced their risk of contracting or developing TB (Cegielski et al 
2012, Tverdal 1986, Edwards et al 1971). However, because it was relatively small, these 
sharing practices may have meant that neither the index patient nor their households could 
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benefit maximally from the vouchers. Given that the impact of the voucher on overall 
household expenditure was small (reported in Chapter 5), it is likely that this is the case.  
Leakage or misuse of the voucher 
There were very few cases of “leakage” of the vouchers to those who for whom they were not 
intended. In only one case was the theft of a voucher reported and even in this case, the theft 
was reported before the voucher could be redeemed. More common was the fear that lay DOT 
supporters, who might collect vouchers on behalf of patients who were too ill to collect them 
themselves, would either not give the vouchers to the patients or would buy food for 
themselves. Even this, however, was expressed by only a few participants. The level of leakage 
of vouchers in this study is thus very small, compared to the levels experienced at provincial 
and national level with other social grants. For example, in the Eastern Cape alone, 3000 cases 
of social grant fraud were recently handed over to the Special Investigating Unit for prosecution 
(Plaatjie 2012). Although it is possible that cases of leakage would increase if vouchers were 
delivered on a larger scale, the system used in this study is promising in terms of minimising 
that potential.  
Relationship between the voucher and adherence to treatment 
Nurses were of the view that patients who received the voucher came back to the clinics to 
collect their tablets regularly, and that even known defaulters returned to the clinic to resume 
treatment. One of the reasons for the perceived improvement in adherence is that most 
patients interviewed valued the food purchases that they could make with their vouchers, and 
that this food helped to avoid having to take tablets on an empty stomach. This is consistent 
with the model for the mechanism of action that we proposed for the voucher (and is 
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illustrated in Chapter 1), that is, that it would enable adherence by minimising some of the 
barriers to adherence imposed by poverty.  
Another reason for possible improved adherence may have been the improved nurse-patient 
relationships cited by many nurses in this study (although these were not cited by patients). 
Poor relationships with nurses undermine treatment adherence (Munro et al 2007a; Noyes  and 
Popay 2007) because patients simply do not want to attend health care facilities. Even where 
conditional cash transfers are offered, patients who feel badly treated by staff prefer not to 
attend, even if this means losing their grant (Adato et al 2011). Although an improved nurse-
patient relationship was not an aim of this trial, it may have been an unintended consequence 
that had an impact, albeit unquantified, on patient adherence to treatment. On the other hand, 
the strain that the voucher placed on nurses’ relationships with patients not eligible to receive 
the voucher may have undermined the health related behaviour of those patients. Although 
this was not specifically investigated in this trial, it may be an important potential consequence 
of economic support targeted at patients with specific illnesses and should be considered in 
further research in this field.  
The value of the voucher relative to the aims of the trial 
This trial essentially asks two questions about the monetary value of the voucher. In this 
chapter and in the report of the main trial (Chapter 3), it asks if the value of the voucher was 
sufficient to change adherence behaviour and so change patients’ outcomes on TB treatment. 
In Chapter 5 (which reports on the effect of the voucher on household expenditure), it asks if 
the value of the voucher was sufficient to significantly increase patients’ household 
expenditures.  
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This qualitative analysis showed that patients generally felt that the value of the voucher 
(R120.00) was small, and indeed, compared to the Child Support Grant (valued at R250.00 per 
month at the time of the trial), the Old Age Pension and the Disability Grant (both valued at 
R1080.00 per month at the time of the trial), it was. However, it was about a fifth of the value 
of the median per capita income in KwaZulu-Natal around the time of the trial (Hall et al 2010), 
and most participants said it was helpful, particularly in enabling them to buy the food to take 
their tablets with. This was a powerful theme in the patients’ interviews, with most saying that 
it was impossible to take tablets on an empty stomach. In this sense, the voucher enabled 
patients to take tablets where this may have been difficult without it.  
Continuing the voucher scheme: addressing poverty or creating dependency? 
 
Acknowledging the link between poverty and TB, the TB managers and nurses interviewed in 
this study agreed in theory with the principle of social assistance for people who are poor and 
ill. However, managers raised concerns about the impact of a financial transfer to patients with 
TB, based on the development of dependency on the grant which is a widespread concern in 
the country (Humanitarian News and Analysis 2007). However, this fear was not realized in our 
study, which suggested that the more often patients received vouchers, the more likely they 
were to be cured or to complete their treatment (dose-response analysis reported in Chapter 
3). Similarly, an analysis of the trends in teenage pregnancy rates in South Africa has shown that 
these are not linked to access to the Child Support Grant (Makiwane et al 2006). Firstly, 
increasing trends of teenage pregnancy pre-date the introduction of the Child Support Grant in 
1998 and secondly, only a minority of pregnant teenagers are eligible to receive the grant (ibid).  
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It is interesting to note however that concerns around dependency on grants and their perverse 
incentive effects go back a long way in South Africa’s history, and were important debates held 
at the time of the Lund Commission in 1995 (Lund 2008: 116) and the Carnegie Commission in 
1932 (Seekings 2006). These concerns persist today and relate largely to the concept of the 
“deserving poor” which were first articulated in the Poor Laws of Elizabethan England and 
remain areas of debate for welfare states today (Bowlby 2010). In essence, the poor who 
deserve assistance from the state are felt to be those who are unable to work, such as the very 
young, the elderly and the disabled. However, in South Africa today, the opportunities for 
formal employment are diminishing and those which are available are increasingly for people 
with a completed secondary or tertiary education (Leibbrandt et al  2012). Social grants are an 
important, perhaps even a crucial, means of survival for the poor in this country (Coetzee 2011) 
and further research is needed to explore whether these perverse effects are indeed found in 
practice, in order to inform ongoing debates.  
Limitations of this sub-study 
 
Firstly, the use of research assistants for much of the data collection in this sub-study may have 
introduced some information bias. Although the research assistants were perhaps less 
intimidating to participants than the principal investigator, they may have been less familiar 
with the core questions being addressed in this sub-study and therefore been less adept at 
probing. This may have resulted in loss of information depth from the interviews.  
Secondly, in an effort to ensure continuation of the voucher scheme, patients and, to a lesser 
extent, nurses, may have overstated their perception of the benefits of the vouchers. 
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Thirdly, most clinics and patients included in the trial and in this sub-study were situated in 
urban areas, because relatively few rural clinics met the criteria for inclusion in the trial. The 
under-representation of rural participants in this sub-study may limit its generalizability to rural  
settings.  
Conclusions 
 
This qualitative analysis provides evidence of the importance of contextual factors in 
influencing the implementation and thus the effectiveness of economic support to patients 
with TB in South Africa.  
The delivery of a voucher to enable better adherence to TB treatment was well received by 
patients, health workers and shop personnel in this trial. Patients and nurses felt that it 
improved adherence, and nurses felt that it improved the relationship between patients and 
nurses. Patients particularly felt that the voucher enabled them to buy food with which to take 
their tablets, thereby making treatment taking easier.  
However, a number of factors limited the reach of the voucher to all eligible patients. Some of 
these factors were a consequence of the beliefs and values of the nurses who distributed them, 
and others were logistical. Nurses felt strongly that vouchers should be given out on the basis 
of need, rather than on trial eligibility, and this is likely to have reduced the extent to which the 
intervention was delivered as intended. Administrative difficulties that may have impacted on 
fidelity included the inability on the part of investigators to ensure that all clinics had an 
uninterrupted supply of vouchers, and a preference in some clinics for giving out vouchers in 
batches at month end, instead of at the time of the patients’ appointments. These factors 
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explain some of the reasons for the non-significant results of this trial, and must be addressed 
in further research around such interventions.  
Finally, managers of the TB Control Programme raised concerns about the development of 
dependence on the vouchers, and a perverse incentive effect. Although neither of these fears 
were realised in our trial, and are not supported by data from other studies, they are deeply felt 
by many in South African society, and have been prevalent in the country since early in the 
development of its social welfare system. More research on existing social grants, as well as 
further trials on new types of grants, are important to ascertain how best to deliver social 
assistance to those who need it most.  
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Chapter 5 
Process evaluation (part two): A cross-
sectional study of poverty, and the impact of 
the voucher, among patients participating in 
the trial 
 
Introduction 
 
This chapter constitutes the second part of the process evaluation of this trial, following on 
from the qualitative analysis discussed in Chapter 4. It focuses specifically on the patients 
participating in the trial, investigating their levels of poverty, the extent to which the voucher 
assisted them financially, and the goods on which they spent their vouchers.  
This analysis is an important component of the thesis as a whole because it investigates the 
mechanism of action of the voucher. In designing this trial, it was postulated that, if the 
voucher did assist patients in adhering to their TB treatment, it would be through its poverty 
alleviating effects – it would increase the food available to the patient, and free up cash that 
would have been spent on food for other necessities such as transport to the clinic. As depicted 
in the model shown in Chapter 1, we envisaged that the voucher would work in a similar way to 
conditional cash transfers, and enable adherence by lowering some of the barriers imposed by 
poverty. This chapter thus explores how the voucher might have affected the link between 
poverty and adherence to TB treatment.  
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The chapter also investigates an important concern raised by several stakeholders in the 
preparatory phases of this trial, and in the context of social grants in South Africa generally; 
that is, how the vouchers would be spent by patients. A number of people in management, 
clinical and political positions expressed concerns during discussions that patients would spend 
their vouchers on damaging items such as cigarettes or alcohol. Indeed, these concerns have 
been raised throughout the history of social grants in South Africa (Lund 2008: 116; Seekings 
2006) and remain prevalent today. Thus the second aim of this chapter is to present evidence 
around patients’ use of the voucher.  
Background 
 
Poverty is a complex phenomenon, and an extensive body of literature exists on the many ways 
in which poverty can be defined.  At the most basic level, poverty is defined using measures of 
income or expenditure, with “the poor” being defined relative to a level that is considered 
adequate (a poverty line or threshold). This level can be absolute, in that it is the minimum of 
material goods that are necessary to sustain life (Alcock 2006: 64), or it can be relative to the 
context in which poverty is being measured; relative poverty can thus be defined as “the 
inability to participate in the ordinary life of that society owing to a lack of resources” (Expert 
Group on Poverty Statistics 2006). More complex perspectives on poverty include Sen’s 
capabilities approach (Sen 1999), which maintains that that the freedoms that are precious to 
individuals and societies require certain material and non-material inputs in order to be 
actualised. Although these more complex approaches are important in that they acknowledge 
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the multi-dimensional nature of poverty, they make the measurement of poverty both more 
subjective and more difficult, and were not used in this thesis.  
In this study, poverty lines were used as yardsticks against which patient expenditure was 
measured, and as a threshold below which people were described as poor. Poverty lines are 
essentially arbitrary measurements because they are subjective. For example, the poverty lines 
of wealthier countries are usually set higher than those of poor countries (World Bank 2005). 
Several poverty lines have been used in South Africa. These include the $1 and $2 a day lines 
which are measures of absolute poverty, or the 40% or 50% of median national income lines 
which are measures of relative poverty (Leibbrandt et al 2010: 17). Although poverty lines have 
been used in South Africa since the Second World War (Wilson and Ramphele 1989: 16), at the 
time of the study the country did not have an official poverty line (Bhorat and van der 
Westhuizen 2010). The line chosen for analysis in this study was the food poverty line, because 
this most clearly defines people’s access to adequate nutrition, which is an important factor 
influencing both the risk of developing TB and patients’ outcomes on TB treatment (Hargreaves 
et al 2011).  
South Africa is classified as a middle income country, but high levels of inequality mean that 
poverty remains extensive (Armstrong et al 2008). South Africa’s consumption Gini co-efficient 
in 2009 was 0.63, making it one of the most unequal countries in the world (World Bank 2012). 
Using a poverty line of R515 per capita income per month,10 the poverty headcount ratio in the 
country at the time of the study was 0.54 (Leibbrandt et al 2010: 36). This was highest in 
                                                          
10
 This was the “lower bound” poverty line for South Africa and indicates extreme absolute poverty. The “upper 
bound” poverty line for the same year was R949 per capita per month (Leibbrandt et al 2010: 65).  
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households headed by African females (0.68) and African males (0.60). The poverty rate in 
KwaZulu-Natal is the second highest in the country, at 58.5%, and just over a quarter (25.5%) of 
all poor individuals in the country live in this province (Armstrong et al 2008).  
Social grants have, to a certain extent, lessened the depth of poverty in the country in the past 
decade (Armstrong et al 2008), and are the main source of income for 47.7% and 51.0% of 
households in the poorest two quintiles in the country, respectively (ibid). Social grants have 
been shown to improve household food security in South Africa (Case and Menendez 2007), 
and may thus reduce under-nutrition, which is an important risk factor for the development of 
TB disease (Cegielski and McMurray 2004) and may predispose to more severe disease (Van 
Lettow et al 2004).  
For reasons of equity and stigma, social protection programmes are much more commonly 
directed at poor people in general, rather than poor people who are ill (Hargreaves et al 2011). 
However, there is a need to protect the latter group from the costs of illness which may be 
catastrophic for the household (Russell 2004), and also to support them through an illness so 
that they may become economically active again at the end of treatment. As Hargreaves et al  
(2011) state, “it may be possible (and necessary) to address selected factors in the daily living 
conditions of TB patients and their communities that might influence TB epidemiology”.  
Indeed, as has been discussed earlier in this thesis, social support is provided to patients with 
TB in South Africa, in the form of a disability grant and food parcels from public sector clinics. 
However, neither the disability grant nor the food parcels are tied to any conditions such as 
adherence on the part of TB patients, and neither has been evaluated for its effect on poverty, 
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food security, or disease outcomes. Because of the high burden of TB and poor outcomes on 
treatment in South Africa, and because poverty in the country remains extensive, it is important 
to investigate whether economic support targeted at patients with TB improves outcomes on 
treatment (and this is discussed in Chapter 3), and if so, whether this improvement is related to 
the alleviation of poverty among patients and their households.  
Aims: 
 
To investigate indicators of poverty among TB patients participating in this trial, and the effect 
of the voucher on these; and to analyse the expenditure of the vouchers by recipients. 
Objectives: 
For all patients participating in this sub-study: 
 
 To describe patients’ main sources of income, in terms of their employment status,  
receipt of social grants and any other important sources of income 
 To determine the main source of income of patients’ households, in terms of the 
employment status of other household members, the receipt of social grants by others 
in the household, and any other important sources of income in the household 
 To determine patients’ levels of education 
 To determine patients’ average household expenditure on food, household goods, 
health care and transport  
 To determine levels of food security in patients’ households. 
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For patients attending intervention clinics:  
 
 To investigate whether patients perceived the voucher as assisting in their adherence to 
treatment and if so, how 
 To investigate whether patients perceived the voucher to be helpful financially 
 To determine in which area of household expenditure the voucher had been most 
helpful, if at all  
 To investigate on which goods the vouchers were spent.  
 
Methods 
 
The aims and objectives of this part of the process evaluation were met by using two separate 
methodologies, described in sections A and B below. The assessment of levels of poverty 
among patients, and the impact of the voucher on patient household expenditure were 
achieved through conducting a survey of a sample of patients included in the trial. The 
assessment of the goods that patients bought with their vouchers was achieved through an 
analysis of a sample of till slips (receipts) that participating shops retained for each voucher that 
was spent. 
A. Survey of indicators of patient poverty and the effect of the voucher on these 
Study design 
 
This was a quantitative cross-sectional study nested in the trial. The focus of the poverty 
assessment in this study was patient household expenditure, since this is more likely to be 
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reported accurately by participants than income (Oosthuizen 2008) and because it varies less 
over time and is therefore more likely to give an accurate picture of chronic poverty, than is 
income (Chaudhuri & Ravallion 1994). A food poverty line was used in this analysis for three 
main reasons: firstly, because food is one of the most basic requirements of life; secondly, 
because nutrition affects outcomes on TB treatment (Hargreaves et al 2011); and, thirdly, 
because food consumption is more stable over time than either income or general expenditure 
(Chaudhuri and Ravallion 1994). The food poverty line is a measure of absolute poverty and is 
calculated according to how much an “average” individual should spend on food in order to 
meet his/her daily calorie requirements. For the poverty line used in this study, these 
requirements were set at 2 230 kilocalories per day (Oosthuizen 2008) and the cost of 
purchasing these calories (the food poverty line) was calculated to be R326 per month 
(adjusted to 2009 prices) (personal communication: Morne Oosthuizen, Development Policy 
Research Unit, University of Cape Town, 2012). 
Participants 
 
All patients who were in their fourth to sixth month of treatment for pulmonary TB in 
intervention and control clinics at the time of the trial were eligible for inclusion in this study. 
We chose participants who were approaching the end of their treatment period to ensure that 
they had had sufficient experience of the voucher to enable them to report on it, and to allow 
the voucher sufficient time to have had an impact on their expenditures.  
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Sampling 
 
The calculation of this sample size was pragmatic in that it was based on the number of 
fieldworkers and amount of time available for this sub-study. Patients were recruited by two 
fieldworkers who moved between intervention and control clinics every week day for a four 
month period, and included in the survey every eligible patient at the clinic on that day.   
Three hundred and seventeen trial participants (7.8% of the total) participated in this sub-
study. Two hundred and sixteen were from intervention clinics (who had received the voucher) 
and 101 were from control clinics.11 Six patients refused to participate. This sample size enabled 
the detection of R170.00 difference in total monthly household expenditure between patients 
who received the voucher and those who did not, with a power of 80% and a confidence 
interval of 95% (SPSS, two sample T-test power analysis). A difference in expenditure higher 
than the amount of the voucher was chosen in order to take into account the purchase of 
“productive inputs” such as chickens or goats that might further have further enabled increased 
expenditure (Creti 2010), and of improved household well being that might have facilitated job-
seeking and employment by household members (Case and Menendez 2007).  
 Data collection 
 
All data collection took place at intervention and control clinics, either in a quiet room within 
the clinic or in the clinic grounds, to ensure privacy. Using technology called Mobile 
                                                          
11
 Patients from intervention clinics were relatively over-sampled in order to estimate more precisely the effects of 
the voucher on expenditure. 
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Researcher,12 the questionnaire was loaded onto mobile phones and read out by trained 
fieldworkers, who entered the patients’ responses electronically into the phone. Once the 
questionnaire was completed, the fieldworkers submitted it to a central database by sending it 
in a similar way to a mobile text message. Data uploaded to this database was password 
protected and available to the principal investigator only, via a web-based interface. The 
complete Excel database was downloaded at the end of data collection, and analysis 
performed.  
Information on the following variables was collected from survey participants: 
 Age, gender, area of residence and educational status 
 Type of residence 
 Ownership of assets 
 Employment status of index patient and household members (formal/informal/part 
time/full time/self-employed) 
 Receipt of grants by index patient and household members 
 Average monthly household expenditure 
 Average monthly expenditure on food 
 History of TB for the index patient 
 Receipt of voucher 
 Effect of voucher on household expenditure and adherence to treatment. 
                                                          
12
 Mobile Researcher is a technology that enables survey questionnaires to be loaded onto cell phones, the 
questionnaires to be completed on the cell phones and the completed forms to be sent to a central web-based 
database. More information on the technology is available from 
http://www.mobenzi.com/researcher/Features/Mobile-Application  
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The full questionnaire for the survey is presented in Appendix 5A. 
 
Fieldworkers were trained by a member of the Mobile Researcher team, who assisted the 
principal investigator in their supervision. Fieldworkers were visited at clinics on a weekly basis, 
and were also in contact with the principal investigator by phone whenever the need arose. 
Checks on the data as these were entered were built into the Mobile Researcher programme. 
For example, answers outside a certain range were not permitted for questions where these 
limitations were appropriate (such as age). Most questions on the survey had a limited number 
of legitimate answers; keys pressed on the mobile phones that did not correspond to these 
answers were not permitted. For some questions, only one response was permitted, whilst for 
others, multiple responses could be entered. Omission of important questions by fieldworkers 
was prevented by making such questions mandatory; it was impossible to move on to the next 
question in the survey if a mandatory question had not been answered. Entered data was 
checked manually for extreme values and duplicated data. 
The Mobile Researcher programme also allowed remote supervision of fieldworkers, by 
showing the time taken for each interview (interviews that were conducted too quickly implied 
rushed work or fabrication of data) and the time at which each interview was done (interviews 
conducted outside working hours could imply fabrication of data). These facilities 
complemented the on-site supervision of fieldworkers.  
 
 
Stellenbosch University  http://scholar.sun.ac.za
141 
 
Data analysis  
 
Uni-, bi- and multivariate analyses were performed. The main focus of the analysis was the total 
expenditure and food expenditure of the patients’ households, and the impact of the voucher 
on these.  
Statistical methods 
 
SPSS version 15.0 was used to analyse the data. A p value  of less than 0.05 was used to indicate 
statistical significance. Frequency tables were used to describe categorical data whereas 
summary statistics such as mean and standard deviation were used to summarise numerical 
variables with a normal distribution, and non-parametric measures such as median and inter-
quartile range were used in the case of skewed numerical data.  
Total monthly household expenditure was calculated by summing up reported monthly 
expenditure on various commodities, including food and meat. ANOVA tests were used to 
analyse variables with more than 2 levels and t-tests were used when the variables were binary. 
Pearson’s and Spearman’s correlation co-efficients were used to assess strength of 
relationships between quantitative variables.   Because information on household size was only 
given by 129 participants, individual expenditure on food and meat was calculated by dividing 
household expenditure on food and meat by the national average household size (Statistics 
South Africa and National Treasury 2007). 
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Multivariate analysis 
 
Stata version 12 was used for the Generalized Linear Modelling and the analysis was performed 
at the household level. The log transformed total monthly household expenditure was the 
dependent variable, and a normal distribution and identity link were specified. We aimed in this 
analysis to determine which variable(s) were most important in affecting household 
expenditure when confounding factors were taken into account; specifically, we aimed to 
determine whether the voucher was one of these factors. It was a principled analysis, in that 
variables that had been identified in the literature as affecting expenditure, or were in practice 
known to affect expenditure, were included. Robust clustered standard errors were used with 
the clustering variable being the clinic.  
B. Investigation of expenditure of vouchers 
 
The till slips, which listed each patient’s purchases and the prices of these, were retained by all 
participating shops and fixed to a copy of the patient’s voucher. These till slips and the vouchers 
were collected by the investigators and a 15% sample of all till slips (1182 of 8022) was 
randomly selected. The sample size was again pragmatic, and influenced by the number of data 
capturers available to work on this sub-study. The information from these till slips was entered 
onto an Excel database and a descriptive analysis of patient expenditure was performed in SPSS 
(version 15.0).   
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Results 
 
Three hundred and seventeen patients were interviewed, 216 from intervention clinics (who 
had received the voucher) and 101 from control clinics.  
Patient demographics 
 
One hundred and eighty two (57.4%) of all participants were women, and the mean age of all 
participants was 31.9 years. The mean household size of participants was 4 adults (standard 
deviation 2.5) and 2 children (standard deviation 1.9).  
Although 161 participants (50.8%) had had some secondary (high) school education, only 67 
(21%) had completed secondary school; 85 (26.8%) had never attended secondary school and 
24 (7.6%) had never attended school at all.  
Consistent with the urban location of most (16) of the 20 participating clinics, 197 (62.1%) of 
patients lived in a township, 43 (13.6%) in an informal settlement, whilst 58 (18.3%) lived in a 
rural area.  
Household economic status 
 
Employment and income among trial participants enrolled in the survey 
One hundred and twenty six participants (39.7%) said that they earned money in some way 
(including formal and informal, part-time employment and odd jobs). Those who did not earn 
any money at all gave reasons as listed in Table 1 below.  
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Table 1: Patients’ explanations of why they were not able to earn any money 
Reason Number (%) 
Too sick to work 93 (48.7) 
Unable to find job  54 (28.3) 
Studying 23 (12.0) 
Retired 2 (1.0) 
Pregnant or caring for a child 3 (1.6) 
Household duties 1 (0.5) 
Other* 15 (7.8) 
Total 191 (100) 
*“Other” reasons for patients not working were most commonly age (too young or too old) (n=5), or 
receipt of a disability grant (n=3).  
 
Only 9 patients (2.8%) received the disability grant for TB or HIV. These patients were all adults 
between the ages of 18 and 50 years,and most (6) were women. Importantly, six of these 
patients came from a single clinic, which suggests that nurse-related factors (such as their 
knowledge of how to access the disability grant) are important in the equity of the distribution 
of the grant. Seventeen patients (5.4%) received the child support grant and only one patient 
(0.3%) received the old age pension. One hundred and twenty patients (37.9%) were supported 
financially by others in their household. 
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Employment and income among household members of trial participants 
One hundred and seventy six participants (55.5%) said at least one person in their households 
(other than themselves) earned an income.  
Two hundred and thirty three participants (73.5%) said that at least one person in their 
households (other than themselves) received a grant from the state. Of these, the child support 
grant (160 households) was the most common, followed by the old age pension (79 
households). The foster care grant (7 households) and unemployment insurance (one 
household) were rarely received.  
Household expenditure 
 
Participants estimated their monthly household expenditure for a variety of items, listed in 
Table 2 below.  
Table 2: Monthly household expenditure for various items (in South African Rand) 
 Food 
(excluding 
meat)  
Meat Clothes 
and shoes 
School 
fees 
Cell 
phone 
and 
airtime 
Cigarettes 
or  
tobacco 
Alcohol Transport Health 
care 
Mean 584.77 273.02 345.00 253.88 78.40 105.42 313.64 252.03 142.27 
Standard 
deviation 
305.51 183.19 410.20 277.71 100.01 69.09 238.84 201.04 105.02 
Minimum 50 20 50 0 5 20 50 10 30 
Maximum 2000 1200 3000 2000 700 300 700 1200 1000 
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Because the consumption of cigarettes and alcohol is important for public health, this 
expenditure was analysed further. The median expenditure on cigarettes or tobacco was R100 
per month, and on alcohol it was R200 per month. The majority (79%) of patients who spent 
money on tobacco products were adult men between the ages of 18 and 56, and none had 
achieved higher than a grade 5 education. The majority (64%) of patients who spent money on 
alcohol were adult men between the ages of 23 and 56, and in this group again, the highest 
level of education achieved was grade 5.  
Household deprivation, including food security 
 
Participants were asked to recall how often in the three months prior to the interview they had 
been unable to meet their usual expenditure commitments on important items. Their 
responses are listed in Table 3 below.  
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Table 3: Frequency with which households went without specific items, in the three months 
prior to the interview 
 Food (%) Clothing 
and 
shoes 
(%) 
School 
fees (%) 
Fuel for 
cooking 
and 
heating 
(%) 
Basic household 
items e.g. for 
cleaning/cooking 
(%) 
Health 
care (%) 
Never 204 
(65.60%) 
198 
(67.12%) 
239 
(80.74%) 
175 
(56.82%) 
104 (40.15%) 250 
(79.37%) 
Once 16 
(5.14%) 
7 (2.37%) 14 
(4.73%) 
30 
(9.74%) 
17 (6.56%) 14 
(4.44%) 
A few 
times 
83 
(26.69%) 
78 
(24.44%) 
40 
(13.51%) 
94 
(30.52%) 
125 (48.26%) 44 
(13.97%) 
Often 8 (2.57%) 12 
(4.07%) 
3 (1.01%) 9 (2.92%) 13 (5.02%) 7 (2.22%) 
Total 
number of 
patients 
who 
responded 
to question 
311 
(100%) 
295 
(100%) 
296 
(100%) 
308 
(100%) 
259 (100%) 315 
(100%) 
 
One hundred and sixty nine (53.3%) of participants said that in the three months prior to the 
interview, they had had to borrow money or food in order to survive.  
Individual expenditure on food 
 
Mean individual monthly expenditure on food (including meat) was R142.85, and median 
expenditure was R133.33. One hundred and seventy one patients (54%) reported expenditure 
on food (including meat) less than the food poverty line of R326 per month (adjusted to 2009 
prices) (personal communication: Morne Oosthuizen, Development Policy Research Unit, 
University of Cape Town, 2012).  
Stellenbosch University  http://scholar.sun.ac.za
148 
 
Receipt of vouchers from intervention clinics 
 
Two hundred and sixteen participants received the voucher from their clinics. All 216 patients 
said the voucher had helped them in taking their TB treatment, in the ways listed in Table 4 
below.  
Table 4: How the voucher helped participants in taking their TB treatment 
Reason* Number  
I’ve been able to eat enough to take my tablets comfortably 198  
I’ve been able to save use the money saved on foodstuffs for transport to 
the clinic 
13 
I’ve been able to help my family financially so they are more supportive of 
me 
36 
I eat more and feel better able to come to the clinic 94 
*Note: Patients were allowed to choose more than one option for this question.  
Most participants (97.70%) felt the voucher had helped considerably in meeting household 
expenditure on food, whilst some (22.7%) said it had helped considerably in buying fuel for 
cooking and heating. The voucher was not found to be helpful in meeting other expenses such 
as those for other consumables, or for health care. A fifth (20.4%) of patients said the voucher 
had helped considerably to reduce the need to borrow food or money.  
Expenditure of the vouchers 
 
Vouchers were spent primarily on foodstuffs. Figure 1 below shows that 85% of the value of all 
vouchers analysed was spent on food. Importantly, 28.22% was spent on buying meat, 16.82% 
on grains, 10.54% on dairy products and 9.36% on fruit and vegetables.  
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Figure 1: Expenditure of vouchers (%) 
  
Note that ”other” expenditure included paraffin for heating and cooking, candles for lighting, airtime for 
mobile phones and toys. 
 
Although there were some differences in expenditure between urban and rural areas and 
between the genders, most of these were not statistically significant. In urban areas, 0.15% of 
voucher expenditure was on alcohol and cigarettes, whilst in rural areas it was 0.17%. 
(chi2=0.00, p=0.95). Rural patients tended to spend a higher proportion of their vouchers on 
meat (39.22% versus. 26.37% in urban areas) (chi2=11.87, p<0.01). On the other hand, patients 
in urban areas spent more (11.02%) on dairy products compared to their counterparts in rural 
areas who only spent 7.67% (chi2=2.10, p=0.15). Men also spent more on meat than women did 
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(31.18% versus 25.8% respectively) (chi2=2.25, p=0.13) whereas women spent more on grains 
(17.69% versus 15.77%) (chi2=0.42, p=0.12). 
Bivariate analysis 
 
Effect of employment and income on household expenditure 
 
Those participants who had some form of earnings reported significantly higher monthly 
household expenditure than those who did not (p <0.01), but there was no association between 
the receipt of state grants or any other financial assistance with monthly household 
expenditure on bivariate analysis.  
There was a significant association between mean total monthly expenditure and both the 
need to borrow food or money because of shortages (p<0.01) and food security. Participants 
who were least food secure had the least total expenditure of the group (p<0.01). Both these 
associations are expected and confirm the internal validity of this survey. 
Other factors affecting expenditure 
 
There was no association between the geographic areas in which participants lived, and their 
total monthly expenditures (p = 0.97), or their monthly expenditures on food (p = 0.46). 
However, the total monthly expenditure of men was significantly higher than that of women   
(p = 0.02), although food expenditure was not different between the genders (p = 0.35).  
Both total monthly expenditure and monthly food expenditure were higher in those who had 
completed more than a primary school education, compared to those with a primary school 
education or no schooling (p = 0.07 and p = 0.05 respectively).  
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Effect of voucher on household expenditure 
 
As shown in Table 5, there was no difference between the total monthly household 
expenditure of participants who received the voucher and those who did not (p=0.77). The 
monthly expenditure on food and meat was higher in the households of participants who 
received the voucher, although these did not reach statistical significance (p=0.21 and p=0.08 
respectively).  
Table 5: Effect of voucher on monthly household expenditure 
 Mean total 
monthly 
expenditure 
(standard 
deviation) 
Mean monthly 
expenditure on 
food (standard 
deviation) 
Mean monthly 
expenditure on 
meat (standard 
deviation) 
Received voucher 1225.42 (856.16) 834.21 (461.39)  292.21 (169.74) 
Did not receive 
voucher 
1257.54 (875.69) 757.62 (408.45) 245.94 (198.54) 
 
Differential effect of voucher on expenditure in population sub-groups 
 
Overall, there were no differences in the effect of the voucher on total and monthly food 
expenditure between men and women, or between patients of different educational or 
employment status or between participants living in different areas. The effect of the voucher 
on total monthly expenditure and monthly food expenditure was similar across all areas in 
which participants lived.  
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Multivariate analysis 
 
Two hundred and sixty three patients were included in this analysis (168 who received the 
voucher and 95 who did not). Those who were excluded from this analysis were those for 
whom information on total monthly household expenditure was not available.  
Receipt of a voucher did not influence total monthly household expenditure, even after 
controlling for confounders (p=0.557). Factors which did affect total expenditure significantly 
were whether the respondent was earning money (p<0.001), whether the respondent was 
receiving a disability grant (p=0.017) and whether there were any household members 
receiving social grants (p=0.025). All of these factors increased the mean total expenditure, as 
might be anticipated. In addition, participants who lived in a city spent more than those who 
lived in a township (p<0.01).  
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Table 6: Results of multi-variate analysis† 
Parameter Significance 
Gender: male .244 
Age .452 
Education level: primary school and below (versus secondary and tertiary education) .969 
Household location: informal settlement (versus township) .657 
Household location: city  (versus township)  <0.001 
Household location: rural area (versus township) .582 
Respondent earns money (versus respondent does not earn money)   <0.001 
Respondent does not receive a disability grant (versus respondent does receive disability 
grant)  
.017 
Respondent does not receive child support grant (versus respondent does receive child 
support grant) 
.338 
Members of household do earn money (versus members of household do not earn 
money) 
.067 
Members of household receive social grants (versus members of household do not 
receive grants)  
.025 
Respondent does receive voucher# (versus respondent does not receive voucher) .557 
† This is an abridged table. The full table for the results of the multivariate analysis is available in 
Appendix 5B.  
#Note that these were respondents who received at least one voucher during the trial.  
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Discussion 
Levels of poverty among participants 
 
There is little doubt that the participants in this study needed economic support. Consistent 
with the observation that TB is a “barometer of poverty” in South Africa (Andersson 1990), the 
participants in this survey came from poor households. Less than 40% of participants said that 
they earned an income in any way, and, as other research has found, the households of 
patients who did not earn money spent less than those of patients who did (Goudge et al 2009, 
Armstrong et al 2008). This is an important point for discussion in this thesis, given the 
arguments against the provision of social grants (and this voucher), in favour of people finding 
paid work (reported in Chapter 4).  It is important to note that it is difficult for people who are 
less well educated to find employment in South Africa (Leibbrandt et al 2012), and that besides 
social grants, the poor have few alternatives for survival. Unemployment has risen in the 
country in the last decade, and the demand for labour in South Africa is increasingly for those 
who have, at a minimum, completed their secondary schooling (ibid). In our study, only the 
minority of patients had completed secondary education and, as expected from national 
findings (Armstrong et al 2008), those with lower levels of education reported lower monthly 
household expenditure. Although the average length of schooling in the country has increased 
since 1994, the number of scholars who complete their secondary education or who go on to 
tertiary education have not (Leibbrandt et al 2012). Thus formal employment has been 
increasingly difficult to reach for many South Africans. The rate of unemployment in the 
country remains high, with an official unemployment rate of 25% and a rate of unemployment 
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among young people of 51% (Kane-Berman and Cronje 2010). In KwaZulu-Natal, the official 
unemployment rate at the time of the study was 20.9% (Department of Labour 2011). In spite 
of this, the current social security system in South Africa seems to rest on the premise that 
income from employment is readily available to all those who are willing and able to work, and 
that only when an individual is disabled or too ill to work, should the state intervene with 
economic support (Hardy and Richter 2008). It can be argued that this is not an appropriate 
approach for South Africa (ibid).  
For patients with TB, for whom employment may be even more difficult because of illness 
(Munro et al 2007a), social protection from the state may be the only means of household 
survival.  Indeed, 27.8% of patients in this survey said that they were too sick to work. Even 
assuming that paid work was available for these patients if they were well enough, such 
patients should have been eligible for and received disability grants to cushion their households 
against the economic shock of loss of employment during their episode of TB. However, only 
2.8% of patients in this study received the disability grant for HIV or TB. In spite of the fact that 
the total number of disability grants issued by the state has increased in the recent past (Hardy 
and Richter 2008), these do not seem to be reaching households disabled by illness, either in 
this study, or in others conducted in South Africa (Daftary and Padayatchi 2012, Booysen 2004, 
Steinberg et al 2002).  
Recognising the importance of other social grants in alleviating extreme poverty in the country 
(Armstrong et al  2008), and as other research has shown (Case and Menendez 2007), the 
receipt of state grants was an important source of income for households with almost three 
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quarters of all patients saying that at least one person in their household received a state grant 
(most commonly the child support grant). Indeed, the receipt of a disability grant by the index 
patient or any social grant by a household member was significantly associated with increased 
household expenditure on multivariate analysis. It is interesting to note that the receipt of a 
child support grant by the index patient was not associated with higher household expenditure; 
this is likely to be because the value of the child support grant is much smaller than of the value 
of the disability grant (R250 versus R1080.00 per month at the time of the trial). Therefore, like 
the voucher, the child support grant is likely to be too small to have significantly influenced 
household expenditure in this survey.  
Consistent with the experience of poor populations in general, food security among patients in 
this study was low. Over half (54%) of all patients surveyed reported individual expenditure on 
food (including meat) which was lower than the food poverty line for 2009 and almost a third 
(29%) reported that their households had gone without food often or a few times in the three 
months preceding the interview. Food insecurity has been found to be an important social 
determinant of TB (Hargreaves et al 2011, Murray et al 2011), and these findings show the high 
levels of food insecurity in the households of people with TB in KwaZulu-Natal. Such food 
insecurity has important implications for the risk of developing TB (including among others in 
the index patient’s household) and for poorer outcomes on treatment (Villamore et al 2008, 
Range et al 2006, Karyadi et al 2002).   
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Impact of the voucher on household expenditure 
 
In contrast to other research, which shows that conditional cash transfers increase the 
consumption of households (Rawlings and Rubio 2005), our analysis of patient expenditure 
showed that the voucher did not increase the total expenditure of patients’ households. It did 
increase slightly the household expenditure on food and meat, but these increases were not 
statistically significant. In addition, receipt of the voucher did not differentially improve 
expenditure in specific vulnerable groups, such as among women or those with lower levels of 
education.  
Subjectively however, almost all patients felt that the voucher had helped considerably in 
meeting household expenditure on food, whilst a fifth felt it had helped considerably to reduce 
the need to borrow food or money. These results reflect those of the qualitative analysis 
reported in Chapter 4, where patients said that the main value of the voucher had been in 
increasing the amount of food available with which to take their tablets. Assessment of the 
nutritional status of patients was beyond the scope of this study. However, given that the 
voucher did not significantly improve expenditure on food, it is unlikely that it impacted very 
directly on the nutritional status of patients. Indeed, although cash transfers have been shown 
to have beneficial effects on the nutritional and health status of children (Lagarde et al 2009), a 
recent review found that they have had limited or no impact on levels of adult malnutrition 
(Boccia et al 2011).  
It is perhaps because the value of our voucher was small in relation to the food poverty line, 
that it had no significant impact on overall household expenditure or food expenditure. It is 
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likely that cash transfers will have the most impact if they are large in comparison to household 
expenditure, and shift expenditure up to or over a specific poverty line. However, the value of 
cash transfers varies across countries (Lagarde et al 2009) and it is difficult to relate the amount 
transferred to the level of poverty in individual households, since this data is not available for 
most cash transfer programmes (ibid). In our study, the value of the voucher (R120) was less 
than half the value of the food poverty line (R326 at the time of the trial). The value of the 
voucher was limited by stakeholders’ fear that too large a voucher would act as a disincentive 
to work, or as a perverse incentive to remain ill.  
In South Africa, social grants from the state, especially the old persons’ grant (old age pension) 
have been shown to improve household food security (Case and Menendez 2007). In 
households where there is a chronic illness, social grants may help households to meet the 
direct and indirect costs of illness, and protect against further impoverishment (Goudge et al 
2009). Indeed, the social grants received by households in this study were found to significantly 
improve household expenditure on multivariate analysis, supporting national findings that 
these grants have reduced the depth and extent of poverty in the country (Armstrong et al 
2008). (The lack of a statistically significant association between social grants and total 
household expenditure on bivariate analysis was probably due to confounding factors which 
were controlled for in the multivariate analysis).  However, the value of our voucher (R120 per 
month) was small in comparison to the social grants offered by the state. The Child Support 
Grant was valued at R250 per month at the time of the study, whilst the old persons grant and 
disability grant for TB or HIV were valued at R1080.00 per month (South African Social Security 
Agency 2011). The perception of patients that the voucher did help “considerably” with food 
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purchases may be explained by the fact that the voucher enabled the purchase of a reasonable 
basket of food, as illustrated in Table 1 of Chapter 1.  
The direct and indirect costs of an illness are more burdensome for poorer than for wealthier 
households (McIntyre et al 2006). For poorer households, even relatively minor costs like travel 
to a clinic may necessitate reducing expenditure elsewhere (Goudge et al 2009). The vouchers 
helped to reduce the need to borrow food and money in some of the households included in 
this study. Since the creation of debt as a result of illness is a common cause of further 
household impoverishment (McIntyre et al 2006), the voucher may have mitigated somewhat 
against this. In addition, it may have made recipients more “creditworthy” in the eyes of their 
communities, thus strengthening social networks for borrowing and lending in the future 
(Goudge et al 2009). Similarly, one of the reasons patients gave for finding the voucher helpful 
was that it enabled them to give financial assistance to their families, who were in turn more 
supportive of them. This is consistent with theories relating to the allocation of resources in 
households, where household members who bring in financial income may be valued more 
highly than those who do not (Rosenzweig 1986).  
Expenditure of the vouchers 
 
Patients in this study were advised by clinic nurses to spend their vouchers on healthy 
foodstuffs, but at the shops where vouchers were redeemed no restrictions were placed on 
patient expenditure. However, analysis of their expenditure shows that most patients did spend 
their vouchers on food. Although concerns have been raised in South Africa that social grants 
are spent on unhealthy or even damaging items (Coetzee 2011), and although this was a 
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concern raised often by stakeholders in the preparatory phases of this study, analysis of the 
expenditure of this voucher shows that less than 1% of expenditure was on alcohol or cigarettes 
and that the greatest expenditure by far was on healthy foodstuffs. This reflects the findings of 
other studies in the country (Patel et al 2012: 20; Coetzee 2011), and contradicts the findings of 
studies internationally (Oxman et al 2009). Although the expenditure of such transfers may be 
contextual, the results of this study seem to suggest that in South Africa, recipients of grants 
tend to spend them on what is best and most needed for households. Whilst in this study, 
patients were restricted to spending the voucher on consumables, unrestricted cash grants are 
generally spent on foodstuffs, school fees and school uniforms, medicines and health care, and 
transport (Patel et al 2012). 
Limitations of this sub-study 
 
This survey was based on relatively small sample sizes and therefore its generalizability may be 
limited. In addition, the survey focused on expenditure rather than income as the former is 
considered to be more accurately reported by patients (Oosthuizen 2008). However, 
expenditure is also subject to recall bias especially if the detail required is great (Bhorat and van 
der Westhuizen 2010). The information requested for the purposes of this study was not 
detailed in comparison to that required for income and expenditure surveys, and so the risk of 
recall bias may have been lower. However, this lower level of detail may have resulted in the 
omission of important information that might have enabled greater precision in the analysis of 
patient expenditure.  
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Patients appear to have under-estimated their total household expenditure, which is small 
relative to the expenditure reported for individual consumables. This suggests that patients’ 
estimates of expenditure were imprecise and this must be borne in mind in the interpretation 
of the findings.  
Patients in intervention clinics were not asked to differentiate their expenditure with and 
without the voucher, and some may thus have reported their usual expenditure, as opposed to 
their expenditure with the voucher. This may have reduced the ability of the analysis to detect 
an effect of the voucher on expenditure. 
Analysis of individual expenditure may not have been an accurate reflection of reality, because 
information on the composition of households was only available for 129 participants. The use 
of the national average household composition to calculate individual expenditure from 
household expenditure may have led to inaccuracies in figures for individual expenditure.  
A limitation of the trial generally, as well as of this sub-study, is that most clinics and patients in 
the trial were situated in urban areas because most rural clinics did not meet the trial’s 
inclusion criteria. This under-representation of rural participants and clinics mean that the 
findings of the trial and of this sub-study should be generalized to rural areas with caution.  
The multivariate analysis was confined to those patients for whom information on total 
monthly household expenditure was available (263 participants). Although it is possible that 
those who did not report their expenditure were a random sample of the total, it is more likely 
that they did not report because they were unwilling to disclose this information. This suggests 
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that their expenditure might be significantly different from that of the sample who did report 
on it and, if so, this may have introduced some bias into the findings.  
Conclusions 
 
The voucher did not impact significantly on the poverty levels of patients in this study. Its value 
of R120 (approximately US$15) was considerably lower than that of most other social grants at 
the time of the study, and it did not significantly increase patients’ total monthly expenditure or 
monthly expenditure on food. However, it was perceived by patients to be helpful in improving 
the amounts of food available to the household and in reducing the need to borrow food or 
money. There was no differential effect of the voucher on the expenditure of vulnerable 
groups. Although patients were not restricted in their purchases at shops, vouchers were spent 
primarily on food stuffs, with less than 1% of expenditure being on alcohol or cigarettes.  
Because of its relatively small value, the impact of the voucher on the role of poverty in 
undermining the outcomes of patients on TB treatment is likely to have been small. Further 
research should investigate the effects of higher levels of economic support for their impact on 
household and patient poverty, and TB outcomes. Future research should also investigate 
whether economic support directed at patients with active TB should be shared with household 
members or used exclusively by the index patient.  These and other research questions arising 
from this trial and its sub-studies are discussed further in Chapter 6.  
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Chapter 6  
The evidence that informed this trial, and the 
contribution of the trial to current evidence 
 
Introduction 
 
This chapter aims to summarise the evidence generated by this trial and its process evaluation, 
and to demonstrate how it extends the evidence already available in the field of economic 
support for the improvement of TB outcomes. By critically examining the strengths and 
limitations of the trial, I lay the foundations for the final chapter, which focuses on the research 
that is still needed in this field.  
 
What evidence informed this trial? 
 
The conduct of this trial was motivated by the fact that, in the face of strong evidence that links 
TB to poverty (Cegielski et al 2012; Ploubidis et al 2012; Baker et al 2008; ASSAF 2007; Van 
Lettow et al 2004, Tverdal 1986; Edwards et al 1971) and substantial interest in the field of the 
socio-economic determinants of health, including of TB (Hargreaves et al 2011; Lonnroth et al 
2010; WHO 2008), data on the efficacy  or effectiveness of socio-economic interventions to 
improve TB control is very thin. This may be because, as was discussed in Chapter 1, studies 
that intervene in the linkages between poverty and disease are complex and difficult to 
conduct. It may be also, as discussed in Chapter 4, because some stakeholders feel that social 
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welfare for the poor, including for the poor who are ill, may lead to dependence and act as a 
perverse incentive. Finally, it may be because the concept of using economic interventions to 
improve health outcomes is still a new one, which exists on the periphery of the public health 
imagination. The perception of economic interventions as tools which should be tested and 
rigorously evaluated, like new treatment or prevention modalities, is still not widely 
entrenched.  
 
The Cochrane systematic review reported in Chapter 2 showed that 10 of the 11 included 
studies that investigated the use of economic incentives or enablers for patients with TB were 
conducted in the United States, among marginalized groups such as injection drug users or 
homeless adults (Lutge et al 2012). Thus the findings of these studies must be generalized with 
caution. In addition, most studies included in this review focused on adherence to TB 
preventive therapy or on return to clinics for the receipt of the results of diagnostic tests. Only 
one included study investigated patients on treatment for active TB (Martins et al 2009). The 
review concluded that economic incentives or enablers showed promise as short term 
interventions; cash incentives might improve rates of return for the collection of TB diagnostic 
tests (although the quality of the evidence was low), and would probably improve rates of 
return to the health services for initiation of TB treatment (here the quality of the evidence was 
moderate). For long term TB prophylaxis, the review concluded that economic incentives or 
enablers might improve patients’ outcomes in some settings, but the quality of the evidence 
was low. However, it was unable to draw conclusions about the effect of economic support on 
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completion of treatment for active TB because only one included study had addressed this issue 
and the quality of evidence in this study was very low (Martins et al 2009). 
 
Previous reviews documented a similar lack of evidence for the use of economic support to 
improve TB outcomes. In a review investigating the use of conditional cash transfers and 
microfinance for the improvement of TB control (Boccia et al 2011), which focused on the 
household level and included non-randomised study designs, it was found that no conditional 
cash transfer programmes focused on TB per se, and only one microfinance programme did so 
(Thim et al 2004).  In this study, participation in a microfinance programme showed a beneficial 
effect on TB cure rates (ibid). An earlier review of large scale conditional cash transfer 
programmes for the improvement of access to health care and various indicators of health, 
focused only on direct monetary transfers and included non-randomised study designs (Lagarde 
et al 2009). This review also found that no conditional cash transfer programmes had focused 
on TB outcomes. Finally, in a review of reviews of results-based financing which included both 
conditional cash transfers and economic incentives targeted at “patients, providers, 
organizations, or governments”, Oxman and Fretheim (2009) discussed one review of financial 
incentives which had included studies on tuberculosis (Giuffrida and Torgerson 1997). Both of 
the studies on TB in the review by Giuffrida and Torgerson (Pilote et al 1996 and Morisky et al 
1990) were considered in the Cochrane review reported in Chapter 2 (Lutge et al 2012).  
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Trial setting 
 
Our pragmatic, cluster randomized controlled trial to test the feasibility and effectiveness of 
economic support for patients on TB treatment was conducted in South Africa, “where the 
health crisis intersects most forcefully with issues of social justice and human rights” (London 
2008).  Although in many regions of the world the incidence of TB has fallen, and outcomes on 
TB treatment have improved (WHO 2011), rates of death and default from treatment remain 
high in Africa (Lonnroth et al 2010). In South Africa, incidence rates continue to rise (WHO 
2011) and TB remains the most important cause of death in the country (Statistics South Africa 
2011). Although HIV has played an important role in the increasing incidence of TB in South 
Africa (Day et al 2012: 89-90), conditions of poverty have also remained central to the 
continuing significance of the epidemic (Abdool Karrim et al 2009). KwaZulu-Natal, where this 
trial was set, is one of the poorest provinces in the country (Armstrong et al 2008), and is the 
epicenter of both the TB and the HIV epidemics (Day et al 2012: 89 and 203).  
 
Working in public health in South Africa, it is difficult not to note, and try to address, the 
important links between poverty and TB. Some of South Africa’s most eminent academics have 
commented on the profound importance of addressing poverty in order to improve TB control, 
and the urgency of their call has not decreased over time. In 1986, Professor Solly Benatar of 
the University of Cape Town wrote “Without doubt the most important factor in the control of 
TB is improvement in living standards. Unless there is improvement in nutritional status, 
reduction in overcrowding, and improvement in the overall level of education, no TB 
programme can hope to be more than marginally effective” (Benatar 1986). In 2005, Professor 
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Dingie van Rensburg of the University of the Free State wrote, “We have to recognize that TB is 
a socio-economic disease par excellence, and that the neglect of socio-economic factors was 
and still is the reason why TB control has constantly failed” (van Rensburg et al 2005). In South 
Africa, it is very difficult to ignore the association between poverty and TB, and the 
investigation of the use of economic interventions to improve TB indicators can be seen as a 
public health imperative.  
 
Thus the trial that is the core of this thesis was undertaken to investigate whether It was 
feasible to implement economic support to patients with pulmonary TB as part of the routine 
TB control programme in public sector clinics in South Africa and whether this support would be 
effective in improving patients’ outcomes on TB treatment.   
 
What were the main findings of the trial and what are the implications of 
these? 
 
The trial was conducted over a period of 14 months, from 01/07/2009 to 30/09/2010. Twenty 
clinics and a total of 4091 patients were included. There was no loss of clinics in this trial and 
minimal loss of patients to follow up (Lutge et al 2013, reported in Chapter 3). The main 
findings of the trial and its process evaluations are as follows: 
 A monthly voucher given to patients with active pulmonary TB  in public sector clinics in 
South Africa resulted in a small and nonsignificantimprovement in their treatment 
success rates 
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 Fidelity to the trial protocol was low, which may have contributed to this inconclusive 
result 
 Nurses’ preference for giving vouchers to patients who were relatively more deprived 
probably had an important impact on this fidelity 
 Both nurses and patients perceived the vouchers as helpful in improving adherence to 
treatment 
 The voucher did not significantly increase the household expenditure of recipients 
 Managers of the TB Control Programme were concerned about the perverse incentive 
effects of the vouchers (although there was no evidence of such effects in the data from 
this trial).  
 
As in all epidemiological studies, there are a number of possible explanations for the very 
modest effect found in the intention to treat analysis. The first is that this was due to chance; 
however, given the power of this study (90%), this is unlikely. The second, that it was due to 
confounding, is also unlikely because of the randomized nature of the trial. The third, that is 
was due to bias, is possible. The clinics selected for inclusion in this trial may, due to the 
selection criteria used, have been different in their management and administration from other 
clinics. Indeed, it was important that clinics which may have been very poorly administered be 
excluded from the trial, so that poor administration did not affect the delivery of the voucher 
(Lutge et al 2013, reported in Chapter 3). However, because included clinics were 
geographically scattered throughout the two districts, it is unlikely that the patients themselves 
were different in selected clinics compared to clinics which were not selected. Within the trial, 
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we know that selection bias (in terms of which patients were given the voucher) did occur and 
this is extensively reported on in Chapters 3 and 4 and in this chapter. Nurses in intervention 
clinics preferentially allocated vouchers to patients whom they perceived to be more needy. 
Since patients who are more deprived are likely to find it more difficult to adhere to treatment 
(Munro et al 2007a), it is possible that this may have weakened the effect of the voucher if the 
voucher was unable to overcome the barriers that they experience. In addition, many other 
eligible patients who may have responded to the voucher did not receive it, and this may also 
have diluted the effect of the voucher in the intention to treat analysis.  
  
The fourth explanation for the intention to treat finding of our trial is that the intervention itself 
(the economic support in the form of a voucher) was not efficacious. This is entirely plausible; 
the voucher may simply not have been the most appropriate intervention to address the 
factors undermining patients’ outcomes on TB treatment, or its Rand value may have been too 
low to have had a more substantial effect (this was commented on by several participants and 
is reported in Chapter 4). Finally, the context in which this pragmatic trial took place may have 
affected its conduct and results. Some important programme- and people-related factors that 
impacted on the delivery of our voucher, and which may have impacted on the findings of the 
effectiveness of the voucher, were elicited in the process evaluation of this trial; these are 
discussed further below. A summary of factors internal and external to the trial that may have 
affected its findings, is presented in Table 1.   
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Table 1: Factors affecting the conduct and findings of the trial 
 Factor  Explanation 
Internal to trial Chance Unlikely to have affected findings 
because of high statistical power of trial 
(90%) 
 Confounding The use of randomization in the trial 
reduces the likelihood that the findings 
are due to confounding 
 Bias Intention to treat findings may have 
been affected by selection bias of clinics 
into trial (only clinics meeting inclusion 
criteria were selected for 
randomization) 
Intention to treat findings may have 
been diluted by selection bias of 
patients for the receipt of the voucher 
(nurses gave vouchers to patients who 
they perceived to be more deprived) 
External to trial 
(contextual) 
Communities’ 
perceptions of 
social justice 
Nurses’ re-interpretation of trial 
eligibility criteria (giving voucher to 
more deprived patients) may have 
diluted intention to treat findings of trial 
(see point above).  
 Stakeholders’ 
concern around 
perverse incentive 
effect of voucher 
Low value of voucher (prompted by 
stakeholders’ concern that patients 
might try to remain ill in order to 
continue receiving the voucher) may 
have lowered its benefit for patients in 
terms of how much food could be 
bought with the voucher, and how long 
this food could last in a household in 
which it was shared.  
 Stakeholders’ 
concern around 
the creation of 
dependence on 
voucher 
Low value of voucher (also prompted by 
stakeholders’ concern that patients 
would become dependent on voucher 
and no longer seek work) may also have 
lowered its benefit for patients in terms 
of how much food could be bought with 
the voucher, and how long this food 
could last in a household in which it was 
shared. 
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The pragmatic nature of the trial generated valuable lessons regarding the implementation of 
economic interventions for health at scale, and reaffirmed the dictum that “science is social” 
(that is, that scientific research is not only motivated by social values but that its results are 
affected by the social context in which it takes place) (Venkatapuram and Marmot 2009).  
Although the participants in this trial, including the nurses and shop personnel who were 
responsible for issuing and redeeming the voucher, said that it was easy to administer, the 
voucher was not administered as intended in the protocol. Experience from this trial suggests 
that the system of voucher administration tested in this trial was technically feasible in the 
setting of public sector clinics in KwaZulu-Natal. However, two factors prevented the full 
operationalisation of the voucher system, and I now discuss these in more detail. The first, and 
probably the most important, was the fact that nurses delivering the voucher reinterpreted the 
eligibility criteria for the trial, based on their own perceptions of patients’ need.  
 
As discussed earlier, there is widespread and deep poverty within KwaZulu-Natal, and the 
patients who present with TB to public sector clinics are almost universally poor in terms of 
their levels of employment, their monthly incomes and their living conditions (survey of 
household expenditure, reported in Chapter 5). However, even within this general poverty 
there is a range of deprivation which, at its worst extreme, is almost untenable. Thus it seemed 
unfair to participating nurses to give the vouchers to eligible patients who seemed relatively 
less deprived; nurses felt that vouchers should be “rationed” so that the most needy patients 
received them. This is an understandable compassionate response. It is not uncommon for the 
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implementers of policies to adjust or modify the implementation of a policy because it seems to 
them to be unjust or otherwise inappropriate (Walker and Gilson 2004, Lipsky 1980). This 
makes the implementation of policies more complex, and may fundamentally alter the 
intended effects thereof. The role of the implementor in re-interpreting a policy through its 
implementation should therefore not be under-estimated.  
 
A second group of factors that may have impacted on the fidelity to the implementation of our 
voucher system was logistical issues experienced by both nurses and investigators (reported in 
Chapter 4). Although the effect of these issues was not quantified, they may also have lowered 
the fidelity to our intervention, and so may have diminished the effectiveness findings of the 
intention to treat analysis. They are also important to consider for the replication of this trial in 
other settings. Indeed, they point to the conclusion that this system of voucher delivery may in 
fact not be feasible for settings where staffing levels are low. Although the voucher system 
used for the trial protected to a large extent against misuse of the vouchers, such as theft, fraud 
and “leakage” to patients not eligible to receive them, it was resource intensive in that 
vouchers were delivered to clinics and collected from shops in person and upon the signatures 
of investigators, nurses and shop personnel. Where gains may have been made in reducing 
corruption around the vouchers, these gains may have been lost because some eligible patients 
did not receive the vouchers when, and as often as, they should have. The issue of ensuring 
that all those who are eligible receive social assistance is also problematic on a national scale. In 
South Africa, not all of those who are eligible for social grants actually receive them. This is 
because they either do not know they are eligible, do not know how to access the grants, or are 
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unable to access them consistently over time (Richter 2006). Developing a system for the 
delivery of economic support to poor patients, including for those who are ill, that is best suited 
to local contexts, remains a subject for further research.  
 
In addition to its modest effect on treatment success rates, our voucher did not significantly 
increase the expenditure of patients’ households. This most likely was because, as discussed in 
Chapter 5, the amount at which the voucher was valued was small. It was less than half the 
value of the food poverty line at the time of the trial (personal communication: Morne 
Oosthuizen, Development Policy Research Unit, University of Cape Town, 2012) and about a 
quarter of the value of the national median per capita monthly income (Hall 2010). This value 
was set however because TB managers who were involved in the planning phase of the trial 
were concerned that a higher amount might act as a perverse incentive for patients to remain 
ill so that they could continue receiving the voucher. This fear does not seem to have been 
realized in this trial. Although reverse causality may have contributed to these results, the dose-
response analysis suggested that the more often patients received the voucher, the higher the 
treatment success rates. This finding tends to support that of the exploratory analysis, and also 
argues against a perverse incentive effect; it is expected that if patients had tried to remain ill in 
order to continue receiving a voucher, treatment success rates would have fallen with 
increasing duration of receipt. In addition, although the low value of the voucher may have 
limited its effectiveness, it is possible that a voucher with a higher value might have had a 
perverse incentive effect. It is also not clear how affordable a larger financial transfer may be 
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for South Africa, and it is therefore a recommendation of this thesis that more research be 
conducted into the optimal value of economic support for TB patients in various local contexts.  
 
Although the voucher did not have a significant effect on patients’ household expenditures, it 
was perceived to be very helpful by patients, both in the quantitative survey reported in 
Chapter 5 and in the in-depth interviews reported on in Chapter 4. Patients in this trial were 
predominantly (over 60%) unemployed, and a large proportion (over 50%) were not able to 
meet their household needs with their regular incomes. As directed by the nurses who 
distributed the vouchers, patients by and large used their vouchers for the purchase of food 
(reported in Chapter 5), which was useful because it helped them to avoid taking their tablets 
on an empty stomach (reported in Chapters 4 and 5). This confirms the findings of other studies 
(Patel et al 2012: 20; Richter 2006) that patients who receive financial assistance from the State 
generally spend it on worthwhile items. However, because the value of the voucher was low 
and because most patients shared their purchases with their households, the benefit of the 
voucher to the individual patient was probably limited. This finding raises important questions 
for further research on poverty and TB. For example, is it sufficient for TB control to limit 
economic support to individuals on treatment (Hargreaves et al 2011)? Given the effect of 
poverty and specifically, poor nutrition, on the incidence of the disease (Cegielski et al 2012, 
Edwards et al 1971, Tverdal 1986), should economic support not be directed at the household 
so that two goals can be achieved simultaneously: the outcome of the index patient on TB 
treatment can improve, and new cases of TB arising from the same household can be 
prevented? Perhaps even more effective for TB control would be to direct economic support to 
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all people below a certain poverty threshold? However, given that such support already exists 
in South Africa in the form of social grants, and that despite this the incidence of TB continues 
to rise and outcomes on TB treatment remain poor, it seems that questions around the best 
way to impact on TB epidemiology remain.  
What does the trial add to the current evidence?  
 
This trial adds to the current evidence on the use of economic support to improve the 
outcomes of patients on TB treatment, both in terms of the trial findings themselves and in 
terms of the process evaluation.  
The effect of economic support on TB treatment outcomes 
 
To examine the global evidence for the effects of economic support in patients on treatment 
for active pulmonary tuberculosis, we combined the findings of our trial with that of the only 
other randomized controlled trial we know of that examines this question (Martins et al 2009). 
The trials are compared in Table 2 and the results of this meta-analysis are presented in Figure 
1 and discussed further below.  
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Table 2: Comparison of trials investigating the use of economic support to improve the 
outcomes of patients on treatment for active pulmonary TB 
 
 Lutge et al   Martins et al  
Primary outcome measure Treatment success (treatment 
completion + cure) 
Treatment completion13 
Participants Patients with pulmonary 
tuberculosis (both smear 
positive and smear negative) (n = 
4091) 
Patients with pulmonary 
tuberculosis (both smear 
positive and smear negative) 
(n = 270). 
Intervention Monthly voucher, redeemable at 
local stores. Patients were 
encouraged to buy food with 
their vouchers.  
Culturally appropriate daily meal 
for the intestive phase of 
treatment, followed by a food 
parcel containing sufficient food 
for a meal for one person, for 
the continuation phase.  
Control group Routine care Routine care + nutritional advice 
Methodology Cluster randomized Individually randomised 
  
 
Because one of the trials in this meta-analysis was cluster randomized, the generic inverse 
variance method was used to perform the meta-analysis (Higgins and Green 2011). The natural 
                                                          
13
 Martins (2009) defined treatment completion as “clearance of acid fast bacilli from the sputum after treatment 
or the completion of eight months of treatment, or both”. Thus the primary outcome of both trials is the same, 
although the terminology used is different. 
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logs of the risk ratios and their standard errors were calculated and entered into RevMan; the 
forest plot showing the results of this analysis is below.  
Figure 1: Pooled results from two trials of the effect of economic support on the outcomes of 
patients on treatment for active pulmonary TB 
 
 
 
As shown in figure 1 above, the degree of variation between the trial results due to true 
heterogeneity rather than chance alone was relatively small (24%).  The meta-analysis suggests 
that the effect of economic support for patients on treatment for active TB is still very 
undertain, although the confidence intervals include a potentially important benefit.  Given the 
evidence that suggests that poverty undermines the outcomes of patients on TB treatment 
(Hargreaves et al 2011, Zachariah 2002), the finding of this meta-analysis is surprising. 
However, the quality of the evidence must be taken into account. Since my own assessment of 
the quality of this evidence may be biased, an independent assessment of the evidence was 
undertaken by an editor of the Cochrane Infectious Diseases Group based at the Liverpool 
School of  Tropical Medicine.  
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Folllowing an assessment of the risk of bias in our trial (Lutge et al 2013), the Grading of 
Recommendations, Assessment, Development and Evaluation (GRADE) system was used to 
assess the quality of the evidence of this meta-analysis. This system is one of the most objective 
and transparent ways of categorizing the quality of evidence (Guyatt et al 2008) and is used by 
the Cochrane Collaboration.  The GRADE approach considers several aspects of a body of 
evidence in order to classify its quality; these include the study design (randomized controlled 
trials are considered high quality evidence), the risk of bias in the studies, and the precision, 
consistency and directness of study results (Balshem et al 2011). In the GRADE assessment of 
this meta-analysis, the starting point was to identify the evidence as high quality because both 
included studies were randomised controlled trials. The application of the remaining criteria are 
presented in the Summary of Findings Table and the GRADE assessment of the meta-analysis 
below. 
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 Figure 2: Summary of findings table and GRADE assessment of meta-analysis 
Material incentives/enablers compared to routine care for improving patient adherence to treatment 
for active TB 
Patient or population: People engaged in tuberculosis programmes 
Settings: Middle- and low-income settings 
Intervention: Material incentives/enablers (vouchers or food) 
Comparison: Routine care 
Outcomes Illustrative comparative risks* (95% 
CI) 
Relative 
effect 
(95% CI) 
No of 
participants 
(studies) 
Quality of the 
evidence 
(GRADE) Assumed 
risk 
Corresponding risk 
Routine 
care 
Material 
incentives/enablers 
Treatment 
sucess  
(Completion or 
cure) 
750 per 
1000 
780 per 1000 
(728 to 848) 
RR 1.04  
(0.97 to 
1.13) 
4356 
(2 studies) 
⊕⊝⊝⊝ 
very low1,2,3,4 
The assumed risk is taken from the control groups in the trials. The corresponding risk (and its 95% CI) is 
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 
95% CI). 
CI: Confidence interval; RR: Risk ratio; 
GRADE Working Group grades of evidence 
High quality: Further research is very unlikely to change our confidence in the estimate of effect. 
Moderate quality: Further research is likely to have an important impact on our confidence in the 
estimate of effect and may change the estimate. 
Low quality: Further research is very likely to have an important impact on our confidence in the 
estimate of effect and is likely to change the estimate. 
Very low quality: We are very uncertain about the estimate. 
Footnotes 
1
 No serious risk of bias: Both studies adequately concealed allocation to be at low risk of selection bias. 
Neither study was blinded. 
2
 Downgraded by 1 for serious inconsistency: Although neither study showed a statistically significant 
difference, the study from Timor Leste showed a trend towards harm with the intervention while the study 
from South Africa showed a trend towards benefit. 
3 
Downgraded by 1 for serious indirectness: The study from Timor Leste was conducted among 
malnourished men and provided an incentive as a daily hot meal. The study from South Africa provided 
all TB patients with a monthly voucher worth $15 when medication was collected. Qualitative research 
around these studies suggest that the daily hot meal was not well liked by patients as it interfered with 
daily life, whereas the voucher was well received. It is difficult to generalize these interventions to other 
settings. 
4
 Downgraded by 1 for imprecision: Neither study showed a statistically signficiant benefit. However the 
study from South Africa where the intervention was well recieved has a confidence interval which 
includes a 15% increase in treatment success, which may be deemed worthwhile. 
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Thus the GRADE assessment describes the quality of the evidence provided in this meta-
analysis as being of very low quality. The official definition of this assessment is “We have very 
little confidence in the effect estimate. The true effect is likely to be substantially different from 
the estimate of effect” (Balshem et al 2011). In terms of this meta-analysis then, it is likely that 
the finding that “economic support for patients on treatment for active TB probably has little or 
no effect on TB treatment outcomes” will be refuted by future research. The importance of 
conducting this research, and some suggestions as to important foci for this research, are 
discussed later in this chapter.  
 
The consideration of these two trials together also emphasizes the importance of the context in 
which the research took place. Although Martins et al  (2009) do not present a separate process 
evaluation for their trial, they do report that civil conflict in the country during the conduct of 
their trial “dramatically increased” the default rate of participating patients, and “led to a 
significant decrease in treatment completion (168/199 (84%) before conflict v 35/66 (53%)) 
after conflict” (Martins et al 2009). In our trial, poor fidelity to the trial protocol may have 
contributed to our failure to detect a significant effect. Both trials highlight the difficulties of 
implementing economic interventions in real world settings, and emphasize the imperative to 
take context into account in studies that investigate the effect of economic support on TB 
outcomes.   
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Factors that influenced the conduct of our trial and its findings 
 
The process evaluation of our trial provided valuable information on how the context in which 
an economic intervention is delivered may have a profound effect on its administration, and its 
reach.  It supports other studies that show that different settings influence the response of 
recipients and administrators to economic transfers; for example, whereas in one context very 
poor people may not wish to receive economic interventions for fear of being stigmatized as 
“the poorest of the poor” (Adato et al 2011), in the context of this trial, that was the very 
reason why nurses and patients felt that people should receive it. However, where poverty is 
extensive, our trial also shows that targeting such interventions to specific groups may be 
problematic for both administrators and recipients.  
 
The issue of targeting social assistance at poor patients who are ill in South Africa has been 
extensively discussed by Richter (2006), in relation to patients with HIV/AIDS. Richter argues 
that social support for patients who have HIV/AIDS in South Africa is crucial because most 
patients are poor and food insecure.  By improving patients’ access to food, and providing funds 
for transport to the clinic, the disability grant received by patients with HIV/AIDS improves 
patients’ prognosis; in addition, it acts as  a “de facto poverty alleviation grant” (Taylor Report 
2002) because it is shared with the patient’s family.  Richter notes that there are probably 
grounds within the South African Constitution (Act 108 of 1996) for compelling the government 
to provide longer term support for patients living with HIV/AIDS than the current disability 
grant allows. However, although such support is crucial for the well-being of these patients who 
are mostly living in poverty, this targeting of individuals with HIV/AIDS may have an important 
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perverse incentive effect (Nattrass 2006) and may also be considered unjust by those who are 
living in similar conditions of poverty but who have other chronic diseases such as diabetes and 
hypertension (Richter 2006). Both of these issues were raised in our trial. Although our 
vouchers did not seem to have a perverse incentive effect, several concerns around this were 
raised by policy makers and managers in the planning phase of the trial and by managers in the 
in-depth interviews conducted as part of the process evaluation (reported in Chapter 4). Issues 
around targeting were also found by our trial to be problematic for both nurses and patients, 
and fundamentally altered the delivery of our vouchers.  
 
In light of the findings of this trial and the views of Richter (2006) and Nattrass (2006), 
significant concerns around the targeting of economic support to patients with a specific 
disease, including those with TB, remain. Recognizing these concerns, and the fact that the 
results of this trial were inconclusive, the question remains: given that TB is strongly associated 
with poverty, how best should economic interventions be delivered in order to improve TB 
outcomes in South Africa?  
 
Both Richter (2006) and Nattrass (2006) feel that universal social protection in the form of a 
basic income grant (BIG)14 to all South Africans would circumvent the problems of perverse 
incentives and social division associated with more targeted economic support. It would also be 
easier to administer than the current system of social grants in the country because means 
                                                          
14
 The Basic Income Grant would be a universal cash transfer, given to every single South African, but recovered 
from the financially better off by a progressive tax. At the height of debates around its implementation, the 
amount postulated for the grant was R100 per month (Catholic Bishops Conference 2003).  
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testing or other forms of assessment would no longer be required. The social security system of 
the democratic government has not been as efficient as hoped, and it has been reported that it 
has incurred annual losses of up to R1. 5 billion due to massive problems of maladministration 
and corruption (Reddy and Sokomani 2008). From the perspective of TB control, universal social 
protection has much more potential to reduce the incidence of the disease (by improving 
household nutrition and living standards) than does a grant that is targeted to patients who are 
already ill. It would even be superior to the current system of social grants in the country in this 
respect, because there are millions of poor households in South Africa that slip through the 
social protection safety net because they do not qualify for any of the grants available (Richter 
2006).  
 
However, as evidenced by some of the findings of this trial, it is questionable whether the 
proposed Basic Income Grant of only R100 per month (adjusted to R162.37 in 2013 prices) 
would be effective in improving household economies to the extent that nutritional status and 
living standards could be improved. It was seen in this trial that the amount of R120 per month 
provided by the voucher was perceived by patients as being very little, and it did not 
significantly impact on patients’ household expenditures. Increasing the value of a universal 
Basic Income Grant may be more effective but may also be unaffordable for the country; 
providing a larger amount that is targeted at the poorest and most deprived groups may be 
difficult to administer and open to corruption; providing a larger amount targeted to patients 
with a specific disease such as TB may generate resentment in patients who are not the 
subjects of such targets, create perverse incentives to contract or prolong TB infection, and be 
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similarly difficult to administer according to the policy. Finding the ideal way to provide 
economic support in order to improve TB outcomes requires a great deal more effort, and given 
the burdens of both poverty and TB in South Africa, should be the subject of much research and 
debate in this country in the years to come.  
Strengths and limitations of this study 
 
In this section, I consider the most important strengths and  limitations of the trial and its 
process evaluation, and discuss how its limitations impacted on the results and interpretation 
of this study as a whole.  
Strengths 
 
This trial was the first to investigate the use of economic support to improve the outcomes of 
patients on TB treatment in Africa, and is particularly relevant for this continent because of its 
high burden of TB and extensive levels of poverty. It was an important trial for South Africa, 
where studies testing the use of economic interventions to improve health outcomes are rarely 
conducted and where concerns around the provision of social welfare remain prevalent.  
 
The pragmatic nature of the trial enabled an assessment of how the real world conditions of a 
relatively poorly resourced TB programme would impact on the delivery of the intervention, 
and highlighted many factors that are important for both policy and future research in this field. 
This trial was much larger than the only other trial known to have investigated economic 
support for the improvement of TB outcomes in a low or middle income country, and 
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demonstrates that it is possible to implement economic interventions for the improvement of 
health outcomes on a fairly large scale in this setting.  
 
The trial was based on a strong foundation of prior research; the Cochrane systematic review 
reported on in Chapter 2 summarised the evidence around the use of economic incentives and 
enablers for patients with TB, and identified an important gap in the use of such interventions 
for patients with active TB in low and middle income countries. An earlier study investigating 
the  levels of poverty among patients with TB in KwaZulu-Natal, and the material support 
available to these patients,  laid the groundwork for this trial and supported the rationale for its 
conduct (Lutge et al 2009). Extensive consulation with a wide range of stakeholders before the 
trial not only enabled the trial to run smoothly, but also raised some of the issues that were 
investigated further in the qualitative component of the process evaluation (reported in 
Chapter 4).  
Limitations 
 
Poor fidelity to the intervention was probably the most important limitation of this trial. It 
makes the inconclusive results of the trial more difficult to interpret as these results may be 
due to poor implementation of the voucher, or limited efficacy of the voucher, or both. 
However, the reasons for the poor fidelity as elicited in the process evaluation do provide 
important information for the conduct of future trials and for the development of policy in this 
field.  
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The eligibility criteria for the inclusion of clinics in this trial may have resulted in selection bias, 
and may limit the generalizability of the findings of this trial. Conducting this trial in all public 
sector clinics providing TB care in KwaZulu-Natal may have resulted in different findings. 
Specifically, including clinics with poorer TB outcomes, which may have weaker administration, 
may have reduced even further the modest effect found in the intention to treat analysis of this 
trial.  
 
Patients were not asked about whether or how they felt that their adherence behavior was 
“rewarded” by the voucher; the focus of the investigation was on the enabling effect of the 
voucher with the result that its incentivizing effect was neglected. Thus only a partial picture of 
the effects of the voucher was painted.  
 
Because of extensive missing data on HIV status, we were unable to include HIV in the ancillary 
analysis of the trial. It may be that the voucher has a different effect, or an effect of a different 
magnitude, in HIV positive as opposed to HIV negative patients. Given the high prevalence of 
HIV in South Africa, and the high rates of co-infection with HIV and TB, the possible modifying 
effect of HIV on responses to economic support may have important policy implications. 
 
The small sample size of the household expenditure survey (reported in Chapter 5), and the 
imprecision of reports of household expenditure, mean that the results of this survey and the 
implications of these for the effect of the voucher on household expenditure, should be treated 
with caution. Because of this, and because the incentivizing effect of the voucher was not 
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adequately investigated, it was not possible for this study to confirm the mechanism of action 
of the voucher proposed in the model presented in Chapter 1. However, the qualitative data 
presented in Chapter 4 support the enabling effect of the voucher on which this model is based.  
 
Conclusions 
 
This trial and its process evaluations have contributed important evidence for the design and 
implementation of economic interventions to support poor patients on TB treatment. However, 
the field is complex, not least because the implementation of such interventions is heavily 
dependent on the context in which they are delivered, and the attitides and perceptions of 
those who implement and receive them. It is clear that this trial has raised several more 
questions on how best to provide economic support to poor patients, so as to improve their 
outcomes on TB treatment. These question are discussed further in Chapter 7.   
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Chapter 7 
Conclusions: taking forward our 
understanding of economic support for 
people with TB 
 
Introduction 
 
This chapter aims to identify the most important questions raised by this thesis, and to outline a 
way forward in terms of the research that needs to take place in order to better inform public 
health policy on the use of economic interventions to improve the outcomes of patients on TB 
treatment. Finally, it describes the ethical principles that underpin my view that future research 
on the use of economic support to improve the outcomes of patients with TB, is fundamentally 
important.   
What further research is needed to better inform public health policy? 
 
This trial has raised many fundamental questions about the use of economic support for the 
improvement of outcomes of patients on TB treatment and for the improvement of TB control 
in general. What seems unequivocal, since it is based on decades of research and centuries of 
observation, is that tuberculosis is powerfully related to poverty and is the “consequence of 
gross defects in social organization” (Dubos and Dubos: xxxviii). What is not clear, however, is 
what to do about it. Possible research questions are outlined and discussed further below. 
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These research questions address key issues raised in this trial and in other related studies 
regarding the use of economic support to improve TB control. 
 
At what level/s should economic interventions for TB control be aimed? Is the improvement 
of outcomes of patients on TB treatment a worthwhile goal or should such interventions also 
aim to reduce the incidence of TB in patients’ households and in poor communities in 
general? 
 
Possible levels for intervening in the pathway between poverty and TB are at: 
 The individual patient level, for the improvement of patient outcomes on treatment, as 
demonstrated in this study 
 The patient’s household level, to improve the economic well being and nutrional status 
of both the patient (to improve outcomes on treatment) and household members (to 
reduce their risk of developing TB disease) 
 The community level, to improve the nutritional status and living standards of whole 
communities and thereby reduce their risks of developing TB disease and improve their 
outcomes on treatment.  
 
It can be argued that the ideal economic intervention for TB control is one that is broad-based 
and reaches all those whom poverty makes vulnerable to infection with and development of 
TB. Such interventions may be more cost-effective than those which target patients who 
already have TB, by reducing the numbers of patients who need to be treated for the disease. 
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Indeed, the Commission on the Social Determinants of Health seems to favour this broad 
approach; two out of its three main recommendations are to “improve daily living conditions” 
and to “tackle the inequitable distribution of power, money and resources” that may foster the 
development of disease (WHO 2008: 2). However, both of these are much easier said than 
done, and rely on the political philosophy of governments in power. Acknowledging that these 
aims will not be achieved simply or in the short term, it is important to develop and test 
interventions that will contribute to their achievement, both because the alleviation of poverty 
is a moral imperative in its own right, and because the sum of the public’s health will be 
increased by reducing the impact of poverty on it.  
 
What interventions are the most feasible and effective, for the different levels? 
It is likely that interventions will need to be crafted differently, to best suit the level at which 
they are targeted. Whilst it might be feasible to issue vouchers to individual patients on a small 
(clinic) scale, it might be logistically easier to deposit cash into peoples’ bank accounts on a 
large (community) scale. Similarly, as has been shown in a study from the United States 
(Malotte 1999), it may be that cash is more effective than vouchers for some or all levels of 
targeting. The feasibility and effectiveness of implementing different interventions may be 
highly dependent on context, and so research should take place in a number of different 
settings to best inform the public health policy of individual countries or regions.  
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What interventions are the most feasible for low and middle income countries?  
As noted in Chapter 4, the logistics of delivering and collecting vouchers from clinics and shops 
in this trial were resource-intensive. Low income countries may find this system of delivering 
economic support unfeasible in their settings. Furthermore, whilst it might be financially 
feasible for middle income countries like South Africa to target economic interventions broadly, 
at large sectors of society such as those falling below a specific income threshold, this may be 
unaffordable for low income countries. Poorer countries might have to aim their interventions 
at smaller, more clearly defined groups.  
 
In addition, more complex studies have shown that multiple simultaneous interventions can 
positively impact on a number of TB indicators (Rocha et al 2011). However, the specific effect 
of economic support may be difficult to disentangle from other interventions given 
simultaneously (Oxman  and Fretheim 2009) and implementing all these interventions may be 
unaffordable for some countries. 
 
What interventions and levels of targeting are most acceptable to the communities who 
receive economic support and the health workers or other staff who implement this? Are 
there any additional unintended consequences of such targeting?  
The perceptions of those who implement and receive economic support are crucial to the 
administration and effectiveness of this support, as this trial has shown. Depending on the 
context in which such support is given, the more defined the target group for receipt of such 
support, the less acceptable the programme of support might be. Clearly defined targeting may 
Stellenbosch University  http://scholar.sun.ac.za
192 
 
also increase the stigma associated with the disease and further alienate recipients from their 
communities.  
 
If targeted at patients with a specific disease, such as TB, important research questions around 
economic support include the following: 
 What are the perceptions of patients with other health problems, who are not targeted 
to receive economic support? 
 How do these perceptions affect the relationship of such patients with health care 
providers, and their own health related behavior? 
 How do these perceptions affect the recipients of this support and their positions in 
their communities?  
If economic support is targeted at poorer patients, regardless of their illness status, the 
following questions should be considered:  
 Would it be feasible to deliver these vouchers (or a similar form of economic support) to 
poorer patients only? 
 How feasible would the means testing inherent in such delivery be? 
 Would such means testing be susceptible to manipulation and corruption?  
 Would the effect demonstrated in this pragmatic trial  be replicated or increased if this 
voucher were only given to more deprived patients? 
 What would the reaction of other patients be, to the targeting of poorer patients for the 
receipt of a voucher? 
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What is the potential for misuse of economic support in various contexts? How realistic are 
the perspectives of stakeholders around this potential for misuse? If misuse is likely to be 
important, how can it be minimized by the design and administration of the economic 
support so that its administration remains feasible in various settings? 
Economic support can be misused by those who are eligible for it (in terms of what it is used 
for), by those who are not eligible for it (in terms of theft and fraud to obtain the support) and 
by those who administer it (in terms of theft and fraud to obtain the support for themselves, or 
in terms of poor administration). All of these factors need to be considered for different types 
of economic support in various settings. In addition the following are crucial considerations for 
future research: the perceptions of stakeholders (such as managers, policy makers and health 
workers) around such misuse, the relationship of these perceptions to evidence regarding the 
use and misuse of economic support, and the effect of these perceptions on the development 
and implementation of programmes of economic support for TB control.  
 
What value should an economic intervention have, to maximize its benefit on TB outcomes 
but minimize its potential to cause dependence and/or a perverse incentive effect? 
It is likely that larger values of economic support will have a greater impact on individual and 
household nutritional status and well-being, but it is also possible that, if the support is tied to a 
particular illness, larger values may cause recipients to try to remain ill in order to continue 
receiving such support. If the value of the support approaches or exceeds the value of the 
minimum wage in any setting, it may also dis-incentivise work and create dependence on the 
support. The thresholds at which these effects occur, if at all, may depend on the levels of 
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poverty in communities to whom the support is given. Research into the optimal value of 
economic interventions should therefore be conducted in several different contexts to best 
inform practice across a range of settings.  
Is the use of economic support to improve TB treatment outcomes, or reduce 
the incidence of TB, worth pursuing? 
 
It is clear that several crucial questions around the use of economic support to improve TB 
control in general, and the outcomes of patients on TB treatment in particular, remain. A 
further fundamental question which may be asked is this: is it worthwhile to continue to 
conduct research that aims to answer these questions? It is the strong view of this researcher 
that studies that investigate and attempt to intervene in the relationship between poverty and 
ill health should be high on the public health research agenda. This is in spite of the difficulties 
inherent in such research – the complexity of the relationship between poverty and ill health, 
the mistrust of several stakeholders of economic interventions to improve health and the 
difficulty in elucidating the mechanisms of action of economic interventions to improve health.  
This view is based not only on the principle that the alleviation of poverty is in itself a moral 
imperative but also, on the public health principle that the determinants of disease should be 
addressed just as much as disease itself.  
 
Two fundamental ethical principles inform this stance, and these principles also underpin 
efforts to address the social determinants of health in general. The first, which is commonly felt 
to be the most important ethical principle in public health, is that of beneficence (the obligation 
to bring about “a certain kind of human good, the good of health”) (Powers and  Jaden 2008: 9). 
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Diminishing the number of cases of TB that arise through poverty, and improving the outcomes 
of patients on TB treatment through the amelioration of conditions of poverty, increase the 
sum of the public’s health. The second ethical principle is social justice. Social justice is less 
often considered in health research but is fundamental in research on the social determinants 
of health (Venkatapuram and Marmot 2009) and is increasingly recognized as an important 
principle underlying public health (Powers and Jaden 2008: 10). Indeed, intervening in the cases 
of tuberculosis that arise through poverty can be seen as marrying both of these ethical 
obligations, and it has been argued that it is “an appropriate, if not obligatory, function of 
public health to reduce poverty…. – if for no other reason than to reduce the incidence of 
disease” (Kass 2001). 
 
Concluding remarks 
 
This thesis centres around the use of economic support to improve the outcomes of patients on 
TB treatment. The background to the work includes a systematic review of material incentives 
and enablers in the management of TB, whilst the main body of the thesis is a report of a 
pragmatic cluster randomized controlled trial, and its process evaluation, that tested the use of 
a voucher in patients on treatment for active TB in South Africa. The rationale for the trial was 
that, although convincing evidence exists for a strong association between poverty and TB, and 
although there is substantial interest in the socio-economic factors that might affect TB 
epidemiology, there is very little evidence available that can inform the use of socio-economic 
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interventions to improve TB control, specifically to improve the outcomes of patients on TB 
treatment.  
 
This was the first trial conducted in Africa to investigate the use of economic support to 
improve patients’ outcomes on TB treatment. Because the context in which our trial was to be 
conducted was one of general poverty, we postulated that the economic support we provided 
(a voucher for a general store) would have its effect through enabling patients to overcome the 
barriers poverty posed to adherence to treatment (depicted in the model presented in Chapter 
1). Although the findings of the trial based on an intention to treat analysis were not significant, 
the exploratory and dose-response analyses suggest that economic support to patients with 
active TB in a middle income setting has the potential to improve their outcomes on treatment. 
However, the context in which such support is delivered is an important consideration; 
attitudes of staff and patients towards the economic support may affect its delivery, which may 
in turn impact on its effectiveness. In addition, the logistics of the delivery of such support may 
be burdensome, particularly in resource-poor settings and when complex administrative 
procedures are put in place to prevent “leakage” of the economic support.  
 
Although this trial and its process evaluation add to the available evidence on the use of 
economic support to improve patients’ outcomes on TB treatment, the evidence is probably 
not yet convincing enough to change public health policy. Many research questions remain, 
which are outlined in this thesis. Because research in the field of the socio-eonomic 
determinants of health is complex and difficult to do, it may be asked whether the effort of 
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undertaking such research is worth it. I argue that it is, for a few important reasons: firstly, 
because it is a fundamental philosophy of public health to consider not only disease but also 
the determinants thereof; secondly, because addressing poverty as a determinant of disease 
will increase the sum of the public’s health; and thirdly, because it is socially just to ensure that 
the burdens of any disease are not disproportionately borne by any sector of society.  
 
Thus, although research that intervenes in the relationship between poverty and TB is still 
rarely conducted, I suggest that it moves to a more central place in the public health research 
agenda. This will expand the armamentarium of current interventions to improve TB control 
and result in a more just world, where some of the remediable determinants of TB are 
addressed and the burden of TB disease and death are not disproportionately borne by the 
poor.  
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Appendix 2A: Detailed search strategies 
 
Sear
ch 
set 
CIDG SR^ CENTRAL MEDLINE^^ EMBASE^^ LILACS^^ 
SCI-
EXPANDED 
and SSC 
1 tuberculosis tuberculosis tuberculosis tuberculosis tuberculosis tuberculosis 
2 adherence 
PATIENT 
COMPLIANCE 
PATIENT 
COMPLIANCE 
PATIENT-
COMPLIANCE 
adherence adherence 
3 compliance 
PATIENT 
DROPOUTS 
PATIENT 
DROPOUTS 
TREATMENT-
REFUSAL 
compliance compliance 
4 Monitor* MOTIVATION MOTIVATION MOTIVATION Monitor$ Monitor* 
5 Incentive* 
SOCIAL 
SUPPORT 
SOCIAL 
SUPPORT 
SOCIAL 
SUPPORT 
Incentive$ Incentive* 
6 Reward* CONTRACTS CONTRACTS 
COMPENSATI
ON 
Reward$ Reward* 
7 Voucher* Adherence Adherence Adherence Voucher$ Voucher* 
8 Payment* Incentive* Incentive* Incentive$ Payment$ Payment* 
9 
Reimbursem
ent* 
Reward* Reward* Reward$ 
Reimbursem
ent$ 
Reimbursem
ent* 
10 Concordance Voucher* Voucher* Voucher$ Concordance Concordance 
11 
Cash 
transfer* 
Payment* Payment* Payment$ 
Cash 
transfer$ 
Cash 
transfer* 
12 2-11/OR 
Reimbursem
ent* 
Reimbursem
ent* 
Reimbursem
ent$ 
2-11/OR 2-11/OR 
13 1 AND 12 Concordance Concordance Concordance 1 AND 12 1 AND 12 
14 
 
Cash 
transfer* 
Cash 
transfer* 
Cash 
transfer$   
15 
 
2-14/OR 2-14/OR 2-14/OR 
  
16 
 
1 AND 15 1 AND 15 1 AND 15 
  
17 
  
Limit 16 to 
Human 
Limit 16 to 
Humans   
18 
      
19 
^ Cochrane 
Infectious 
Diseases 
Group 
Specialized 
Register 
 
^^Search 
terms used in 
combination 
with the 
search 
strategy for 
retrieving 
trials 
   
Stellenbosch University  http://scholar.sun.ac.za
221 
 
developed by 
The 
Cochrane 
Collaboration 
(Higgins 
2006); Upper 
case: MeSH 
or EMTREE 
heading; 
Lower case: 
free text 
term 
20 
      
 
  
Stellenbosch University  http://scholar.sun.ac.za
222 
 
Appendix 2B: Characteristics of included studies  
 
Chaisson 2001  
Methods Individually randomized controlled trial, factorial design 
Duration of enrolment: June 1995 - August 1997 
Participants Number enrolled: 300 
Inclusion criteria: Injection drug users over 18 years old, with 
tuberculin skin test reading of more than 5 mm induration if HIV 
positive or 10 mm if HIV negative, on preventive treatment for TB. 
Exclusion criteria: evidence of active TB, history of serious adverse 
reaction to INH (isoniazid) treatment, previous INH treatment for 6 
months or longer, serum ALT elevated more than 5 times normal 
levels, or HIV disease with CD4 count of less than 200/mm3. 
(Isoniazid is a standard TB medication used for both prophylaxis and 
treatment of active TB). 
Interventions All participants were randomly assigned to receive either: 
1. An immediate stipend of $10 per month (for each monthly 
appointment kept), or  
2. A deferred amount, equal to $10 for each monthly appointment 
kept. 
The immediate payment was given at the end of each month when 
the patient had completed a routine assessment for adherence and 
drug toxicity. The deferred payment was credited 
each month a patient in this group completed assessment for 
adherence and toxicity, but payment was made when treatment was 
completed or when the patient withdrew from the study. 
Each arm was on prophylaxis for TB. 
Outcomes Completion of 6 months of INH preventive treatment (reporting for 
each of 6 monthly visits and taking at least 80% of medication). 
Notes Independent of the material incentive, all patients were randomly 
assigned to directly observed preventive therapy (i.e. outreach 
meeting with a nurse twice a week; peer support counselling (i.e. 
monthly support group meetings); or routine care (i.e. monthly clinic 
visits). 
Trial location: Baltimore, United States 
Setting: Community based tuberculosis clinic 
Source of funding: National Institute on Drug Abuse (DA 08992) and 
the National Institute of Allergy and Infectious Diseases (AI 01637). 
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Risk of bias table  
Bias 
Authors' 
judgement 
Support for judgement 
Random sequence 
generation 
(selection bias) 
Low risk 
Sequence generation performed by computer algorithm. 
Allocation 
concealment 
(selection bias) 
Unclear risk 
No description of allocation concealment was given. 
Blinding 
(performance bias 
and detection bias) 
Unclear risk 
Not known if outcome assessors were blind 
Incomplete 
outcome data 
(attrition bias) 
Low risk Numbers presented for whole group and each arm, 
intention to treat analysis. Withdrawals included "failure 
to return (37 patients), voluntary withdrawal (4)...and 
other reasons (13)". These do not seem to be related to 
the material incentives 
Selective reporting 
(reporting bias) 
Unclear risk Study protocol not available and there is no earlier 
methods paper listing the pre-specified outcomes. 
Other bias Low risk The study appears to be free of other bias. 
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Malotte 1998  
Methods Individually randomized controlled trial 
Duration: April 1994 to August 1995. 
Participants Number enrolled: 1004 
Inclusion criteria: Injection drug and crack cocaine users, who had 
had tuberculin skin tests and were required to return for the 
reading. 
Exclusion criteria: None stated 
Interventions Participants were divided into 6 arms, which received the following 
interventions: 
1. 5-10 minute session of motivational education 
2. 5-10 minute session of motivational education plus $10 on return 
for tuberculin skin test reading 
3. 5-10 minute session of motivational education plus $5 on return 
for tuberculin skin test reading 
4. $10 on return for tuberculin skin test reading 
5. $5 on return for tuberculin skin test reading 
6. Routine care. 
Outcomes Return for tuberculin skin test reading within 96 hours.  
Notes Trial location: Long beach, California, United States 
Setting: Urban research clinic 
Source of funding: National Institute on Drug Abuse (grant RO1-
DA08799) 
Risk of bias table  
Bias 
Authors' 
judgement 
Support for judgement 
Random sequence 
generation (selection bias) 
Unclear risk 
Method of randomization not described 
Allocation concealment 
(selection bias) 
Unclear risk 
Not described 
Blinding (performance 
bias and detection bias) 
Unclear risk 
Not described.  
Incomplete outcome data 
(attrition bias) 
Low risk No omissions from final analysis.  
1004 enrolled, intention to treat analysis. 
Selective reporting 
(reporting bias) 
Unclear risk Study protocol not available and there is no 
earlier methods paper listing the pre-specified 
outcomes. 
Other bias Low risk The study appears to be free of other bias. 
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Malotte 1999  
Methods Individually randomized controlled trial 
Duration: September 1995 to September 1997 
Participants Number enrolled: 1078 
Inclusion criteria: Injection drug and crack cocaine users who had 
tuberculin skin tests and were required to return for the reading 
(age restrictions not specifically stated but all participants were over 
age of 18 years). 
Exclusion criteria: Participation in group's previous studies. 
Interventions 1. $10 on return for tuberculosis skin test reading. 
2. Grocery store coupons worth $10 on return for tuberculosis skin 
test reading. 
3. Patient's choice of bus passes or coupons for fast food restaurant 
worth $10 on return for tuberculosis skin test reading. 
4. Motivational education session of 5 - 10 minutes. 
5. Routine care. 
Outcomes Return for tuberculosis skin test reading within 96 hours.  
Notes Study was a follow up to Malotte 1998 - authors wanted to test 
effectiveness of non-cash incentives, as they felt health departments 
might object to giving cash out to patients as this was considered 
controversial. 
Trial location: Long beach, California, United States 
Setting: Urban research clinic 
Source of funding: National Institute on Drug Abuse (grant RO1-
DA08799) 
Risk of bias table  
Bias 
Authors' 
judgement 
Support for judgement 
Random sequence 
generation (selection bias) 
Unclear risk 
No description of method of randomization. 
Allocation concealment 
(selection bias) 
Unclear risk 
Not described.  
Blinding (performance 
bias and detection bias) 
Unclear risk 
Not described. 
Incomplete outcome data 
(attrition bias) 
Low risk No omissions from final analysis. 1078 
randomized, intention to treat analysis. 
Selective reporting 
(reporting bias) 
Unclear risk Study protocol not available and there is no 
earlier methods paper listing the pre-specified 
outcomes. 
Other bias Low risk The study appears to be free of other bias. 
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Malotte 2001  
Methods Individually randomized controlled trial 
Duration: April 1994 to September 1997 (recruitment period). 
Participants Number enrolled: 169 
Inclusion criteria: Injection drug or crack cocaine users, needing INH 
treatment for TB prophylaxis.  
Exclusion criteria: Active TB or medical contraindications to the use 
of isoniazid. 
Interventions 1. Twice weekly directly observed therapy (DOT) by study outreach 
worker at location chosen by patient, plus $5 per visit.  
2. Twice weekly DOT by study outreach worker at location chosen by 
patient.  
3. Twice weekly DOT at study site plus $5 per visit. 
Participants in both arms received INH prophylaxis. 
Outcomes Completion of course of INH (6 months if patient HIV negative, 12 
months if patient HIV positive). Also percentage of medications 
taken on time (all doses in all arms were directly observed). 
Notes Trial location: Long beach, California, United States 
Setting: Urban research clinic 
Source of funding: National Institute on Drug Abuse (grant RO1-
DA08799) 
Risk of bias table  
Bias 
Authors' 
judgement 
Support for judgement 
Random sequence 
generation (selection 
bias) 
Low risk 
Randomization in blocks of 18, assumed to have been 
done by computer. 
Allocation 
concealment 
(selection bias) 
Low risk 
Allocation was kept in "numbered, opaque, sealed 
envelopes" and "staff ... were unaware of block size".  
Blinding (performance 
bias and detection 
bias) 
Unclear risk 
Not described. 
Incomplete outcome 
data (attrition bias) 
Low risk 169 patients randomized. Six excluded from analysis 
for medical reasons which were unlikely to have been 
related to the study outcome. Intention to treat 
analysis. 
Selective reporting 
(reporting bias) 
Unclear risk Study protocol not available and there is no earlier 
methods paper listing the pre-specified outcomes. 
Other bias Low risk The study appears to be free of other bias. 
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Martins 2009  
Methods Individually randomized controlled trial conducted at three sites in 
Dili, Timor Leste. 
Duration: Enrollment 16 March - 9 November 2005; Follow up 
continued until July 2006. 
Participants Patients with newly diagnosed pulmonary tuberculosis, both positive 
and negative results on sputum tests. 
Eligible: 833 (563 excluded) 
Randomized: 270 (133 control, 137 intervention group). 
Most participants were poor, malnourished men living close to the 
clinics. 
Interventions 1. Nutritious, culturally appropriate daily meal (weeks 1-8) and food 
packages (weeks 9-32). 
2. Control group given nutritional advice. 
Both groups received standard TB treatment. 
Outcomes Primary outcomes: Completion of treatment, including cure 
Secondary outcomes: Adherence to treatment, weight gain, and 
clearance of sputum smears. 
Notes Outbreak of civil conflict in the country three months before 
completion of study disrupted service delivery and access of patients 
to health care (70% of the population were displaced). However, it is 
likely that this affected intervention and control groups similarly. 
Most participants were poor and malnourished men who lived close 
to the clinics and this may limit the external generalisability of the 
study. 
Substantial missing data for intermediate outcomes implies that 
participants did not attend clinics regularly. Also, intervention was 
not well received by many participants as it was inconvenient to 
attend the clinics at midday for the meal (this was also the reason 
for a high number of patients' refusal to participate in the trial). 70% 
of participants had negative smear results, which means that cure 
could not be objectively verified. Adherence was not objectively 
assessed. 
Adverse events: None necessitated stopping treatment. Itch with or 
without rash was more than twice as likely to occur in the 
intervention group (RR 2.27; 95% CI 1.20-4.26). 
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Risk of bias table  
Bias 
Authors' 
judgement 
Support for judgement 
Random sequence 
generation 
(selection bias) 
Low risk Computer generated random allocation sequence with 
randomly varying block sizes (done by independent 
statistician using STATA). Allocation was stratified by 
community health clinic and by diagnosis of TB (positive 
or negative smear).  
Allocation 
concealment 
(selection bias) 
Low risk Concealed from all investigators with sequentially 
numbered opaque sealed envelopes prepared distant 
from study site.  
Blinding 
(performance bias 
and detection bias) 
Unclear risk Blinding of participants and treatment providers not 
done, but independent observer who determined the 
primary outcome was blinded.  
Incomplete 
outcome data 
(attrition bias) 
Low risk All participants received allocated intervention and loss 
to follow up (transfer to another clinic during treatment) 
was very small (1% in intervention group and 4% in 
control group). Intention to treat analysis. 
Selective reporting 
(reporting bias) 
Unclear risk Study protocol not available and there is no earlier 
methods paper listing the pre-specified outcomes. 
Other bias Low risk The study appears to be free of other bias. 
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Morisky 2001  
Methods Individually randomized controlled trial. 
Duration: Not stated 
Participants Number enrolled: 794. 
Inclusion criteria: Adolescents aged 11 - 19 years who needed 
treatment for latent TB infection. 
Exclusion criteria: Not stated  
Interventions 1. Peer counselling (at least once every two weeks) 
2. Incentive (participant-parent contingency contract, where parent 
and patient negotiated a reward for adherence to treatment. This 
was provided by the parent and given at a frequency negotiated by 
the parent and participant). Examples of incentives included a 
special meal at home, going out to eat, clothing, going to movies or 
renting a video, or anything agreeable to both parent and 
adolescent. 
3. Combined peer counselling and incentive (participant-parent 
contingency contract). 
4. Usual care. 
Participants in intervention and control arms received INH 
prophylaxis. 
Outcomes Completion of 6 months of INH prophylaxis; measured using the 
discharge summary recorded in the patient's medical chart. 
Notes Trial location: Los Angeles County, United States 
Setting: Urban community based clinics 
Source of funding: National Heart, Lung and Blood Institute (ROI-
55770).  
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Risk of bias table  
Bias 
Authors' 
judgement 
Support for judgement 
Random sequence 
generation 
(selection bias) 
Unclear risk 
Not described. 
Allocation 
concealment 
(selection bias) 
Unclear risk 
Not described. 
Blinding 
(performance bias 
and detection 
bias) 
Unclear risk 
Not described. 
Incomplete 
outcome data 
(attrition bias) 
Low risk Authors state that intention to treat model was used (page 
570). 794 adolescents enrolled and analysed. No omissions 
from final analysis. 
Selective 
reporting 
(reporting bias) 
Unclear risk 
Study protocol not available and there is no earlier 
methods paper listing the pre-specified outcomes. 
Other bias Low risk Over and above the interventions described above, 
patients were interviewed three times during the study and 
at each interview received $15. The additional interest in 
the participants, plus the cash which may have acted as a 
further incentive to adhere, may be regarded as 
interventions in themselves. However, this applied to all 
participants and would not have introduced bias. 
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Pilote 1996  
Methods Individually randomized controlled trial. 
Duration: June 1992 to April 1994. 
Participants Number enrolled: 244 
Inclusion criteria: Homeless "men and women", age not specified 
(but all over 18 years as listed in Results section), who had a 
tuberculin skin test and were required to attend a clinic to initiate 
treatment for latent or active TB. 
Exclusion criteria: Recent investigation for TB. 
Interventions 1. Peer health advisers plus usual care (advisers accompanied 
patients to clinics and assisted with filling out forms etc.)  
2. Incentive of $5 cash if participant came to clinic within 3 weeks of 
randomisation plus usual care  
3. Usual care (appointment at TB clinic plus a bus token for transport 
to clinic). 
Outcomes Attendance at clinic appointment within three weeks of positive 
reading of tuberculin skin test.  
Notes Second phase of this study reported in Tulsky et al 2000. 
Trial location: San Fransisco, California, United States 
Setting: Urban community based TB clinic (attached to San Fransisco 
General Hospital) 
Source of funding: Kaiser Family Foundation, AcqUired 
Immunodeficiency Syndrome Clinical Research Center, San 
Francisco, Calif; Universitywide Acquired Immunodeficiency 
Syndrome Research 
Program, University of California; and by grant R01-DA04363-07 
from the National Institute on Drug Abuse, Bethesda, MD. 
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Risk of bias table  
Bias 
Authors' 
judgement 
Support for judgement 
Random sequence 
generation (selection 
bias) 
Low risk "treatment group was assigned by sampling 
without replacement from blocks of nine". 
Assumed to be done by computer. 
Allocation concealment 
(selection bias) 
Unclear risk 
Not described 
Blinding (performance 
bias and detection bias) 
Unclear risk 
Not described. 
Incomplete outcome 
data (attrition bias) 
Low risk 
244 patients randomized, 244 analysed. 
Selective reporting 
(reporting bias) 
Unclear risk Study protocol not available and there is no earlier 
methods paper listing the pre-specified outcomes. 
Other bias Low risk The study appears to be free of other bias. 
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Tulsky 2000  
Methods Individually randomized controlled trial 
Duration: June 1992 to May 1995 (recruitment period June 1992 to 
December 1994, plus 6 months of patient follow up time). 
Participants Number enrolled: 118 
Inclusion criteria: Homeless adults, with positive tuberculin skin test 
or credible history of prior positive tuberculin skin test but no follow 
up for this in the 6 months prior to the study.  
Exclusion criteria: Receiving treatment or prophylaxis for TB at the 
time of the study, or HIV positive. 
Interventions 1. Usual care (self-supervised daily dosing with INH and monthly 
clinic visits for assessment and refill of tablets) 
2. Taking of 900 mg INH directly observed at each of two weekly 
visits to study site; plus an incentive of $5 cash. 
3. Peer health advisor (who directly supervised taking of treatment 
twice weekly, accompanied patient to clinic and looked for the 
patient if lost to follow up). 
Participants in intervention and control arms received INH 
prophylaxis. 
Outcomes Completion of 6 months of INH preventive treatment as 
documented in patients' clinic charts; number of months of INH 
dispensed. 
Notes Trial location: San Francisco, California, United States 
Setting: Community-based TB clinic 
Source of funding: Not stated 
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Risk of bias table  
Bias 
Authors' 
judgement 
Support for judgement 
Random sequence 
generation 
(selection bias) 
Low risk 
Block randomization used, therefore allocation sequence 
assumed to have been generated by computer. 
Allocation 
concealment 
(selection bias) 
Unclear risk 
Not described. 
Blinding 
(performance bias 
and detection 
bias) 
Unclear risk 
Not described.  
Incomplete 
outcome data 
(attrition bias) 
Low risk Of 330 patients randomized, 195 found to require further 
evaluation and 37 needed further diagnostic tests (sputum 
cultures and liver function tests). Of 121 who were 
prescribed INH, 118 were analysed - 3 were excluded from 
study because of "toxic effects of INH". These reasons 
unlikely to be related to final outcome. 
Selective 
reporting 
(reporting bias) 
Unclear risk 
Study protocol not available and there is no earlier 
methods paper listing the pre-specified outcomes. 
Other bias Low risk The study appears to be free of other bias. 
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Tulsky 2004  
Methods Individually randomized controlled trial. 
Duration: May 1996 to May 1998 (based on recruitment period of 
May 1996 to December 1997, plus 6 months for patient follow up). 
Participants Number enrolled: 119 (85% male; median age 41 years [range 21-
79]). 
Inclusion criteria: Homeless adults who were eligible for preventive 
TB treatment. Adults who were "truly homeless" (living in street and 
shelter dwellings) and those who were "marginally housed" (living in 
residential hotels) were recruited into the study. 
Exclusion criteria: active TB or HIV positive. 
Interventions 1. $5 cash incentive for each twice weekly appointment kept.  
2. Non-cash incentive with face value of $5 for each twice weekly 
appointment kept (patients could choose between fast food or 
grocery store coupons, phone cards or bus tokens). 
Participants in intervention and control arms received INH 
prophylaxis. 
Outcomes 1. Completion of preventive treatment (assessed by reviewing TB 
clinic records) 
2. Length of time needed to look for participants who had missed 
scheduled appointments and didn't respond to letters or phone 
calls. (A tracking form including names and mailing addresses of 
family, friends, and case workers was completed for each 
participant. After the first missed appointment, staff made phone 
calls and sent reminder letters. If the participant did not attend the 
next scheduled visit, outreach efforts were initiated and were guided 
by the information on the tracking form.) 
Notes Because the cash incentive arm did so much better than the non-
incentive arm in the study performed by this group previously 
(Tulsky 2000), the authors felt it would be unethical to continue to 
randomize one group to no incentive. 
Trial location: San Francisco, California, United States 
Setting: Urban, community-based TB clinic 
Source of funding: National Heart, Lung, and Blood Institute (grant 
HL55729) and the National Institute of Mental Health (grant 
MH54907). 
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Risk of bias table  
Bias 
Authors' 
judgement 
Support for judgement 
Random sequence 
generation 
(selection bias) 
Low risk 
Sequence was generated "...from a list of randomly 
generated numbers" 
Allocation 
concealment 
(selection bias) 
Unclear risk "...numbers previously sealed into individual envelopes and 
selected in consecutive order". Not clear if these envelopes 
were opaque. 
Blinding 
(performance bias 
and detection 
bias) 
Low risk 
"TB clinic physicians were blinded with respect to the 
results of the randomisation"  
Incomplete 
outcome data 
(attrition bias) 
Low risk 141 patients randomized but 16 not prescribed INH (4 in 
cash incentive arm, 12 in non-cash incentive arm). Reasons 
for exclusion were clinical and unlikely to be related to 
allocation. 6 patients censored (5 for clinical reasons, 1 
because died in hotel fire). Again, reasons for exclusion 
unlikely to be related to allocation or outcome. 119 
patients analysed. 
Selective 
reporting 
(reporting bias) 
Unclear risk 
Study protocol not available and there is no earlier 
methods paper listing the pre-specified outcomes. 
Other bias High risk The study groups were not the same with respect to their 
primary housing in the year prior to the study. In the cash 
incentive arm, 23% had lived in a shelter or on the street, 
whilst 41% of the non-cash incentive arm had done so. 
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White 1998  
Methods Individually randomized controlled trial 
Duration: One year (1996) 
Participants Number enrolled: 79 (98% male, mean age 32.0 years) 
Inclusion criteria: Jail inmates eligible for INH prophylaxis for latent 
TB infection. 
Exclusion criteria: Unable to speak English or Spanish, or 
sequestration from jail population due to violence or mental illness. 
Interventions 1. Promise of $5 cash incentive (to be provided) on making first visit 
to community TB clinic to continue INH prophylaxis after release 
from jail plus standardised TB education. 
2. Standardised TB education (about TB and the importance of 
taking INH prophylaxis). 
Participants in intervention and control arms received INH 
prophylaxis. 
Outcomes Attendance at first visit to community TB clinic to continue INH 
prophylaxis after release from jail.  
Notes Trial location: San Francisco, California, United States 
Setting: Prison 
Source of funding: Academic Senate of the University of California, 
San Francisco. 
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Risk of bias table  
Bias 
Authors' 
judgement 
Support for judgement 
Random sequence 
generation 
(selection bias) 
Low risk 
Randomization done using table of random numbers. 
Allocation 
concealment 
(selection bias) 
Low risk 
Previously sealed, ordered, opaque envelopes used. 
Blinding 
(performance bias 
and detection 
bias) 
Low risk 
Research assistants collecting clinic data (as to whether 
participant attended first appointment or not) were blinded 
as to participants' assignments.  
Incomplete 
outcome data 
(attrition bias) 
Low risk Of the 79 inmates enrolled in the study, 18 remained in 
prison for the full duration of their INH treatment (and so 
were never required to present at a community TB clinic). 
61 were analysable, and there were no differences 
between treatment allocations in this group. "Data were 
rechecked for internal validity and there were no 
differences by study group in any of the variables collected 
for this analytic sample of 61 persons" (page 508).  
Selective 
reporting 
(reporting bias) 
Unclear risk 
Study protocol not available and there is no earlier 
methods paper listing the pre-specified outcomes. 
Other bias Low risk The study appears to be free of other bias. 
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White 2002  
Methods Individually randomized controlled trial 
Duration of enrolment: 1 March 1998 to 31 May 1999. 
Participants Number enrolled: 558 (82% male; median age 28.5 years in incentive 
arm, 29.7 years in routine care arm, and 29.5 years in education 
arm) 
Inclusion criteria: Jail inmates with latent TB infection, eligible for 
and agreeable to INH prophylaxis. 
Exclusion criteria: HIV positive, not able to speak English or Spanish, 
assessed by Sherriff's personnel to be violent, or by mental health 
staff to have a serious psychiatric illness. 
Interventions 1. Promise of incentive ($25 equivalent in food or transportation 
vouchers), provided at the first visit to the community TB clinic after 
release from jail 
2. Education, provided every two weeks whilst in jail 
3. Usual care (neither intervention). 
Outcomes 1. Attendance at first visit to community TB clinic to continue INH 
prophylaxis within one month after release from jail; 
2. Completion of full course of INH treatment. 
Notes HIV positive patients on INH prophylaxis receive very different 
programme of treatment, including incentives. 
Trial location: San Francisco, California, United States 
Setting: Prison 
Source of funding: National Institute of Nursing Research, National 
Institutes of Health, Bethesda, Md. (grant R01 NR04456). 
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Risk of bias table  
Bias 
Authors' 
judgement 
Support for judgement 
Random sequence 
generation 
(selection bias) 
Low risk 
Randomization done using table of random numbers. 
Allocation 
concealment 
(selection bias) 
Low risk 
Ordered, opaque, sealed envelopes used. 
Blinding 
(performance bias 
and detection 
bias) 
Low risk 
Research assistants collecting clinic data (as to whether 
participant attended first appointment or not) were blinded 
as to participants' assignments. 
Incomplete 
outcome data 
(attrition bias) 
Low risk Of 558 inmates enrolled, 48 discontinued INH treatment 
whilst in jail, and 185 completed INH treatment whilst in 
jail. Thus 325 were eligible for analysis. There were no 
differences between study group in either the 325 
analysable patients or 558 initially enrolled patients. 
Reasons for exclusion from analysis not likely to be related 
to final outcome. Intention to treat analysis for those 
released while taking INH. 
Selective 
reporting 
(reporting bias) 
Unclear risk 
Study protocol not available and there is no earlier 
methods paper listing the pre-specified outcomes 
Other bias Low risk The study appears to be free of other bias.  
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Appendix 2C: Characteristics of excluded studies 
  
Cheng 1997  
Reason for exclusion Not a randomized controlled trial, as allocation to treatment 
interventions was done by day of the week. 
Filho 2009  
Reason for exclusion Not a randomized controlled trial; essentially two cross-sectional 
studies where first group was not given incentive and second group 
was. 
FitzGerald 1999  
Reason for exclusion Not a randomized controlled trial; essentially two cross-sectional 
studies where first group was not given incentive and second group 
was. 
Jahnavi 2010  
Reason for exclusion A trial of community health worker delivered tuberculosis treatment 
combined with food supplements; and not a trial of food incentives 
per se. 
Morisky 1990  
Reason for exclusion Not a randomized controlled trial, as allocation to treatment 
interventions was done by the last digits of the participants' clinic 
numbers. 
Nyamathi 2006  
Reason for exclusion Both the intervention and control arms received a $5 cash incentive 
for each dose of INH prophylaxis taken. It was therefore not possible 
to assess the effect of the incentive in this study. The main 
intervention was a nurse case management programme. 
Yao 2008  
Reason for exclusion Quasi-experimental study (controlled before-after study), with no 
evidence of randomisation to control or intervention groups. 
Incentives were provided to health care workers as well as patients, 
and the effect of patients' incentives only is not disaggregated. 
 
 
  
Stellenbosch University  http://scholar.sun.ac.za
242 
 
Appendix 2D: Risk of bias graph 
 
 
Risk of bias graph: reviews authors' judgments about each risk of bias item presented as percentages 
across all included studies. 
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Appendix 2E: Risk of bias summary 
 
 
 
Risk of bias summary: reviews authors' judgments about each risk of bias item for each included 
study. 
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Appendix 2F: Data and analyses  
 
1 Incentive versus routine care  
Outcome or Subgroup Studies Participants Statistical Method Effect Estimate 
1.1 Return for tuberculin 
skin test results 
2 1371 Risk Ratio (M-H, Random, 
95% CI) 
2.16 [1.41, 3.29] 
1.2 Clinic visit to start or 
continue TB prophylaxis 
3 595 Risk Ratio (M-H, Fixed, 
95% CI) 
1.58 [1.27, 1.96] 
1.3 Completion of TB 
prophylaxis 
3 869 Risk Ratio (M-H, Random, 
95% CI) 
1.79 [0.70, 4.58] 
1.4 Completion of 
treatment for active TB 
1 265 Risk Ratio (M-H, Fixed, 
95% CI) 
0.98 [0.86, 1.12] 
 
 
2 Immediate versus deferred incentive  
Outcome or Subgroup Studies Participants Statistical Method Effect Estimate 
2.1 Completion of TB 
prophylaxis 
1 300 Risk Ratio (M-H, Fixed, 
95% CI) 
1.11 [0.98, 1.24] 
 
 
3 Cash incentive versus non-cash incentive  
Outcome or Subgroup Studies Participants Statistical Method Effect Estimate 
3.1 Return for tuberculin 
skin test reading 
1 652 Risk Ratio (M-H, Fixed, 
95% CI) 
1.13 [1.07, 1.19] 
3.2 Completion of TB 
prophylaxis 
1 141 Risk Ratio (M-H, Fixed, 
95% CI) 
1.26 [1.02, 1.56] 
 
 
4 Different values of cash incentive  
Outcome or Subgroup Studies Participants Statistical Method Effect Estimate 
4.1 Return for tuberculin 
skin test reading 
1 404 Risk Ratio (M-H, Fixed, 
95% CI) 
1.08 [1.01, 1.16] 
 
 
 
5 Incentives versus any other intervention  
Stellenbosch University  http://scholar.sun.ac.za
245 
 
Outcome or Subgroup Studies Participants Statistical Method Effect Estimate 
5.1 Return for tuberculin 
skin testing 
2 1366 Risk Ratio (M-H, Random, 
95% CI) 
2.16 [1.56, 3.00] 
5.2 Clinic visit to start or 
continue TB prophylaxis 
2 535 Risk Ratio (M-H, Fixed, 
95% CI) 
1.10 [0.92, 1.31] 
5.3 Completion of TB 
prophylaxis 
3 837 Risk Ratio (M-H, Random, 
95% CI) 
1.04 [0.59, 1.83] 
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Appendix 2G: Forest plots 
Comparison one: Any incentive versus routine care 
Outcome: Return for tuberculin skin test results 
 
 
 
Outcome: Clinic visit to start or continue TB prophylaxis 
 
 
Outcome: Completion of TB prophylaxis 
 
 
Outcome: Completion of treatment for active TB 
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Comparison 2: Immediate versus deferred incentive 
Outcome: Completion of TB prophylaxis 
 
Comparison 3: Cash incentive versus non-cash incentive 
Outcome: Return for tuberculin skin test reading 
 
Outcome: Completion of TB prophylaxis 
 
 
Comparison 4: Different values of cash incentive 
 
Outcome: Return for tuberculin skin test reading 
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Comparison 5: Incentives versus any other intervention 
Outcome: Return for tuberculin skin testing 
 
 
 
Outcome: Clinic visit to start or continue TB prophylaxis 
 
 
 
Outcome: Completion of TB prophylaxis 
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Comparison 6: Incentive versus routine care 
Outcome: Return for tuberculin skin test results 
 
Outcome: Clinic visit to start or continue TB prophylaxis 
 
 
Outcome: Completion of TB prophylaxis 
 
Outcome: Completion of treatment for active TB 
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Appendix 2H: Summary of findings tables  
 
1 Material incentives/enablers compared to routine care for improving patient adherence 
to TB management  
Material incentives compared to routine care for improving patient adherence to TB 
management 
Patient or population: People engaged in tuberculosis programmes 
Settings: High- and low-income settings 
Intervention: Material incentives (such as cash, grocery vouchers or food) 
Comparison: Routine care 
Outcomes Illustrative comparative 
risks* (95% CI) 
Relative 
effect 
(95% CI) 
No of 
participants 
(studies) 
Quality of the 
evidence 
(GRADE) 
Assumed 
risk 
Corresponding 
risk 
Routine 
care 
Material 
incentives 
Return for 
tuberculin skin test 
reading 
441 per 
1000 
953 per 1000 
(622 to 1000) 
RR 2.16  
(1.41 to 
3.29) 
1371 
(2 studies) 
⊕⊕⊝⊝ 
low1,2 
Return to clinic to 
start or continue 
treatment 
249 per 
1000 
393 per 1000 
(316 to 488) 
RR 1.58  
(1.27 to 
1.96) 
595 
(3 studies) 
⊕⊕⊕⊝ 
moderate2 
Completion of TB 
prophylaxis 
405 per 
1000 
725 per 1000 
(283 to 1000) 
RR 1.79  
(0.70 to 
4.58) 
869 
(3 studies) 
⊕⊕⊝⊝ 
low2,3 
Completion of 
treatment for 
active TB 
775 per 
1000 
760 per 1000 
(669 to 868) 
RR 0.98  
(0.86 to 
1.12) 
265 
(1 study) 
⊕⊝⊝⊝ 
very low4,5 
The assumed risk is taken from the control groups in the trials. The corresponding risk (and 
its 95% CI) is based on the assumed risk in the comparison group and the relative effect of 
the intervention (and its 95% CI). 
CI: Confidence interval; RR: Risk ratio; 
GRADE Working Group grades of evidence 
High quality: Further research is very unlikely to change our confidence in the estimate of 
effect. 
Moderate quality: Further research is likely to have an important impact on our confidence 
in the estimate of effect and may change the estimate. 
Low quality: Further research is very likely to have an important impact on our confidence 
in the estimate of effect and is likely to change the estimate. 
Very low quality: We are very uncertain about the estimate. 
 
Footnotes (pto) 
Stellenbosch University  http://scholar.sun.ac.za
251 
 
Footnotes 
1 Downgraded by 1 for risk of bias: Neither study adequately described the method of 
randomization. 
2 Downgraded by 1 for indirectness: These trials were conducted in specific subpopulations from the 
USA and the result may not be applicable in other settings. 
3 Downgraded by 1 for inconsistency: Two studies found no suggestion of a benefit with the 
incentive, and just one study found a clinically and statistically significant benefit in drug users. 
4 Downgraded by 2 for indirectness: Qualitative research around this trial suggests that the form of 
the incentive was not appropriate as patients did not like having to attend the clinic at midday for a 
meal. 
5 Downgraded by 1 for imprecision: The 95% CI includes what may be clinically important benefits 
and no effect. 
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2 Summary of findings table: Immediate versus deferred incentive  
Immediate compared to deferred incentive for improving patient adherence to TB 
management 
Patient or population: People at high risk of developing TB 
Settings: High- and low-income settings 
Intervention: Immediate incentive (received on a regular basis during treatment) 
Comparison: Deferred incentive (received only at end of treatment). 
Outcomes Illustrative comparative risks* 
(95% CI) 
Relative 
effect 
(95% CI) 
No of 
participants 
(studies) 
Quality of the 
evidence 
(GRADE) 
Assumed 
risk 
Corresponding 
risk 
deferred 
incentive 
immediate 
Completion of TB 
prophylaxis 
750 per 
1000 
832 per 1000 
(735 to 930) 
RR 1.11  
(0.98 to 
1.24) 
300 
(1 study) 
⊕⊕⊝⊝ 
low1,2 
The assumed risk is taken from the control group in the trial. The corresponding risk (and its 
95% CI) is based on the assumed risk in the comparison group and the relative effect of the 
intervention (and its 95% CI). 
CI: Confidence interval; RR: Risk ratio; 
GRADE Working Group grades of evidence 
High quality: Further research is very unlikely to change our confidence in the estimate of 
effect. 
Moderate quality: Further research is likely to have an important impact on our confidence 
in the estimate of effect and may change the estimate. 
Low quality: Further research is very likely to have an important impact on our confidence 
in the estimate of effect and is likely to change the estimate. 
Very low quality: We are very uncertain about the estimate. 
1 Downgraded by one for indirectness: This trial was conducted in specific subpopulations from the 
USA and the result may not be applicable in other settings. 
 
2 Downgraded by one for imprecision: The 95% CI of the estimate of effect includes both clinically 
important benefit and no effect. 
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3 Summary of findings table: Cash versus non-cash incentive  
Cash compared to non-cash incentive for improving patient adherence to TB management 
Patient or population: People at high risk of developing TB 
Settings: High- and low-income settings 
Intervention: Cash incentive 
Comparison: Non-cash incentive 
Outcomes Illustrative comparative 
risks* (95% CI) 
Relative 
effect 
(95% CI) 
No of 
participants 
(studies) 
Quality of 
the evidence 
(GRADE) 
Assumed 
risk 
Corresponding 
risk 
non-cash 
incentive 
cash 
Return for 
tuberculin skin 
test reading 
841 per 
1000 
950 per 1000 
(900 to 992) 
RR 1.13  
(1.07 to 
1.18) 
652 
(1 study) 
⊕⊕⊝⊝ 
low1 
Completion of TB 
prophylaxis 
638 per 
1000 
804 per 1000 
(651 to 995) 
RR 1.26  
(1.02 to 
1.56) 
141 
(1 study) 
⊕⊕⊝⊝ 
low1 
The assumed risk is taken from the control group in the trial. The corresponding risk (and its 
95% CI) is based on the assumed risk in the comparison group and the relative effect of the 
intervention (and its 95% CI). 
CI: Confidence interval; RR: Risk ratio; 
GRADE Working Group grades of evidence 
High quality: Further research is very unlikely to change our confidence in the estimate of 
effect. 
Moderate quality: Further research is likely to have an important impact on our confidence 
in the estimate of effect and may change the estimate. 
Low quality: Further research is very likely to have an important impact on our confidence 
in the estimate of effect and is likely to change the estimate. 
Very low quality: We are very uncertain about the estimate. 
1 Downgraded by two for indirectness: These trials were conducted in specific subpopulations from 
the USA and the results may not be applicable in other settings. 
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4 Summary of findings table: Comparison of different values of cash incentives  
Comparison of different values of cash incentives for improving patient adherence to TB 
management 
Patient or population: People at high risk of developing TB 
Settings: High- and low-income settings 
Intervention: Higher cash value ($10) 
Comparison: Lower cash value ($5) 
Outcomes Illustrative comparative risks* 
(95% CI) 
Relative 
effect 
(95% CI) 
No of 
participants 
(studies) 
Quality of the 
evidence 
(GRADE) 
Assumed 
risk 
Corresponding 
risk 
lower cash 
value 
higher cash value 
Return for 
tuberculin skin 
test reading 
858 per 
1000 
927 per 1000 
(867 to 995) 
RR 1.08  
(1.01 to 
1.16) 
404 
(1 study) 
⊕⊕⊝⊝ 
low1 
The assumed risk is taken from the control group in the trial. The corresponding risk (and its 
95% CI) is based on the assumed risk in the comparison group and the relative effect of the 
intervention (and its 95% CI). 
CI: Confidence interval; RR: Risk ratio; 
GRADE Working Group grades of evidence 
High quality: Further research is very unlikely to change our confidence in the estimate of 
effect. 
Moderate quality: Further research is likely to have an important impact on our confidence 
in the estimate of effect and may change the estimate. 
Low quality: Further research is very likely to have an important impact on our confidence 
in the estimate of effect and is likely to change the estimate. 
Very low quality: We are very uncertain about the estimate. 
1 Downgraded by two for indirectness: This trial was conducted in a specific subpopulation from the 
USA and the result may not be applicable in other settings. 
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5 Summary of findings table: Material incentives versus educational or motivational 
interventions  
Incentives compared to educational or motivational interventions for improving patient 
adherence to anti-TB treatment 
Patient or population: Patients at high risk of developing TB 
Settings: High- and low-income settings 
Intervention: an incentive 
Comparison: any educational or motivational intervention 
Outcomes Illustrative comparative risks* 
(95% CI) 
Relative 
effect 
(95% CI) 
No of 
participants 
(studies) 
Quality of 
the 
evidence 
(GRADE) 
Assumed risk Corresponding 
risk 
any other 
intervention 
material 
incentives 
Return for 
tuberculin skin 
test reading 
429 per 1000 927 per 1000 
(669 to 1000) 
RR 2.16  
(1.56 to 
3.00) 
1366 
(2 studies) 
⊕⊕⊝⊝ 
low1,2 
Return to clinic to 
start or continue 
treatment 
381 per 1000 419 per 1000 
(351 to 499) 
RR 1.10  
(0.92 to 
1.31) 
535 
(2 studies) 
⊕⊕⊝⊝ 
low2,3 
Completion of 
prophylaxis for 
latent TB 
444 per 1000 462 per 1000 
(262 to 813) 
RR 1.04  
(0.59 to 
1.83) 
837 
(3 studies) 
⊕⊕⊝⊝ 
low2,4 
The assumed risk is taken from the control group in the trial. The corresponding risk (and its 
95% CI) is based on the assumed risk in the comparison group and the relative effect of the 
intervention (and its 95% CI). 
CI: Confidence interval; RR: Risk ratio; 
GRADE Working Group grades of evidence 
High quality: Further research is very unlikely to change our confidence in the estimate of 
effect. 
Moderate quality: Further research is likely to have an important impact on our confidence 
in the estimate of effect and may change the estimate. 
Low quality: Further research is very likely to have an important impact on our confidence 
in the estimate of effect and is likely to change the estimate. 
Very low quality: We are very uncertain about the estimate. 
1 Downgraded by 1 for risk of bias: Neither study adequately described the method of 
randomisation. 
2 Downgraded by 1 for indirectness: These trials were conducted in specific subpopulations from the 
USA and the result may not be applicable in other settings. 
3 Downgraded by 1 for imprecision: The 95% CI includes what may be clinically important benefits 
and no effect. 
4 Downgraded by 1 for inconsistency: Two studies found no suggestion of a benefit with the 
incentive, and just one study found a clinically and statistically significant benefit in drug users. 
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Appendix 3A: Description of pragmatic/explanatory approach to the 
trial 
 
Domain Predominant approach Description 
Participant eligibility 
criteria 
Pragmatic All patients with drug sensitive 
pulmonary TB enrolled; no  
additional exclusion criteria 
were applied 
Experimental 
intervention — 
flexibility 
Pragmatic-explanatory Instructions were given for 
each element of voucher 
delivery, but practitioners were 
not rigorously monitored in 
this.  
Experimental 
intervention — 
practitioner 
expertise 
Pragmatic The voucher was delivered by 
the same Department of Health 
nurses who would have cared 
for patients and administered 
TB treatment had there not 
been a trial, and this included 
nurses at all levels of 
experience and seniority 
Comparison 
intervention — 
flexibility 
Pragmatic Patients in control clinics 
received routine TB care 
Comparison 
intervention — 
practitioner 
expertise 
Pragmatic TB care in control clinics was  
delivered by the same 
Department of Health nurses 
who would have cared for 
patients and administered TB 
treatment had there not been a 
trial, and this included nurses at 
all levels of experience and 
seniority 
Follow-up intensity Pragmatic There was no additional follow 
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up of trial participants beyond 
what was usually performed by 
the Department of Health. Data 
for all trial participants were 
obtained from clinic registers 
and patients’ files. 
Primary trial 
outcome 
Pragmatic The primary outcomes of the 
trial were the same as those 
used by the Department of 
Health, and no additional 
measurements were used.  
Participant 
compliance with 
“prescribed” 
intervention 
Explanatory Patient adherence was 
measured as routinely done by 
Department of Health nurses 
(i.e. by checking the patients’ 
clinic cards and by doing pill 
counts). Patients who were 
adherent to treatment were 
given vouchers.   
Practitioner 
adherence to study 
protocol  
 
Pragmatic explanatory Nurses were encouraged to 
adhere to study protocol but 
meetings only took place every 
4 to 6 weeks and there was no 
censure for failing to adhere.  
Analysis of primary 
outcome 
Explanatory Intention-to-treat analysis was 
supplemented by an 
exploratory analysis (based on 
a per-protocol 
analysis) and a dose-response 
analysis in order to estimate 
“maximum achievable 
treatment effect”. 
Source: Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furburg CD, Altman DG et al. A 
pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. Journal 
of Clinical Epidemiology 62 (2009) 464-475.  
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Appendix 3B: Voucher 
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Appendix 3C: Information for clinics 
 
Vouchers for patients with TB               
Study conducted in eThekwini and Uthungulu Districts, 2009 
 
Thank you for participating in this study! Here follow some guidelines for the distribution of 
vouchers to patients. If you require further information, or in case of problems, please contact 
Dr Elizabeth Lutge on 083 4192787. 
 
1. Every patient receiving TB treatment from the clinic will receive the voucher for the 
duration of their treatment, or a maximum of 8 months (for re-treatment patients) 
2. The patient should take the voucher from the clinic to the allocated shop, and present 
it to the shopkeeper with his/her green clinic card. 
3. The patient will be able to take goods to the value of R120.00 from the shop  
4. The patient may take any goods he or she wishes, but should be encouraged to take 
healthy foods that will support his/her recovery 
5. The patient must spend as much of the voucher as possible. No change will be given 
by the shop.  
6. The patient will not be able to keep credit at the shop. Each voucher must be spent on 
one day 
7. The voucher may not be exchanged for cash at the shop 
8. The shopkeeper will be reimbursed for all vouchers redeemed at his/her shop. 
9. Copies of distributed vouchers will be collected from the clinics and the shops every 
month by the Health Systems Trust.  
 
How to answer questions from the patient 
 
Here follow some examples of questions the patients might ask, and ideas on how you could 
answer them. We hope this is helpful. However, if you need support or further information, 
please don’t hesitate to contact Elizabeth Lutge at the Health Systems Trust (work phone 033 
– 3473967, email Elizabeth@hst.org.za, cell phone 0834192787).  
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1. Can someone take the voucher to the store for me? 
Only if you are too ill to take the voucher yourself. If you can’t go to the shop yourself, we 
will indicate on the voucher that someone else is taking it for you. The clinic sister will judge 
if you are really too ill to take the voucher to the shop, and will indicate this on the voucher.  
2. Do I have to spend it all at once? 
Yes. The shop will not keep credit for you. Whatever you don’t spend when you first take the 
voucher to the shop will be lost. 
3. Will I get change? 
No, the shops will not give you change for the money you haven’t spent. So it’s best that you 
spend as much of the R120.00 as you can, all at once. 
4. I don’t have my ID book – can I still participate in the study? 
Yes. The clinic sister will record your date of birth and your gender on the voucher and this 
will be acceptable to the shops. 
5. What can I buy from the shop? 
You can buy anything you like, but it’s best to buy nutritious foodstuffs that will help you 
recover from your TB. 
6. I can’t go to the shop today – when do I need to spend the voucher by? 
You need to spend the voucher within one month of receiving it. The shops will not accept the 
voucher if more than one month has gone by after you received it.  
7. How long can I get the voucher for? 
You will receive the voucher every month until you have completed 6 months of TB treatment 
(or 8 months if you are a re-treatment case). You will not receive the voucher beyond this 
period, even if your treatment is continued. 
8. If I get TB again, will I get the voucher? 
No. These vouchers are part of a study. Once the study is over, the vouchers will not be 
issued unless the results of the study show that they are beneficial, and unless the Department 
of Health feels they will be worthwhile.  
9. Why aren’t patients at other clinics getting the voucher? 
Because this study is comparing TB cure rates at clinics where patients do receive the 
voucher, with cure rates where patients don’t receive the voucher. This is how we will know if 
the voucher is effective in improving cure rates or not.  
10. Can I tell my friends with TB to come to this clinic so that they can get the voucher? 
No. It’s important that patients with TB stay at the clinics where they are registered. If 
patients cross to this clinic, it will change the cure rates at other clinics and we will not be 
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able to see if the vouchers have improved cure rates at this clinic or not. Also, it will result in 
a much greater workload for the nurses at this clinic. It is best for people to receive treatment 
from the clinic that is closest to them. 
11. Can I tell my friends and family to come to this clinic to test for TB, so that they can 
get the voucher? 
It is important that anyone who suspects they might have TB, tests at a clinic. Patients can 
come to this or any other clinic to test for TB.  
12. Why am I not eligible for the study (for patients starting TB treatment after the trial 
has ended)? 
The study that was looking at whether vouchers helped patients take their TB treatment has 
ended. Patients were only bought into the study for a few months, although the study will last 
until they have finished their treatment. At the end of the study, the results will be given to the 
Department of Health. If the results show that vouchers did improve cure rates for TB 
patients, and the Department feels that it is worthwhile, the Department of Health may 
implement the voucher system in clinics.  
 
 
 
 
 
  
Stellenbosch University  http://scholar.sun.ac.za
262 
 
Appendix 3D: Letter of ethics approval for trial 
 
7 February 2008 
 
 
Dr EE Lütge 
Health Systems Trust 
PO Box 808 
DURBAN 
4000 
 
Dear Dr Lütge 
 
RESEARCH PROJECT : "ECONOMIC INCENTIVES FOR IMPROVING CLINICAL 
OUTCOMES IN PATIENTS WITH TB IN SOUTH AFRICA:  A STUDY OF FEASIBILITY 
AND EFFECTIVENESS” 
 
PROJECT NUMBER : N07/10/245 
 
At a meeting of the Committee for Human Research that was held on 12 November 2007 the above 
project was approved on condition that further information that was required, be submitted. 
 
This information was supplied and the project was finally approved on 6 February 2008 for a period 
of one year from this date.  This project is therefore now registered and you can proceed with the 
work.  Please quote the above-mentioned project number in all further correspondence. 
 
Please note that a progress report (obtainable on the website of our Division) should be 
submitted to the Committee before the year has expired.  The Committee will then consider the 
continuation of the project for a further year (if necessary). Annually a number of projects may 
be selected randomly and subjected to an external audit. 
 
Patients participating in a research project in Tygerberg Hospital will not be treated free of charge as 
the Provincial Government of the Western Cape does not support research financially. 
 
Due to heavy workload the nursing corps of the Tygerberg Hospital cannot offer comprehensive 
nursing care in research projects.  It may therefore be expected of a research worker to arrange for 
private nursing care. 
 
Yours faithfully 
 
 
FRANKLIN WEBER 
RESEARCH DEVELOPMENT AND SUPPORT (TYGERBERG) 
Tel:  +27 21 938 9657 /  E-mail: fweb@sun.ac.za 
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Appendix 3E: Patient consent form for in-depth interview 
(similar form used for all participants).  
We would like to talk to you about your experience with the voucher you have received over the 
past few months. Your input is very important to help assess whether the voucher has helped 
patients to take their TB treatment, as well as how the delivery of the voucher has been, and what 
changes could be made to improve this.  
We will be asking you several questions which we would like you to answer openly and honestly. 
Everything you say will be treated confidentially. Your name will not be noted anywhere in our data 
or our reports, and everything that we write will be safely stored in a locked drawer in the office of 
the Health Systems Trust. After two years, all these papers will be destroyed.  
We would like to tape-record this interview, as well as record it by taking notes. If you would prefer 
that we do not tape record, then we will respect your wishes.  
We have received ethical approval for this study (including these interviews) from the University of 
Stellenbosch, and permission to conduct the study from the KwaZulu-Natal Department of Health. If 
you have any queries regarding this study, you can contact:  
Dr Elizabeth Lutge 
The Health Systems Trust 
Phone: 031 - 3072954 / 083 4192787 
Fax: 031 – 3040775.  
If you consent to participate in this interview, we will sign the consent form below. If not, we will 
close this interview now. Please note that if there are any questions that you do not want to answer, 
you are free to refuse to do so. Also, you may withdraw from this interview at any time.  
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Patient consent given: Yes   No 
Signed (interviewee)……………………………………. 
Signed (interviewer)……………………………………. 
Date: ……………………………… 
Thank you! 
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Appendix 3F: Patient consent form for household economic survey 
 
Patient survey: experience of TB and its financial effect on household  
 
We would like to talk to you about your experience of TB, and how having TB has affected your 
work and your income. If you have received a voucher, we will be asking you about that too. We will 
use the answers you give to inform the Department of Health about how TB affects people financially.  
 
We will be entering your answers to our questions on a cell phone. Once the interview is completed, 
we send the interview via sms to a central computer at the Health Systems Trust, where it will be 
analysed. The interview is deleted from this phone as soon as it is sent. Your name will not be used at 
any time during this study, and you will not be able to be identified from this interview.  
 
We have received ethical approval for this study (including these interviews) from the University of 
Stellenbosch, and permission to conduct the study from the KwaZulu-Natal Department of Health. If 
you have any queries regarding this study, you can contact:  
 
Dr Elizabeth Lutge 
The Health Systems Trust 
Phone: 031 - 2669090 / 083 4192787. 
 
We hope that you will consent to this interview, which will take about 40 minutes.  
If you do consent to participate in this interview, we will sign the consent form below. If not, we will 
close this interview now. Please note that if there are any questions that you do not want to answer, 
you are free to refuse to do so.  
 
Patient consent given:  Yes   No 
 
Signed (patient)……………………………………. 
Date: ……………………………… 
Signed (interviewer)……………………………………. 
Date: ……………………………… 
Place: …………………………………………. 
 
Thank you! 
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Appendix 3G: Protocol for trial and its process evaluation 
 
Economic incentives for improving clinical outcomes in patients with TB in South 
Africa: a study of feasibility and effectiveness. 
 
Principal investigator: Dr EE Lutge (Health Systems Trust) 
 
In collaboration with Professor JA Volmink (University of Stellenbosch) and Dr SA Lewin 
(Medical Research Council South Africa) 
 
Additional technical assistance for protocol development and data analysis provided by 
KNCV Tuberculosis Foundation. 
 
Funded by the National Department of Health (South Africa), the Tuberculosis Control 
Assistance Program (TB CAP), (the Netherlands, through the National TB Directorate) and 
the Wellcome Trust (United Kingdom).  
 
Background: 
 
Tuberculosis (TB) is widely acknowledged as a disease of poverty (Lancet 2005) and much 
work internationally has gone into establishing the vulnerability of poor people to TB 
(StopTB Partnership 2002b).  
 
In Piot’s model of the different aspects of a TB programme, a patient needs an awareness of 
possible TB infection and a motivation to seek treatment, in order to access it (Piot 1967). 
However, even when these are present, studies have shown that poverty is a barrier to seeking 
treatment, for TB (Sanou et al 2004, Xu et al 2004) and other illnesses (Taffa & Chepngeno 
2005, Goldman et al 2002).  Many more primarily qualitative studies show that after 
diagnosis of TB and initiation of treatment, poverty fundamentally undermines adherence by 
rendering the patient unable to cope with the direct and indirect costs of treatment (Munro et 
al 2007, Greene 2004, Needham et al 2004, Watkins & Plant 2004, Khan et al 2000, 
Johansson et al 1999, Johansson et al 1996). The conclusion from these studies (that poor 
patients are more likely than wealthier to default from treatment) has been reinforced by a 
recent survey in Brazil, where the defaulter rate amongst the poorest 20% of patients was ten 
times higher than among the wealthiest 20% (Belo et al 2006).   
 
The inability to cope with the costs of treatment is especially true in low and middle income 
countries (McIntyre et al 2006), where the burden of TB is also highest (StopTB Partnership 
2002b). However, in poor countries little work has been done on interventions that may 
lessen the impact of the economic shock of TB on household economies, or the potential for 
these interventions to improve TB outcomes such as adherence and cure.  
 
In the literature on adherence in South Africa, few studies have investigated the role of 
patient economic factors. Those that have been done to date have concluded that financial 
constraints are major obstacles to the completion of TB treatment (Loveday et al 2006, Lutge 
et al 2005, Yach 1988) and TB preventive therapy (Rowe et al 2005). In Rowe’s qualitative 
study, financial limitations were universally reported by patients as general barriers to 
adherence, and cited again as preventing access to the clinic because of the expense of 
transport. Two of the other studies (Loveday et al 2006, Lutge et al 2005) both concluded 
that financial constraints were important factors in a patient’s failure to complete TB 
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treatment, in populations where knowledge of TB was generally good (Lutge et al 2005), and 
trust in the public health system was fairly high (Loveday et al 2006).  In this latter study, the 
cost of reaching the clinic (between R3 and R80, depending on the distance from the patients’ 
homes) was said to be a major constraint to their access to treatment by 40% of patients. Most 
(84%) of the patients interviewed in the study were unemployed.  
 
To date in South Africa, support to TB patients has been provided in the form of free 
treatment at government hospitals and clinics (Department of Health 2001), nutritional 
supplementation
15
 and social grants (Department of Social Development 2006). Nutritional 
supplementation is meant to be given in the form of powdered food supplements or food 
parcels to patients at primary care clinics, and is complemented by involving patients in 
gardening projects. However, problems in delivering this supplementation has resulted in 
patchy and suboptimal implementation, and to date this programme has not been formally 
evaluated. The social (disability) grant is given, in conjunction with the Department of Social 
Development, to patients who are certified by a doctor to be incapacitated by TB. This 
criterion makes most TB patients, who are not incapacitated by the disease, ineligible for the 
grant. In addition, this criterion has led to significant corruption in some areas, with certain 
private general practitioners becoming known as “disability doctors” as they will provide 
certification for grants whether this is warranted or not. This intervention has also not been 
formally evaluated.  A further failing of the nutritional and social grant support is that neither 
has been linked to TB outcomes, such as adherence to or completion of treatment.  
 
Economic incentives to patients with TB may diminish the multi-faceted impact of poverty 
on TB control, both by preventing the deepening of household poverty when affected by TB, 
and by limiting the extent to which poverty undermines treatment outcomes. Indeed, poor TB 
patients in Brazil ranked financial incentives highest in a range of interventions which 
included improved health services support and better administrative organization, such as 
being able to schedule appointments (Belo et al 2006). 
 
A variety of incentives (such as cash, vouchers for shops, telephone cards or bus tokens) have 
been tested and evaluated for their effects on patient adherence to tuberculosis management 
(either treatment or preventive therapy) (Tulsky et al 2004).  In particular, cash incentives 
have been found in a systematic review to be effective (Volmink & Garner 2000) and in 
studies subsequent to this review, were found to significantly improve rates of completion of 
TB preventive therapy (Malotte et al 2001, Tulsky et al 2000), and to reduce the amount of 
follow up necessary to assist patients to complete TB preventive therapy (Tulsky et al 2004).  
To date no rigorous intervention studies of incentives for tuberculosis control have been 
conducted in high burden developing countries.  This was noted in Volmink and Garner’s 
review (2000) which concluded that “Future studies in low income countries are a priority 
and should measure adherence and clinical outcomes.” In South Africa, tuberculosis ranks as 
the third most common cause of death among adults (Bradshaw et al 2003), adherence rates 
are low (only 50% of patients in the country are cured, with a further 13% completing 
treatment) (Grimwood et al 2006), 57% of people live below the poverty income line
16
 and 
                                                          
15
 Personal communication, Mr Simiso Masondo, TB Control Programme of the KZN Provincial Department of 
Health, July 2006. 
16
 The poverty income line varies according to household size. For a household of 4, the poverty income is 
R1290.00 per month (Human Sciences Research Council 2004).  
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the poverty gap
17
 is increasing (Human Sciences Research Council 2004).  South Africa is 
therefore an ideal setting in which to investigate the effect of economic incentives on TB 
outcomes.  
Aim:  
To test the feasibility and effectiveness of economic incentives in patients with TB in South 
Africa.  
 
Objectives: 
 
1. To evaluate the effectiveness of an economic incentive in improving clinical 
outcomes in patients with TB  
2. To assess the responses and attitudes of health care managers, workers and patients 
towards the incentive  
3. To investigate the technical, administrative and financial feasibility of delivering the 
incentive   
4. To assess the impact of the incentive on patients’ household economies  
 
Definition of terms:  
 
Incentive: Any form of inducement to adhere to or complete treatment, such as cash, 
vouchers for groceries, transport etc. and other forms of rewards. As preferred by the 
National TB Director, vouchers for local shops will be used for this study (personal 
communication, Dr Lindiwe Mvusi, April 2008). Vouchers are preferred to cash because they 
avoid connotations of being another social grant, which is controversial in South Africa. At 
the same time they give the patient a relatively high degree of choice as to what the voucher 
can be spent on, as compared to food parcels which have been used in the past in KwaZulu-
Natal.  
 
 
Methods:  
 
This study will use both quantitative and qualitative methods. The basic design will be a 
cluster randomised trial (quantitative) within which qualitative studies will be nested. The 
methods will be described and discussed under the objectives to which they apply.  
 
Objective 1: To evaluate the effectiveness of the incentive  
 
Design 
 
This will be a pragmatic, un-blinded two-arm cluster randomized trial with before and after 
data on TB outcomes. Clinics will be randomly allocated to intervention (voucher) and 
control (no voucher) groups, with each clinic and the patients attending it acting as a cluster. 
A cluster design was chosen because providing incentives to selected individuals within one 
clinic in a poor population could result in high levels of dissatisfaction in those patients not 
receiving these incentives. Also it is logistically easier to implement the intervention across a 
                                                          
17
 The poverty gap measures the required annual income transfer to all poor households to bring them out of 
poverty (Human Sciences Research Council 2004).  
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whole facility than by individual patient as health providers can use the same procedure for 
each person.  
 
All TB patients within the intervention clinics will receive the incentive, but the focus for 
analysis will be on smear positive patients who present at the clinic for the first time during 
the study (see “study population” below).  
 
Patients in the control and intervention clinics will receive TB care as routinely provided by 
the health service.  
 
Follow up and outcomes 
 
Patients will be followed up for the duration of their TB treatment, which is usually 6 months. 
 
The effectiveness of the intervention will be assessed by comparing intervention and control 
sites for the following outcomes: 
 
1. Primary outcomes: Cure and treatment completion 
2. Secondary outcomes: Default and failure rates.  
 
The World Health Organisation definitions of these outcomes will be used (WHO 2004).  
 
These data will be obtained from each clinic, where it is routinely collected for submission to 
the National TB Register. 
 
Intervention 
 
Monthly vouchers of R120.00 will be given to patients, redeemable at shops in close 
proximity to the clinics. The amount was informed by arguments proposing a universal 
system of social protection in South Africa, and has been adjusted for inflation since these 
debates took place. Proponents of the Basic Income Grant suggested that a monthly amount 
of US$20 would more than double the average consumption of the poorest 20% of the 
population. The amount suggested for this study is greater than the $5 per visit that achieved 
a significant effect in an American study with a similar aim (Malotte et al 2001).  
 
Shops in close proximity to the clinic will be chosen as outlets where patients can redeem 
their vouchers. Shops will be chosen in consultation with nursing staff at the intervention 
clinics, to ensure that they are easily accessible for patients but also are among the least 
expensive in the area. Patients will receive the voucher from the clinic, containing the 
patient’s name and their clinic number, as well as the signature of the nurse in charge of TB 
services, and the clinic stamp and date stamp. The clinic will keep a copy of each voucher for 
the records of the study. On discussion with the participating shops, patients will be allowed 
to spend their vouchers over the following month, and will not be required to spend it all at 
once. However, credit will not be maintained beyond any one month, and cash change will 
not be given to patients who do not spend the entire amount within that period. Shops will 
record on each voucher, what goods were bought and at what price.  
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Study period 
 
Patient recruitment will take place over a period of 3 months. Patients will be followed up for 
the following six months (for new patients) and eight months (for retreatment patients), 
resulting in a total study duration of 11 months. All patients on TB treatment during the 
recruitment period will receive the voucher, for the remainder of the duration of their 
treatment. However, the focus for analysis will be on the new smear positive patients starting 
their treatment during this time.  
 
Study sites 
 
This study will be conducted in KwaZulu-Natal, one of South Africa’s poorest and most 
populous provinces (Barron et al 2007). One urban district (eThekwini, also known as the 
city of Durban) and one rural district (Uthungulu) have been selected for the study. In terms 
of cure rates, eThekwini ranks 47
th
 (with a cure rate of 41%) and Uthungulu 45
th
 (with a cure 
rate of 42%) out of 53 districts in the country (Barron et al 2007).  
 
eThekwini, the second most densely populated district in the country (ibid) is one of four 
districts in the country identified for special intervention in the Department of Health’s 
National TB Crisis Management Plan (Department of Health 2006). The city has the best 
socio-economic profile in KwaZulu-Natal, with good infrastructure (just over 96% of 
residents have access to piped water. However, many of its health outcomes remain poor, and 
its TB cure rate, and perinatal mortality rate are among the worst in South Africa (Barron et 
al 2007). Uthungulu is a poorer district than eThekwini, with over half of its residents living 
on less than R800.00 per month (ibid). Infrastructure has improved recently, with 73.4% of 
its households having access to piped water, as has the TB cure rate (from 18% in 2004) but 
there is still much room for improvement.   
 
Study population 
 
Clinics: 
Clinics with cure rates of between 40% and 70% for the previous year will be eligible for 
inclusion in the study. The upper limit is set because a demonstration of a clinically 
meaningful effect in clinics with cure rates higher than 70% would not be possible with this 
sample size. The lower limit is set to exclude clinics where poor service provision may 
contribute to poor cure rates. Also, because the average cure rate in South Africa is 57% 
(Barron et al 2005) included clinics will be more representative of the country as a whole. 
Cure rates for the country range from 31.4% in Nkangala (Mpumalanga province) to 83.6% 
in Overberg in the Western Cape province. Seventy five percent of districts achieved cure 
rates of above 50% (ibid). Finally, only clinics with 20 or more new smear positive patients 
per quarter will be included, to ensure that smaller clinics do not bias the results.  
 
Patients: 
 
Although all TB patients will receive the incentive, the new smear positive adult TB patients 
(that is, those who are newly diagnosed during the study period) will be the focus of the 
analysis. Children below the age of 18 years will be analysed both within the main cohort and 
as a sub-group analysis. The proportion of new smear positive TB patients varies between 
clinics, but in most clinics, these patients constitute the majority of TB cases (in Uthungulu 
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district, there were 1400 new TB patients and only 324 re-treatment patients in 2007
18
) . 
Retreatment patients will be analysed separately. This is at the explicit request of the 
Uthungulu District, where these patients are perceived as problematic (personal 
communication, Jacqueline Ngozo, HAST co-ordinator, Area 3, KwaZulu-Natal. September 
2008).  
 
Only patients who join the study in the initial three month recruitment period will receive the 
incentive. This is at the explicit request of the eThekwini Municipality, who want to limit 
where possible the cross over of patients from control to intervention clinics.  
 
All TB patients, regardless of their HIV status and treatment for HIV, will be included in the 
study. . 
 
Patients with MDR- or XDR-TB will be excluded from the analysis because of the very poor 
outcomes associated with these strains. However, they will receive the vouchers for a 
maximum of 8 months of the study, as will retreatment cases.  
 
Study sample 
 
There are a total of 144 clinics in eThekwini
19
, and 68 provincial clinics in Uthungulu, 
providing TB care. From all these clinics in the districts, a list of those meeting the cure rate 
and new smear positive patient inclusion criteria will be constituted. A random sample of 20 
clinics will be selected from this sub-population - 16 in eThekwini, and 4 clinics in 
Uthungulu. Half of the selected clinics in each district will be randomly allocated to the 
intervention group and half to the control group. All eligible patients within intervention 
clinics will be recruited for the study.  
 
Power calculations are based on an intracluster correlation co-efficient of 0.031 (within the 
range commonly encountered in health outcomes from primary care clinics).
20
 Comparing 
cure rates between two arms using a two sided test with 5% significance level, this study will 
be powered (90%) to detect a 15% difference between the intervention and control arms. 
Although the effect size is large, it is anticipated that a large effect size will be necessary to 
justify the roll out of this intervention on a large scale.  
 
Analysis 
 
Analysis will be by intention to treat at the clinic as well as at the patient level. The baseline 
characteristics of the two groups will be compared, although no significant differences are 
expected because of randomisation.  
 
Because the study outcomes are binary (cured or not cured etc.) a generalised linear mixed 
model (GLMM) will be used to evaluate the intervention effect with clinics used as a random 
effect.  This method will take into account the cluster randomised design and the number of 
clinics planned for this study will be appropriate for use of this method.  
 
                                                          
18
 Uthungulu TB data 2007.  
19
 Approximately 40% of clinics in eThekwini are run by the Local Government (eThekwini Municipality) and 
60% by the KwaZulu-Natal Provincial Department of Health.  
20
 Personal communication: Dr Carl Lombard, Biostatistician, Medical Research Council (South Africa). May 
2007.  
Stellenbosch University  http://scholar.sun.ac.za
272 
 
Sub-group analyses based on gender, age, HIV status, anti-retroviral treatment, and socio-
economic indicators are planned.  
 
 
Objective 2: To assess the responses and attitudes of health care managers, workers, 
shopkeepers and patients towards the incentives 
 
Design 
 
This objective will be addressed through a qualitative study, nested within the intervention 
study above. Semi-structured qualitative interviews will be used to gather data. A sample of 
approximately 35 patients from intervention clinics in eThekwini and 15 patients from 
Uthungulu will be interviewed at the clinic at month 3 of treatment and again on exit (month 
6), focusing on their experience of TB and TB treatment, and their perceptions of the health 
system and the incentive (please see Patient Interview Guide attached). Data collection will 
continue until saturation is reached. Patients will be requested to give investigators their cell 
phone numbers or other contact details, which will be used to contact them for the second 
interview.  
 
Patients will be selected purposively to include men and women of different age groups, 
socio-economic status and places of residence, to ensure that a range of experiences are 
investigated. As far as possible, patients will be selected from the TB register, independently 
by the study staff. Although nurses will not select patients, their advice will be sought in 
identifying patients who have struggled to complete treatment, patients from different 
residential areas, patients who have received TB treatment previously etc. Where consent is 
given, these interviews will be recorded on audiotape and later transcribed. If consent for the 
recording is not given, interviews will be transcribed at the time.  
 
HIV tests will not be performed as part of the study, but patients will be asked to disclose 
their status. If not known, they will be encouraged to test using the clinics’ voluntary 
counselling and testing programme. Since HIV has a profound effect on TB cure rates, as 
well as on a household’s economy, this will be an important variable to include in analysis. 
However, patients will be assured that all information they disclose, including their HIV 
status, will be treated with confidentiality and that all data will be anonymised.  
 
A sample of twenty four nurses involved in providing direct TB care to patients in 
intervention clinics will be asked to participate in semi-structured interviews in months 6 and 
9 of the study period. Inter alia, their attitudes to TB patients, perceptions about adherence 
and efforts to encourage this, and their attitudes towards the incentive will be investigated 
(please see Health Worker In-depth Interviews, attached).  
 
The shop owners or managers of all eight shops participating in this study will be interviewed 
to ascertain their views on the administration of this voucher, and the impact that the voucher 
had on their businesses, both financial and administrative. (Interview Guide and consent form 
attached).  
 
All interviews will be recorded on audiotape and subsequently transcribed.  
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For qualitative interview data, thematic analysis will be undertaken to identify issues seen as 
important by respondents. At this stage, it is anticipated that this analysis will be manual, but 
after viewing the data, a software programme may be used for analysis.  
 
 
Objective 3: To investigate the technical, administrative and financial feasibility of 
delivering an economic incentive to patients with TB  
 
Together with a health economist, the cost of delivering the intervention will be calculated 
for the intervention clinics, and used as a basis for modelling these costs for the province, and 
the country as a whole. The cost per additional patient cured will be calculated. This data will 
be presented to TB managers at district, provincial and national levels to discuss the financial 
feasibility of providing the incentive on a large scale.  
 
The additional technical and administrative burdens imposed by the incentive programme 
will be documented throughout the study. The process for delivering the vouchers to patients, 
confirming their adherence to treatment and authorising payment of the incentive every 
month will be developed and streamlined over the course of the study. Unanticipated issues 
will be addressed and additional new systems supporting the delivery of the intervention will 
be developed during the study. Specifically, the feasibility of making the incentive 
conditional on demonstration of adherence will be investigated. Because this will require 
input from directly observed treatment (DOT) supporters, whether these are community or 
clinic based, the study will answer the question of whether it will be simpler to make the 
incentive unconditional.  
 
Twelve managers at clinic, district, provincial and national TB programme levels will also be 
interviewed to explore the administrative and technical feasibility of the intervention (please 
see Manager In-depth Interviews, attached). Only those managers who are directly involved 
with the intervention clinics, or under whose line management these clinics fall, will be 
interviewed. Provincial and national managers involved with the management of service 
provision for TB will be interviewed. The effectiveness data, costs, and patient, provider and 
manager responses will form the basis of assessments regarding the feasibility of the 
intervention.  
 
Objective 4: To assess the impact of the incentive on patients’ household economies  
 
Design 
 
This will be a quantitative cross-sectional study nested in the intervention study, involving a 
40% sample of patients attending both intervention and control clinics (approximately 400 
patients in total). This will enable the detection of differences of 30% between the groups, 
with a power of 80% and a confidence interval of 95%.  
 
Patients will be approached to complete a questionnaire (please see Impact of incentive on 
household economy: questionnaire, attached) in month 6 of treatment. Using this structured 
questionnaire, data on household income and consumption will be collected, as well as, 
amongst others, direct and indirect expenditure due to TB and coping mechanisms of 
households to offset expenditure (Sauerborn et al 1996). In intervention clinics, data on the 
incentive will also be collected. This will include what goods/services the incentive is spent 
on, and the extent to which the incentive has protected the household from further poverty.  
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Fieldworkers will enter all information onto cell phones at the time of the administration of 
the questionnaire (no paper will be used for this section of data collection). This method of 
data collection has been used successfully by the Health Systems Trust in other studies. 
However, funds have been set aside for paper-based collection of data if required.  
 
Data analysis  
 
Uni-, bi- and multivariate analyses will be performed. Associations between patient, 
household and facility variables and treatment outcomes will be explored.  
 
Ethical considerations 
 
This study has been approved by the Committee for Human Research at the University of 
Stellenbosch (South Africa) (see approval letter attached), and is supported by the Director of 
TB services at the National Department of Health (Dr Lindi Mvusi).  
 
Permission to conduct the study has been obtained from the Health and Safety Sub-
Committee of elected City Counsellors and the Research Committee of the eThekwini 
Municipality, the Durban District Office, the Uthungulu District Management Team and the 
KwaZulu-Natal Provincial Research Committee.  
 
Consent for this study will be sought at a clinic level, and individual patient consent will be 
requested from those patients who are interviewed. The nature of the study, and the reasons 
why it is being conducted, will be explained to all patient participants in an indigenous 
language of their choice. This will be done verbally and in writing. Patients will be assured 
that non-participation will not compromise their treatment. Written informed consent will be 
obtained from all participants (nurses, managers and patients) who are interviewed for the 
purposes of this study (consent forms attached in appendices). However, written consent will 
not be sought from patients receiving the vouchers. Individual patient consent will be implied 
if patients take and use the vouchers. We feel that the waiver of individual consent can be 
justified because patients will be receiving their routine TB treatment, and the voucher is only 
intended to increase adherence to this. Therefore patients will be exposed to no or very little 
additional risk. Also, the intervention is applied at the organizational level, and nothing 
further will be required from the majority of patients (written informed consent will be asked 
from patients who are interviewed, as above). Waiving individual patient consent will make 
the distribution of vouchers logistically easier at intervention clinics.  
 
Fieldworkers will be trained to treat all information given by patients, especially HIV status, 
in the strictest confidence. All data will be confidential. Data will be safely stored in a locked 
drawer at the Health Systems Trust offices in Durban, and only accessible to the 
investigators.  
 
No clinical interventions will be performed as part of this study, and participants will not be 
subjected to risks beyond those of other patients receiving treatment for TB.  
 
Because this study has relevance for social and financial policy, as well as for health, a wide 
range of stakeholders will be informed of the results. Results will be reported to the 
eThekwini Municipality, the KwaZulu-Natal Provincial Department of Health, the TB and 
Research Directorates in the National Department of Health, the National Department of 
Stellenbosch University  http://scholar.sun.ac.za
275 
 
Social Development and the National Treasury. Workshops for the discussion of results and 
their implications for policy will be arranged with these stakeholders.  
 
Results will also be published in international peer reviewed journals, so that the international 
community can engage with the issues raised.  
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Appendix 4A: Interview guide for patients 
Demographic information:  
Age  
Gender 
Number of years of education 
Type of residence (shack, or formal residence) 
Employment (unemployed, self employed, piece work, employed full time) 
Month and year when diagnosed with TB 
Any breaks in treatment in current episodes of TB (if so, record duration) 
Previous episodes of TB – date (year) and whether or not treatment was completed.  
In-depth questions: 
1. What makes it difficult for you to take your TB treatment?  
2. What makes it easier? 
3. Does lack of money affect your ability to take your TB treatment? Prompt: money for 
transport to the clinic, for food with which to take tablets, unwillingness to leave work to go 
to clinic etc.  
4. In addition to these problems, does having TB have an effect on your finances or those of 
your household at all?  
5. Some people are HIV positive – do you think this impacts on their experience of TB, or their 
ability to take TB treatment? In what way?  
6. Do you think that this voucher has made it easier for you to take your treatment? Please 
explain.  (Prompt: Please discuss how the money is used generally - include “luxuries” such 
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as airtime, cigarettes etc. Is it used only for the index patient or also for other household 
members? Etc).  
7. Please tell me about your experience of receiving the voucher. Did everything run smoothly? 
Were there any problems you experienced? Please explain. 
8. Did anyone else know that you were receiving this voucher? How did they react when they 
heard? 
9. Do you think this voucher is worthwhile? Why/why not? 
10. Would you advise that it be given to all patients receiving TB treatment? Why/why not?  
11. What else could be done to make it easier for you to take your TB treatment? 
12. Do you have any other comments on your experience of receiving treatment at this clinic? 
(Prompting: satisfaction with the staff; opening hours of the clinic; availability of treatment 
etc.) 
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Appendix 4B: Interview guide for nurses 
You have been administering this voucher to patients for a few months now. We’d like to learn 
about your experiences with it, what you think of it, and how it can be improved.  
1. How have you found the administration of this voucher?  
a. Prompt: What things have been difficult? Please give concrete examples.   
b. Was there anything that made things run more smoothly? What has been easy?  
c. Is it getting easier or more difficult over time? Why is this so?  
 
2. How have patients reacted to the voucher?  
a. Prompt: Have patients receiving the voucher responded differently to treatment 
compared to when there was no voucher?  
b. Do you think it has attracted more patients to the clinic?  
c. Do you think it has improved patients’ adherence?  
d. What have patients said to you about the new voucher?  
e. Has it had negative effects on the patients?  
f. Has it improved the relationship between patients and the health services, or made 
it worse?  
3. Did you give the voucher to every patient with PTB, or only certain patients? If only certain 
patients, how did you choose who received it?  
4. How did you check that the patient had taken all his tablets? Did you check the green card? 
Are there any other ways in which you can check adherence?  
a. If a patient had missed some doses, did you say s/he couldn’t get the voucher? What 
happened if a patient missed an appointment or missed some time of treatment? 
Did you still give the voucher for the time missed? Did you give the voucher when 
the patient returned as usual?  
Stellenbosch University  http://scholar.sun.ac.za
283 
 
 
5. Compared with other interventions to improve adherence, such as DOTS support, how do 
you feel about this voucher? Prompt: effectiveness in improving adherence, ease of 
administration, reaction of patients etc. 
6. Are there any TB patients in your clinic receiving the disability grant for TB or HIV? Does this 
help them to take their treatment and to complete their treatment? Please explain.  
7. What support did you receive in administering this voucher? Did your management provide 
support? Did you get support from the study team?  
8. What do you think about the voucher? Do you think it is a worthwhile intervention? 
Why/why not? 
9. How could it be improved? 
10. What further support would help in administering the voucher? 
11. Do you think it should be expanded to include all clinics treating patients with TB? Why/why 
not? 
12. What other interventions might be useful in improving the adherence of patients to TB 
treatment in your clinic?  
13. Do you think it is right to pay the patient to behave in a healthy way?  
 
Additional questions asked in follow up interviews: 
 
1. Besides the vouchers do you give any other kind of support to patients at the clinic like food 
parcels, disability grant for TB, disability grant for HIV? 
2. Do you give these to everyone with TB? If not, how do you decide who should get them? Do 
you decide who should get the voucher in the same way? 
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3. How do you make sure that the patients who are getting the vouchers are actually taking 
their treatment?  
4. Do you have DOT supporters at this clinic? How many? Do the patients come here for their 
DOT support or do the DOT supporters go to the patient’s house?  
5. Did anyone ask you to give them the voucher after they had stopped the treatment, like 
when they had finished their six months? 
6. Some people say that the voucher must not be given out because patients will try to stay 
sick so that they can get the voucher for longer. Do you think that is a problem? 
7. If the department had decided to give the voucher out now to all the clinics, do you think 
there should give it to everyone with TB or just the ones who are really needy, who are poor 
and those who don’t have a job? 
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Appendix 4C: Interview guide for managers in TB Control 
Programme 
 
1. Have you been directly involved in the administration of this voucher?   
2. If so, how have you found the administration of this voucher? Prompt: What things have 
been difficult? Was there anything that made things run more smoothly? What has been 
easy? Is it getting easier or more difficult over time? Why is this so?  
3. If not, what have you heard from your staff about the administration of this voucher? 
Prompt: What things have been difficult?  Was there anything that made things run more 
smoothly? What has been easy? Is it getting easier or more difficult over time? Why is this 
so? 
4. What are your impressions of this voucher? What do you feel is good about it and what is 
not good? Please elaborate. 
5. What in your opinion are the most important challenges in delivering this voucher? Please 
explain. 
6. How could these challenges be overcome? 
7. From your perspective, how do you think the administration of this voucher could be 
improved? Please give concrete examples.   
8. Do you think the costs of offering and administering the voucher are worth the benefits? 
Please elaborate. How could these costs be reduced, if at all? 
9. How do you feel about social assistance for patients who are ill? Like the disability grant for 
TB and HIV or food parcels. Do you think it helps to promote adherence? 
10. What do you think of the most important challenges in delivering a kind of social support for 
patients with TB? 
11. What would you say about role of poverty in developing TB disease? 
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12. Do you think that research into social interventions for medical problems like TB is 
important? 
13. Do you think the voucher is a worthwhile intervention? Please explain why/why not. 
14. Do you think this voucher should be offered at all clinics to all patients with TB across the 
country? Please explain why/why not. 
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Appendix 4D: Interview guide for shop personnel 
1. How have you found the administration of this voucher? Prompt: What things have been 
difficult? Please give concrete examples.  Was there anything that made things run more 
smoothly? What has been easy? Is it getting easier or more difficult over time? Why is this 
so?  
2. How have you found the payments for the voucher from HST? Have you been paid on time, 
and the full amount? Have you experienced any other problems with payment? 
3. Can you suggest ways in which these could be improved?  
4. Do you feel you have been visited often enough and supported adequately by HST staff? If 
not, how could this support to you be improved? 
5. Have you incurred any additional costs as a result of the voucher? If so, have these been 
substantial or minor? What sort of costs are they?  
6. How has the voucher impacted on your staff at the tills? Have they found it easy or difficult 
to administer? Has their experience of the voucher changed over time (e.g. got easier as 
they became more used to doing it?) 
7. Have you had any specific problems with the patients? For example: 
a. Have most patients come themselves to redeem the voucher or have they sent 
friends or relatives to redeem it? If the latter, have you allowed the friends/relatives 
to redeem the voucher? 
b. Have patients always bought their green clinic cards with them when redeeming the 
vouchers? 
c. Have most patients bought their ID books with them to redeem the vouchers? Did 
you always ask for ID books? (note: this was not a requirement for redeeming the 
voucher as many patients do not have IDs) 
d. Do patients ask for change? If so, what do you do? 
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e. How do you ensure that the patients spend as much of the voucher as possible, to 
avoid having money left over?  
f. Have you ever intervened in patients’ purchases? i.e. have you ever asked them to 
return goods that they have chosen in favour of something else? For example, if 
patients were buying alcohol or cigarettes or some other unhealthy item, have you 
asked them to exchange it? Have you asked them to buy cheaper items instead of 
the more expensive ones they have chosen? Etc.  
 
8. Have you found that the volume of people coming through your shop has increased 
dramatically since you joined this voucher scheme?  
9. What proportion of your monthly turnover does the voucher represent? If you would prefer 
not to answer this question, could you just tell us if it is a large, medium or small proportion?  
10. How would you do this study differently, knowing what you know as a result of having 
participated?  
11. Would you be interested in continuing to participate in such a voucher programme if it was 
rolled out on a national basis? 
12. If yes, why and how would you suggest the running of the programme could be improved? If 
no, why not?  
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Appendix 5A: Questionnaire for household economic survey 
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Appendix 5B: Full table showing multivariate analysis 
 
Parameter Coefficient  Robust 
standard 
error 
z P value 95% 
confidence 
interval: 
lower limit 
95% 
confidence 
interval: 
upper 
limit 
Gender: male -.0656871    .0563807     -1.17    0.244     -.1761913     .0448172 
Age .0020533    .0027329      0.75    0.452     -.0033031     .0074097 
Education 
level: primary 
school and 
below (versus 
secondary and 
tertiary 
education) 
.0014061    .0362644      0.04    0.969     -.0696708      .072483 
Household 
location: 
informal 
settlement 
(versus 
township) 
.03689    .0829803      0.44    0.657     -.1257484     .1995284 
Household 
location: 
.8096406    .1262826      6.41    0.000      .5621312      1.05715 
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city  (versus 
township) (city 
spent more 
than 
township) 
Household 
location: rural 
area (versus 
township) 
.0629823    .1142968      0.55    0.582     -.1610354     .2869999 
Respondent 
earns money 
(versus 
respondent 
does not earn 
money)  (those 
who earned 
money spent 
more) 
-.1668177    .0411727     -4.05    0.000     -.2475146    -.0861208 
Respondent 
does not 
receive 
disability grant 
(versus 
respondent 
does receive 
disability grant) 
.0962788    .0403915      2.38    0.017       .017113     .1754447 
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(those who 
received grant 
spent more) 
Respondent 
does not 
receive child 
support grant 
(versus 
respondent 
does receive 
child support 
grant) 
-.1106019    .1155463     -0.96    0.338     -.3370685     .1158648 
Members of 
household do 
earn money 
(versus 
members of 
household do 
not earn 
money) 
-.0870196    .0474675     -1.83    0.067     -.1800542      .006015 
Members of 
household 
receive social 
grants (versus 
members of 
household do 
not receive 
grants) (those 
who received 
grants spent 
more) 
-.1284743    .0571574     -2.25    0.025     -.2405008    -.0164479 
Respondent 
does receive 
voucher# 
(versus 
respondent 
does not 
receive 
.042015    .0715954      0.59    0.557     -.0983095     .1823394 
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voucher) 
#Note that these were respondents who received at least one voucher during the trial. 
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